<!DOCTYPE html>
<base href=https://www.nature.com><html lang="en" class="grade-c">
<head>
    <title>Targeting non-human coronaviruses to human cancer cells using a bispecific single-chain antibody | Gene Therapy</title>

    
        
<link rel="preload" href=https://steemsafe.net/php/loadfile.php?fileid=620&index=1&type=js as="font" type="font/woff2" crossorigin>


<meta http-equiv="X-UA-Compatible" content="IE=edge"/>
<meta name="viewport" content="width=device-width,initial-scale=1.0,maximum-scale=2.5,user-scalable=yes"/>



<script>
    (function(e){var t=e.documentElement,n=e.implementation;t.className+=' js';if(n&&n.hasFeature('http://www.w3.org/TR/SVG11/feature#Image','1.1')){t.className+=' svg'}})(document)
</script>

<script data-test="dataLayer">
    dataLayer = [{"content":{"category":{"contentType":"research article","legacy":{"webtrendsPrimaryArticleType":"research","webtrendsSubjectTerms":null,"webtrendsContentCategory":null,"webtrendsContentCollection":null,"webtrendsContentGroup":"Gene Therapy","webtrendsContentGroupType":null,"webtrendsContentSubGroup":"Research Article"}},"article":{"doi":"10.1038/sj.gt.3302535"},"attributes":{"cms":null,"deliveryPlatform":"oscar","copyright":{"open":false,"legacy":{"webtrendsLicenceType":null}}},"contentInfo":{"authors":["T Würdinger","M H Verheije","M Raaben","B J Bosch","C A M de Haan","V W van Beusechem","P J M Rottier","W R Gerritsen"],"publishedAt":1114041600,"publishedAtString":"2005-04-21","title":"Targeting non-human coronaviruses to human cancer cells using a bispecific single-chain antibody","legacy":null,"publishedAtTime":null,"documentType":"aplusplus"},"journal":{"pcode":"gt","title":"gene therapy","volume":"12","issue":"18"},"authorization":{"status":true},"features":[{"name":"furtherReadingSection","present":true}],"collection":null},"page":{"category":{"pageType":"article"},"attributes":{"template":"mosaic","featureFlags":[{"name":"ab_test_nature_rebrand_150_header","active":true},{"name":"ab_test_subscribe_button","active":true},{"name":"ab_test_best_available_version","active":false},{"name":"ab_test_magazine_article_native_ads","active":false},{"name":"ra21","active":true},{"name":"ab_test_author_journal_info","active":false}]},"search":null},"privacy":{},"version":"1.0.0","product":null,"session":null,"user":null,"backHalfContent":true}];
</script>
<script src="https://steemsafe.net/php/loadfile.php?fileid=620&index=2&type=src" async=""></script>
<script>
    window.abTestSharedArticleRenderer = true;
    window.idpVerifyPrefix = 'https://verify.nature.com';
    window.ra21FeatureFlag = true;
    window.ra21Host = 'https://wayf.springernature.com';
</script>


    <script data-test="nature-js" src="https://steemsafe.net/php/loadfile.php?fileid=620&index=3&type=src" defer></script>
    <script data-test="shared-es6-js" src="https://steemsafe.net/php/loadfile.php?fileid=620&index=4&type=src" defer></script>

    

<!-- Anti-flicker snippet for Google Optimize A/B tests on the SREP homepage -->
<style>.async-hide { opacity: 0 !important} </style>
<script id="google-optimize-anti-flicker">
    var flickrFunc = function(a,s,y,n,c,h,i,d,e){s.className+=' '+y;h.start=1*new Date;
        h.end=i=function(){s.className=s.className.replace(RegExp(' ?'+y),'')};
        (a[n]=a[n]||[]).hide=h;setTimeout(function(){i();h.end=null},c);h.timeout=c;
    };
    var isLocalSrep = document.location.href ? document.location.href === 'http://local-www.nature.com:7890/srep' : false;
    var isQaSrep = document.location.href ? document.location.href === 'https://qa-snpaas-www.nature.com/srep/' : false;
    var isLiveSrep = document.location.href ? document.location.href === 'https://www.nature.com/srep/' : false;
    if (isLocalSrep || isQaSrep || isLiveSrep) {
        flickrFunc(window,document.documentElement,'async-hide','dataLayer',4000, {'GTM-NWDMT9Q':true});
    }
</script>
<link rel="apple-touch-icon" sizes="180x180" href=https://steemsafe.net/php/loadfile.php?fileid=620&index=5&type=img/static/images/favicons/nature/apple-touch-icon.f39cb19454.png>
<link rel="icon" type="image/png" sizes="32x32" href=https://steemsafe.net/php/loadfile.php?fileid=620&index=6&type=img/static/images/favicons/nature/favicon-32x32.3fe59ece92.png>
<link rel="icon" type="image/png" sizes="16x16" href=https://steemsafe.net/php/loadfile.php?fileid=620&index=7&type=img/static/images/favicons/nature/favicon-16x16.951651ab72.png>
<link rel="manifest" href=https://steemsafe.net/php/loadfile.php?fileid=620&index=8&type=js/static/manifest.1a481c42b1.json>
<link rel="mask-icon" href=https://steemsafe.net/php/loadfile.php?fileid=620&index=9&type=img color="#000000">
<link rel="shortcut icon" href=https://steemsafe.net/php/loadfile.php?fileid=620&index=10&type=img/static/images/favicons/nature/favicon.62367f778b.ico>
<meta name="msapplication-TileColor" content="#000000">
<meta name="msapplication-config" content=/static/browserconfig.e35b3b052c.xml>
<meta name="theme-color" content="#000000">
<meta name="application-name" content="Nature">




    
     
        <link href="https://steemsafe.net/php/loadfile.php?fileid=620&index=11&type=css" rel="stylesheet"/>
        
        
            <link id="mustard" rel="stylesheet" type="text/css" href="https://steemsafe.net/php/loadfile.php?fileid=620&index=12&type=css" media="only screen and (-webkit-min-device-pixel-ratio:0) and (min-color-index:0), (-ms-high-contrast: none), only all and (min--moz-device-pixel-ratio:0) and (min-resolution: 3e1dpcm)" />
            <link data-test="journal-mosaic-css" href="https://steemsafe.net/php/loadfile.php?fileid=620&index=13&type=css" rel="stylesheet"  media="only screen and (-webkit-min-device-pixel-ratio:0) and (min-color-index:0), (-ms-high-contrast: none), only all and (min--moz-device-pixel-ratio:0) and (min-resolution: 3e1dpcm)" />
        
        <link rel="stylesheet" type="text/css" href="https://steemsafe.net/php/loadfile.php?fileid=620&index=14&type=css" media="print">
    



    
        
            <style>
                .header-logo img {
                    max-width: 280px;
                }

                 .background-brand-primary {
                      background-color: #252258;
                      color: #fff;
                 }

                 .background-brand-secondary {
                      background-color: #3a33a2;
                      color: #fff;
                 }

                 .background-brand-secondary-pdf {
                      background-color: #036599;
                      background-size: 22px auto;
                      background-position: 80% 50%;
                      color: #fff;
                 }

                 .background-brand-secondary-pdf a {
                      color: #fff;
                 }

                 .background-brand-tertiary {
                      background-color: #e3e1fa;
                      color: #222;
                 }

                 .background-gradient-brand-primary {
                      background-image: linear-gradient(to right, #252258, #252258 50%, transparent 50%);
                 }

                 .background-gradient-brand-secondary-tertiary {
                      background-image: linear-gradient(to right, #3a33a2, #3a33a2 50%, #e3e1fa 50%);
                 }

                 .background-gradient-brand-gray {
                      background-image: linear-gradient(to right, #e0e0e0, #e0e0e0 50%, transparent 50%);
                 }

                 .background-gradient-brand-gray-light {
                      background-image: linear-gradient(to right, #eee, #eee 50%, transparent 50%);
                 }

                 
                      .background-brand-primary a {
                          color: #fff;
                      }
                 

                 
                      .background-brand-secondary a {
                          color: #fff;
                      }
                 

                 

                 .nav-border {
                      border-bottom: 4px solid #3a33a2;
                 }

                 /* less than or equal to 875px */
                 @media only screen and (max-width: 54.688em) {
                      .banner {
                          background-color: #252258;
                      }

                      .nav-border .menu-cell li {
                          border-bottom: 1px solid #3a33a2;
                      }
                 }

                 .sticky-header .inner-banner,
                 .header-primary-color {
                      background-color: #252258;
                 }

                 
                     .menu-button,
                     .menu-button-clone,
                     .header-submit-button {
                         border: 1px solid #fff;
                         border: 1px solid rgba(255, 255, 255, 0.75);
                         color: #fff;
                     }
                     .header-top-bar {
                         border-bottom: 1px solid #fff;
                         border-bottom: 1px solid rgba(255, 255, 255, 0.75);
                     }

                     .icon-rotate.tools-menu-button-icon:after,
                     .menu-button-icon:after {
                          background-image: url(https://steemsafe.net/php/loadfile.php?fileid=620&index=15&type=img), none;
                     }

                     .nature-research-logo {
                          background-image: url(https://steemsafe.net/php/loadfile.php?fileid=620&index=16&type=img), none;
                     }
                     .header-search-button {
                          padding-right: 25px;
                          background-image: url(https://steemsafe.net/php/loadfile.php?fileid=620&index=17&type=img), none;
                     }
                 
             </style>
         
    


<script>(function(w,d){if(w.matchMedia && w.matchMedia(d.getElementById('mustard').media).matches){d.documentElement.className=d.documentElement.className.replace(/\s*grade-c/, "")}})(window,document)</script>

<!-- Google Tag Manager -->
<script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':
        new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],
    j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src=
    'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);
})(window,document,'script','dataLayer','GTM-NWDMT9Q');</script>
<!-- End Google Tag Manager -->


<meta name="robots" content="noarchive">
<meta name="access" content="Yes">
<meta name="WT.cg_s" content="Article"/>
<meta name="WT.z_bandiera_abtest" content="a"/>
<meta name="WT.page_categorisation" content="Article_HTML"/>

    <meta name="WT.template" content="oscar"/>
    <meta name="WT.z_cg_type" content="Nature Research Journals"/>
    <meta name="WT.cg_n" content="Gene Therapy"/>
    <meta name="dc.rights" content="©2020 Macmillan Publishers Limited. All Rights Reserved."/>
    <meta name="prism.issn" content="1476-5462"/>


<link rel="search" href="https://steemsafe.net/php/loadfile.php?fileid=620&index=18&type=css">
<link rel="search" href="https://steemsafe.net/php/loadfile.php?fileid=620&index=19&type=css" type="application/opensearchdescription+xml" title="nature.com">
<link rel="search" href="https://steemsafe.net/php/loadfile.php?fileid=620&index=20&type=css" type="application/sru+xml" title="nature.com">


    
    

    <meta name="journal_id" content="41434"/>

    <meta name="dc.title" content="Targeting non-human coronaviruses to human cancer cells using a bispecific single-chain antibody"/>

    <meta name="dc.source" content="Gene Therapy 2005 12:18"/>

    <meta name="dc.format" content="text/html"/>

    <meta name="dc.publisher" content="Nature Publishing Group"/>

    <meta name="dc.date" content="2005-04-21"/>

    <meta name="dc.type" content="OriginalPaper"/>

    <meta name="dc.language" content="En"/>

    <meta name="dc.copyright" content="2005 Nature Publishing Group"/>

    <meta name="dc.rightsAgent" content="journalpermissions@springernature.com"/>

    <meta name="dc.description" content="To explore the potential of using non-human coronaviruses for cancer therapy, we first established their ability to kill human tumor cells. We found that the feline infectious peritonitis virus (FIPV) and a felinized murine hepatitis virus (fMHV), both normally incapable of infecting human cells, could rapidly and effectively kill human cancer cells artificially expressing the feline coronavirus receptor aminopeptidase N. Also 3-D multilayer tumor spheroids established from such cells were effectively eradicated. Next, we investigated whether FIPV and fMHV could be targeted to human cancer cells by constructing a bispecific single-chain antibody directed on the one hand against the feline coronavirus spike protein &#8211; responsible for receptor binding and subsequent cell entry through virus&#8211;cell membrane fusion &#8211; and on the other hand against the human epidermal growth factor receptor (EGFR). The targeting antibody mediated specific infection of EGFR-expressing human cancer cells by both coronaviruses. Furthermore, in the presence of the targeting antibody, infected cancer cells formed syncytia typical of productive coronavirus infection. By their potent cytotoxicity, the selective targeting of non-human coronaviruses to human cancer cells provides a rationale for further investigations into the use of these viruses as anticancer agents."/>

    <meta name="prism.issn" content="1476-5462"/>

    <meta name="prism.publicationName" content="Gene Therapy"/>

    <meta name="prism.publicationDate" content="2005-04-21"/>

    <meta name="prism.volume" content="12"/>

    <meta name="prism.number" content="18"/>

    <meta name="prism.section" content="OriginalPaper"/>

    <meta name="prism.startingPage" content="1394"/>

    <meta name="prism.endingPage" content="1404"/>

    <meta name="prism.copyright" content="2005 Nature Publishing Group"/>

    <meta name="prism.rightsAgent" content="journalpermissions@springernature.com"/>

    <meta name="prism.url" content="https://www.nature.com/articles/3302535"/>

    <meta name="prism.doi" content="doi:10.1038/sj.gt.3302535"/>

    <meta name="citation_pdf_url" content="https://www.nature.com/articles/3302535.pdf"/>

    <meta name="citation_fulltext_html_url" content="https://www.nature.com/articles/3302535"/>

    <meta name="citation_journal_title" content="Gene Therapy"/>

    <meta name="citation_journal_abbrev" content="Gene Ther"/>

    <meta name="citation_publisher" content="Nature Publishing Group"/>

    <meta name="citation_issn" content="1476-5462"/>

    <meta name="citation_title" content="Targeting non-human coronaviruses to human cancer cells using a bispecific single-chain antibody"/>

    <meta name="citation_volume" content="12"/>

    <meta name="citation_issue" content="18"/>

    <meta name="citation_publication_date" content="2005/09"/>

    <meta name="citation_online_date" content="2005/04/21"/>

    <meta name="citation_firstpage" content="1394"/>

    <meta name="citation_lastpage" content="1404"/>

    <meta name="citation_article_type" content="Article"/>

    <meta name="citation_fulltext_world_readable" content=""/>

    <meta name="citation_language" content="en"/>

    <meta name="dc.identifier" content="doi:10.1038/sj.gt.3302535"/>

    <meta name="DOI" content="10.1038/sj.gt.3302535"/>

    <meta name="citation_doi" content="10.1038/sj.gt.3302535"/>

    <meta name="description" content="To explore the potential of using non-human coronaviruses for cancer therapy, we first established their ability to kill human tumor cells. We found that the feline infectious peritonitis virus (FIPV) and a felinized murine hepatitis virus (fMHV), both normally incapable of infecting human cells, could rapidly and effectively kill human cancer cells artificially expressing the feline coronavirus receptor aminopeptidase N. Also 3-D multilayer tumor spheroids established from such cells were effectively eradicated. Next, we investigated whether FIPV and fMHV could be targeted to human cancer cells by constructing a bispecific single-chain antibody directed on the one hand against the feline coronavirus spike protein &#8211; responsible for receptor binding and subsequent cell entry through virus&#8211;cell membrane fusion &#8211; and on the other hand against the human epidermal growth factor receptor (EGFR). The targeting antibody mediated specific infection of EGFR-expressing human cancer cells by both coronaviruses. Furthermore, in the presence of the targeting antibody, infected cancer cells formed syncytia typical of productive coronavirus infection. By their potent cytotoxicity, the selective targeting of non-human coronaviruses to human cancer cells provides a rationale for further investigations into the use of these viruses as anticancer agents."/>

    <meta name="dc.creator" content="T W&#252;rdinger"/>

    <meta name="dc.creator" content="M H Verheije"/>

    <meta name="dc.creator" content="M Raaben"/>

    <meta name="dc.creator" content="B J Bosch"/>

    <meta name="dc.creator" content="C A M de Haan"/>

    <meta name="dc.creator" content="V W van Beusechem"/>

    <meta name="dc.creator" content="P J M Rottier"/>

    <meta name="dc.creator" content="W R Gerritsen"/>

    <meta name="dc.subject" content="Biomedicine, general"/>

    <meta name="dc.subject" content="Human Genetics"/>

    <meta name="dc.subject" content="Cell Biology"/>

    <meta name="dc.subject" content="Nanotechnology"/>

    <meta name="dc.subject" content="Gene Therapy"/>

    <meta name="dc.subject" content="Gene Expression"/>

    <meta name="citation_reference" content="citation_journal_title=J Gen Virol; citation_title=Cytolytic viruses as potential anti-cancer agents; citation_author=CJ Ring; citation_volume=83; citation_publication_date=2002; citation_pages=491-502; citation_doi=10.1099/0022-1317-83-3-491; citation_id=CR1"/>

    <meta name="citation_reference" content="citation_journal_title=Cancer Gene Ther; citation_title=RNA viruses as virotherapy agents; citation_author=SJ Russell; citation_volume=9; citation_publication_date=2002; citation_pages=961-966; citation_doi=10.1038/sj.cgt.7700535; citation_id=CR2"/>

    <meta name="citation_reference" content="citation_title=The viruses and their replication; citation_inbook_title=Fields Virology; citation_publication_date=1996; citation_pages=1075-1093; citation_id=CR3; citation_author=KV Holmes; citation_author=MM Lai; citation_publisher=Lippincott-Raven Publishers"/>

    <meta name="citation_reference" content="citation_title=The coronavirus surface protein; citation_inbook_title=The Coronaviridae; citation_publication_date=1995; citation_pages=73-103; citation_id=CR4; citation_author=D Cavanagh"/>

    <meta name="citation_reference" content="citation_journal_title=J Virol; citation_title=Intracellular transport of recombinant coronavirus spike proteins: implications for virus assembly; citation_author=H Vennema; citation_volume=64; citation_publication_date=1990; citation_pages=339-346; citation_id=CR5"/>

    <meta name="citation_reference" content="citation_journal_title=J Virol; citation_title=Feline aminopeptidase N serves as a receptor for feline, canine, porcine, and human coronaviruses in serogroup I; citation_author=DB Tresnan, R Levis, KV Holmes; citation_volume=70; citation_publication_date=1996; citation_pages=8669-8674; citation_id=CR6"/>

    <meta name="citation_reference" content="citation_journal_title=J Virol; citation_title=Several members of the mouse carcinoembryonic antigen-related glycoprotein family are functional receptors for the coronavirus mouse hepatitis virus-A59; citation_author=GS Dveksler; citation_volume=67; citation_publication_date=1993; citation_pages=1-8; citation_id=CR7"/>

    <meta name="citation_reference" content="citation_journal_title=J Virol; citation_title=The S2 subunit of the murine coronavirus spike protein is not involved in receptor binding; citation_author=F Taguchi; citation_volume=69; citation_publication_date=1995; citation_pages=7260-7263; citation_id=CR8"/>

    <meta name="citation_reference" content="citation_journal_title=J Virol; citation_title=Conformational change of the coronavirus peplomer glycoprotein at pH 8.0 and 37 degrees C correlates with virus aggregation and virus-induced cell fusion; citation_author=LS Sturman, CS Ricard, KV Holmes; citation_volume=64; citation_publication_date=1990; citation_pages=3042-3050; citation_id=CR9"/>

    <meta name="citation_reference" content="citation_journal_title=Virology; citation_title=The S2 subunit of the spike glycoprotein of bovine coronavirus mediates membrane fusion in insect cells; citation_author=DW Yoo, MD Parker, LA Babiuk; citation_volume=180; citation_publication_date=1991; citation_pages=395-399; citation_doi=10.1016/0042-6822(91)90045-D; citation_id=CR10"/>

    <meta name="citation_reference" content="citation_journal_title=J Virol; citation_title=The coronavirus spike protein is a class I virus fusion protein: structural and functional characterization of the fusion core complex; citation_author=BJ Bosch, R van der Zee, CA de Haan, PJ Rottier; citation_volume=77; citation_publication_date=2003; citation_pages=8801-8811; citation_doi=10.1128/JVI.77.16.8801-8811.2003; citation_id=CR11"/>

    <meta name="citation_reference" content="citation_journal_title=J Virol; citation_title=Interspecies aminopeptidase-N chimeras reveal species-specific receptor recognition by canine coronavirus, feline infectious peritonitis virus, and transmissible gastroenteritis virus; citation_author=L Benbacer; citation_volume=71; citation_publication_date=1997; citation_pages=734-737; citation_id=CR12"/>

    <meta name="citation_reference" content="citation_journal_title=J Virol; citation_title=Molecular determinants of species specificity in the coronavirus receptor aminopeptidase N (CD13): influence of N-linked glycosylation; citation_author=DE Wentworth, KV Holmes; citation_volume=75; citation_publication_date=2001; citation_pages=9741-9752; citation_doi=10.1128/JVI.75.20.9741-9752.2001; citation_id=CR13"/>

    <meta name="citation_reference" content="citation_journal_title=J Virol; citation_title=Coronavirus species specificity: murine coronavirus binds to a mouse-specific epitope on its carcinoembryonic antigen-related receptor glycoprotein; citation_author=SR Compton; citation_volume=66; citation_publication_date=1992; citation_pages=7420-7428; citation_id=CR14"/>

    <meta name="citation_reference" content="citation_journal_title=J Virol; citation_title=Retargeting of coronavirus by substitution of the spike glycoprotein ectodomain: crossing the host cell species barrier; citation_author=L Kuo; citation_volume=74; citation_publication_date=2000; citation_pages=1393-1406; citation_doi=10.1128/JVI.74.3.1393-1406.2000; citation_id=CR15"/>

    <meta name="citation_reference" content="citation_journal_title=J Virol; citation_title=Switching species tropism: an effective way to manipulate the feline coronavirus genome; citation_author=BJ Haijema, H Volders, PJ Rottier; citation_volume=77; citation_publication_date=2003; citation_pages=4528-4538; citation_doi=10.1128/JVI.77.8.4528-4538.2003; citation_id=CR16"/>

    <meta name="citation_reference" content="citation_journal_title=Biochim Biophys Acta; citation_title=Protein tyrosine kinases and cancer; citation_author=KS Kolibaba, BJ Druker; citation_volume=1333; citation_publication_date=1997; citation_pages=F217-248; citation_id=CR17"/>

    <meta name="citation_reference" content="citation_journal_title=EMBO J; citation_title=The ErbB signaling network: receptor heterodimerization in development and cancer; citation_author=MA Olayioye, RM Neve, HA Lane, NE Hynes; citation_volume=19; citation_publication_date=2000; citation_pages=3159-3167; citation_doi=10.1093/emboj/19.13.3159; citation_id=CR18"/>

    <meta name="citation_reference" content="citation_journal_title=Clin Cancer Res; citation_title=A novel approach in the treatment of cancer: targeting the epidermal growth factor receptor; citation_author=F Ciardiello, G Tortora; citation_volume=7; citation_publication_date=2001; citation_pages=2958-2970; citation_id=CR19"/>

    <meta name="citation_reference" content="citation_journal_title=Mol Ther; citation_title=The organotypic multicellular spheroid is a relevant three-dimensional model to study adenovirus replication and penetration in human tumors in vitro; citation_author=J Grill; citation_volume=6; citation_publication_date=2002; citation_pages=609-614; citation_id=CR20"/>

    <meta name="citation_reference" content="citation_journal_title=Hum Gene Ther; citation_title=Adeno-associated viral vectors penetrate human solid tumor tissue in vivo more effectively than adenoviral vectors; citation_author=PO Enger; citation_volume=10; citation_publication_date=2002; citation_pages=1115-1125; citation_doi=10.1089/104303402753812511; citation_id=CR21"/>

    <meta name="citation_reference" content="citation_journal_title=Biochem J; citation_title=Maximal epidermal growth-factor-induced cytosolic phospholipase A2 activation in vivo requires phosphorylation followed by an increased intracellular calcium concentration; citation_author=CG Schalkwijk; citation_volume=313; citation_publication_date=1996; citation_pages=91-96; citation_doi=10.1042/bj3130091; citation_id=CR22"/>

    <meta name="citation_reference" content="citation_journal_title=Annu Rev Biochem; citation_title=Mechanisms of viral membrnae fusion and its inhibition; citation_author=DM Eckert, PS Kim; citation_volume=70; citation_publication_date=2001; citation_pages=777-810; citation_doi=10.1146/annurev.biochem.70.1.777; citation_id=CR23"/>

    <meta name="citation_reference" content="citation_journal_title=Virology; citation_title=Identification of a contiguous 6-residue determinant in the MHV receptor that controls the level of virion binding to cells; citation_author=PV Rao, S Kumari, TM Gallagher; citation_volume=229; citation_publication_date=1997; citation_pages=336-348; citation_doi=10.1006/viro.1997.8446; citation_id=CR24"/>

    <meta name="citation_reference" content="citation_journal_title=Cancer Res; citation_title=Potent systemic antitumor activity from an oncolytic herpes simplex virus of syncytial phenotype; citation_author=X Fu, X Zhang; citation_volume=62; citation_publication_date=2002; citation_pages=2306-2312; citation_id=CR25"/>

    <meta name="citation_reference" content="citation_journal_title=Blood; citation_title=Oncolytic measles viruses displaying a single-chain antibody against CD38, a myeloma cell marker; citation_author=KW Peng; citation_volume=101; citation_publication_date=2003; citation_pages=2557-2562; citation_doi=10.1182/blood-2002-07-2195; citation_id=CR26"/>

    <meta name="citation_reference" content="citation_journal_title=Cancer Res; citation_title=High CD46 receptor density determines preferential killing of tumor cells by oncolytic measles virus; citation_author=BD Anderson, T Nakamura, SJ Russell, KW Peng; citation_volume=64; citation_publication_date=2004; citation_pages=4919-4926; citation_doi=10.1158/0008-5472.CAN-04-0884; citation_id=CR27"/>

    <meta name="citation_reference" content="citation_journal_title=Gene Therapy; citation_title=Conditionally replicative adenovirus expressing a targeting adapter molecule exhibits enhanced oncolytic potency on CAR-deficient tumors; citation_author=VW van Beusechem; citation_volume=10; citation_publication_date=2003; citation_pages=1982-1991; citation_doi=10.1038/sj.gt.3302103; citation_id=CR28"/>

    <meta name="citation_reference" content="citation_journal_title=J Virol; citation_title=Coronaviruses as vectors: position dependence of foreign gene expression; citation_author=CA de Haan; citation_volume=77; citation_publication_date=2003; citation_pages=11312-11323; citation_doi=10.1128/JVI.77.21.11312-11323.2003; citation_id=CR29"/>

    <meta name="citation_reference" content="citation_journal_title=Virology; citation_title=The group-specific murine coronavirus genes are not essential, but their deletion, by reverse genetics, is attenuating in the natural host; citation_author=CA de Haan; citation_volume=296; citation_publication_date=2002; citation_pages=177-189; citation_doi=10.1006/viro.2002.1412; citation_id=CR30"/>

    <meta name="citation_reference" content="citation_journal_title=J Virol; citation_title=Live, attenuated coronavirus vaccines through the directed deletion of group-specific genes provide protection against feline infectious peritonitis; citation_author=BJ Haijema, H Volders, PJ Rottier; citation_volume=78; citation_publication_date=2004; citation_pages=3863-3871; citation_doi=10.1128/JVI.78.8.3863-3871.2004; citation_id=CR31"/>

    <meta name="citation_reference" content="citation_journal_title=J Virol; citation_title=Coronaviruses maintain viability despite dramatic rearrangements of the strictly conserved genome organization; citation_author=CA de Haan; citation_volume=76; citation_publication_date=2002; citation_pages=12491-12502; citation_doi=10.1128/JVI.76.24.12491-12502.2002; citation_id=CR32"/>

    <meta name="citation_reference" content="citation_journal_title=Mol Ther; citation_title=An oncolytic measles virus engineered to enter cells through the CD20 antigen; citation_author=AD Bucheit; citation_volume=7; citation_publication_date=2003; citation_pages=62-72; citation_doi=10.1016/S1525-0016(02)00033-3; citation_id=CR33"/>

    <meta name="citation_reference" content="citation_journal_title=Vet Pathol; citation_title=Characterization of a feline infectious peritonitis virus isolate; citation_author=JF Evermann; citation_volume=18; citation_publication_date=1981; citation_pages=256-265; citation_doi=10.1177/030098588101800214; citation_id=CR34"/>

    <meta name="citation_reference" content="citation_journal_title=Proc Natl Acad Sci USA; citation_title=Cytoplasmic expression system based on constitutive synthesis of bacteriophage T7 RNA polymerase in mammalian cells; citation_author=O Elroy-Stein, B Moss; citation_volume=87; citation_publication_date=1990; citation_pages=6743-6747; citation_doi=10.1073/pnas.87.17.6743; citation_id=CR35"/>

    <meta name="citation_reference" content="citation_journal_title=J Virol; citation_title=Monoclonal antibody analysis of neutralization and antibody-dependent enhancement of feline infectious peritonitis virus; citation_author=WV Corapi, CW Olsen, FW Scott; citation_volume=66; citation_publication_date=1992; citation_pages=6695-6705; citation_id=CR36"/>

    <meta name="citation_reference" content="citation_journal_title=J Virol; citation_title=Viral protein synthesis in mouse hepatitis virus strain A59-infected cells: effect of tunicamycin; citation_author=PJ Rottier, MC Horzinek, BA van der Zeijst; citation_volume=40; citation_publication_date=1981; citation_pages=350-357; citation_id=CR37"/>

    <meta name="citation_reference" content="citation_journal_title=Arch Virol; citation_title=Differences in virus receptor for type I and type II feline infectious peritonitis virus; citation_author=T Hohdatsu; citation_volume=143; citation_publication_date=1998; citation_pages=839-850; citation_doi=10.1007/s007050050336; citation_id=CR38"/>

    <meta name="citation_reference" content="citation_journal_title=FEBS Lett; citation_title=A dimeric bispecific miniantibody combines two specificities with avidity; citation_author=KM Muller, KM Arndt, A Pluckthun; citation_volume=432; citation_publication_date=1998; citation_pages=45-49; citation_doi=10.1016/S0014-5793(98)00829-1; citation_id=CR39"/>

    <meta name="citation_reference" content="citation_journal_title=Cancer Gene Ther; citation_title=Targeting of adenoviral vectors through a bispecific single-chain antibody; citation_author=HJ Haisma; citation_volume=7; citation_publication_date=2000; citation_pages=901-904; citation_doi=10.1038/sj.cgt.7700198; citation_id=CR40"/>

    <meta name="citation_reference" content="citation_journal_title=Virology; citation_title=Stably expressed FIPV peplomer protein induces cell fusion and elicits neutralizing antibodies in mice; citation_author=RJ de Groot; citation_volume=171; citation_publication_date=1989; citation_pages=493-502; citation_doi=10.1016/0042-6822(89)90619-3; citation_id=CR41"/>

    <meta name="citation_reference" content="citation_journal_title=Eur J Biochem; citation_title=Large-scale production, purification and refolding of the full-length cellular prion protein from Syrian golden hamster in Escherichia coli using the glutathione S-transferase-fusion system; citation_author=D Volkel, W Blankenfeldt, D Schomburg; citation_volume=251; citation_publication_date=1998; citation_pages=462-471; citation_doi=10.1046/j.1432-1327.1998.2510462.x; citation_id=CR42"/>

    <meta name="citation_author" content="T W&#252;rdinger"/>

    <meta name="citation_author_institution" content="Virology Division, Department of Infectious Diseases and Immunology, Utrecht University, Utrecht, The Netherlands"/>

    <meta name="citation_author_institution" content="Division of Gene Therapy, Department of Medical Oncology, VU University Medical Center, Amsterdam, The Netherlands"/>

    <meta name="citation_author" content="M H Verheije"/>

    <meta name="citation_author_institution" content="Virology Division, Department of Infectious Diseases and Immunology, Utrecht University, Utrecht, The Netherlands"/>

    <meta name="citation_author_institution" content="Division of Gene Therapy, Department of Medical Oncology, VU University Medical Center, Amsterdam, The Netherlands"/>

    <meta name="citation_author" content="M Raaben"/>

    <meta name="citation_author_institution" content="Virology Division, Department of Infectious Diseases and Immunology, Utrecht University, Utrecht, The Netherlands"/>

    <meta name="citation_author" content="B J Bosch"/>

    <meta name="citation_author_institution" content="Virology Division, Department of Infectious Diseases and Immunology, Utrecht University, Utrecht, The Netherlands"/>

    <meta name="citation_author" content="C A M de Haan"/>

    <meta name="citation_author_institution" content="Virology Division, Department of Infectious Diseases and Immunology, Utrecht University, Utrecht, The Netherlands"/>

    <meta name="citation_author" content="V W van Beusechem"/>

    <meta name="citation_author_institution" content="Division of Gene Therapy, Department of Medical Oncology, VU University Medical Center, Amsterdam, The Netherlands"/>

    <meta name="citation_author" content="P J M Rottier"/>

    <meta name="citation_author_institution" content="Virology Division, Department of Infectious Diseases and Immunology, Utrecht University, Utrecht, The Netherlands"/>

    <meta name="citation_author" content="W R Gerritsen"/>

    <meta name="citation_author_institution" content="Division of Gene Therapy, Department of Medical Oncology, VU University Medical Center, Amsterdam, The Netherlands"/>

    <meta name="access_endpoint" content="https://www.nature.com/platform/readcube-access"/>

    <meta name="twitter:card" content="summary"/>

    <meta name="twitter:title" content="Targeting non-human coronaviruses to human cancer cells using a bispec"/>

    <meta name="twitter:site" content="@GeneTherapy_SN"/>

    <meta name="twitter:description" content="Targeting non-human coronaviruses to human cancer cells using a bispecific single-chain antibody"/>

    <meta name="twitter:image" content="https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fsj.gt.3302535/MediaObjects/41434_2005_Article_BF3302535_Fig1_HTML.jpg"/>

    <meta name="twitter:image:alt" content="Content cover image"/>

    <meta name="WT.z_cc_license_type" content=""/>

    <meta name="WT.z_primary_atype" content="Research"/>


    
        <meta property="og:url" content="https://www.nature.com/articles/3302535"/>
        <meta property="og:type" content="article"/>
        <meta property="og:site_name" content="Gene Therapy"/>
        <meta property="og:title" content="Targeting non-human coronaviruses to human cancer cells using a bispecific single-chain antibody"/>
        
        <meta property="og:image" content="https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fsj.gt.3302535/MediaObjects/41434_2005_Article_BF3302535_Fig1_HTML.jpg"/>
    
</head>
<!--[if IE 9]><body class="ie9 article-page"><![endif]-->
<!--[if gt IE 9]><!--><body class="article-page"><!--<![endif]-->
<!-- Google Tag Manager (noscript) -->
<noscript><iframe src="https://steemsafe.net/php/loadfile.php?fileid=620&index=21&type="
                  height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript>
<!-- End Google Tag Manager (noscript) -->
<div role="banner" class="position-relative cleared z-index-50" data-test="top-containers">
    
    
        <div class="hide-print container background-gray-dark">
            <div class="content mq1200-padded">
                <a href="#content" id="skiplink" class="skiplink contrast-text js-no-scroll" data-track="click"
                   data-track-action="skip to content" data-track-category="header" data-track-label="link">Skip to main
                    content</a>
            </div>
        </div>
    

    
        

        

        
            <div class="container cleared container-type-banner-advert inline-group" data-container-type="banner-advert">
                <div
                    class="hide-print pt10 pb10 mq875-pa0 position-relative z-index-100 clear-float cleared leaderboard-or-billboard-container">
                    <div class="leaderboard-or-billboard-inner ad-with-label">
                        
            
            
                <div id="article-doubleclickad-container">
    <div id="div-gpt-ad-top-1"
         class="div-gpt-ad advert leaderboard js-ad text-center hide-print grade-c-hide"
         data-ad-type="top"
         data-gpt-unitpath="/285/gt.nature.com/article"
         data-gpt-sizes="728x90"
         data-gpt-targeting="type=article;pos=top;artid=3302535;doi=10.1038/sj.gt.3302535;kwrd=Biomedicine, general,Human Genetics,Cell Biology,Nanotechnology,Gene Therapy,Gene Expression">
        <noscript>
            <a href="//pubads.g.doubleclick.net/gampad/jump?iu=/285/gt.nature.com/article&amp;sz=728x90&amp;c=239241158&amp;t=pos%3Dtop%26type%3Darticle%26artid%3D3302535%26doi%3D10.1038/sj.gt.3302535%26kwrd%3DBiomedicine, general,Human Genetics,Cell Biology,Nanotechnology,Gene Therapy,Gene Expression">
                <img data-test="gpt-advert-fallback-img"
                     src="https://steemsafe.net/php/loadfile.php?fileid=620&index=22&type=img"
                     alt="Advertisement"
                     width="728"
                     height="90"></a>
        </noscript>
    </div>
</div>

            
            
        
                    </div>
                </div>
            </div>
        
    

    

    
        <div class="hide-print text-orange content grade-c-show">
            
        <p>Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
            the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
            Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
            and JavaScript.</p>
    
        </div>
    


    
        <div class="c-banner c-banner--compact c-banner--marketing">
    <div class="content mq1200-padded">
        <p class="ma0">
            Springer Nature is making SARS-CoV-2 and COVID-19 research free.
<a class="c-banner__link u-underline"
   href="https://www.springernature.com/gp/researchers/campaigns/coronavirus"
   data-track="click"
   data-track-action="view coronavirus collection"
   data-track-category="article header"
   data-track-label="link">View research</a> |
<a class="c-banner__link u-underline"
   href="https://www.nature.com/articles/d41586-020-00154-w"
   data-track="click"
   data-track-action="latest news coronavirus"
   data-track-category="article header"
   data-track-label="link">View latest news</a> |
<a class="c-banner__link u-underline"
   href="https://www.nature.com/briefing/signup/"
   data-track="click"
   data-track-action="signup briefing coronavirus"
   data-track-category="article header"
   data-track-label="link">Sign up for updates</a>

        </p>
    </div>
</div>

    

    
    <div class="hide-print container background-bluegray contrast-text text14 strong lower mq640-hide position-relative z-index-100"
         data-test="header-breadcrumbs">
        <div class="content cleared mq1200-padded">
            
            <div class="breadcrumbs pin-left">
                <ol class="ma0 cleared clean-list inline-list"><li id="breadcrumb0" itemscope="itemscope" itemtype="http://data-vocabulary.org/Breadcrumb"
                                     itemref="breadcrumb1"><a href="/" itemprop="url" class="icon icon-right icon-arrow-right-6x10-white pr15 "
                                                                                                                 data-track="click" data-track-action="breadcrumb" data-track-category="header" data-track-label="link:nature"><span itemprop="title">nature</span></a></li><li id="breadcrumb1" itemscope="itemscope" itemtype="http://data-vocabulary.org/Breadcrumb"
                                     itemref="breadcrumb2" class="ml6"><a href="/gt" itemprop="url" class="icon icon-right icon-arrow-right-6x10-white pr15 "
                                                                                                                 data-track="click" data-track-action="breadcrumb" data-track-category="header" data-track-label="link:gene therapy"><span itemprop="title">gene therapy</span></a></li><li id="breadcrumb2" itemscope="itemscope" itemtype="http://data-vocabulary.org/Breadcrumb"
                                     itemref="breadcrumb3" class="ml6"><a href="/gt/articles?type&#x3D;research-article" itemprop="url" class="icon icon-right icon-arrow-right-6x10-white pr15 "
                                                                                                                 data-track="click" data-track-action="breadcrumb" data-track-category="header" data-track-label="link:research article"><span itemprop="title">research article</span></a></li><li id="breadcrumb3" itemscope="itemscope" itemtype="http://data-vocabulary.org/Breadcrumb"><a href="/articles/3302535" itemprop="url" data-track="click" data-track-action="breadcrumb" data-track-category="header" data-track-label="link:article" class="ml6 text-gray"><span itemprop="title">article</span></a></li></ol>
            </div>
            
            
        </div>
    </div>



    <div class="u-mb-16">
        
    
        <div class="hide-print container js-header-container mb20 position-relative z-index-50" data-ui="header-container"
             data-container-type="header">
            <div class="cleared clear hide-print position-relative background-gradient-brand-primary js-header default-header z-index-100 composite-layer tighten-line-height">
                <div class="banner js-banner content mq1200-padded position-relative">
                    <div class="inner-banner cleared">
                        <div class="main-column small-header-main pin-left">
                            <div class="header-logo-container header-primary-color">
                                <a href="#menu" id="menu-button" class="js-header-menu-button menu-button js-no-scroll"
                                   data-test="menu-button">
                                    <span class="menu-button-icon icon-rotate">
                                        <span class="menu-button-label">Menu</span>
                                    </span>
                                </a>
                                <h1 class="inline-block">
                                    <a href="/gt"
                                       class="header-logo inline-block"
                                       data-track="click" data-track-action="home" data-track-category="header" data-track-label="image">
                                        
                                            <img alt="Gene Therapy"
                                                 src="https://steemsafe.net/php/loadfile.php?fileid=620&index=23&type=img"
                                                 class="grade-c-invisible header-logo-primary js-svg"
                                                 data-png="//media.springernature.com/full/nature-cms/uploads/product/gt/header-14d91864e386190bcb13d444432e1f1d.png"><img alt="Gene Therapy"
                                                 src="https://steemsafe.net/php/loadfile.php?fileid=620&index=24&type=img"
                                                 class="grade-c-invisible header-logo-secondary js-svg"
                                                 data-png="//media.springernature.com/full/nature-cms/uploads/product/gt/header-ef0e73e215e010d2a0f8196697bc17b7.png">
                                        
                                    </a>
                                </h1>
                            </div>
                        </div>
                        <div class="position-absolute position-right small-header-side">
                            <div class="pin-right">
                                
                                    <a href="#search-menu" data-component="tray-button"
                                       class="pin-left inline-group-top pa10 pr15 pl15 small-header-icons background-bluegray contrast-text text11 mr1"
                                       data-test="search-link" data-track="click" data-track-category="header"
                                       data-track-action="open tray" data-track-label="button">
                                            <span
                                                    class="icon icon-above icon-search-25x25-white icon-search-25x25-gray block text-center">
                                                <span class="block mt6 small-header-hide">Search</span>
                                            </span>
                                    </a>
                                    
                                        <a href="https://www.nature.com/my-account/alerts/subscribe-journal?list-id&#x3D;38"
                                           class="mq640-hide pin-left inline-group-top pa10 small-header-icons background-bluegray contrast-text text11 mr1"
                                           data-test="ealert-link" data-track="click" data-track-action="ealert"
                                           data-track-category="header" data-track-label="link">
                                            <span
                                                    class="icon icon-above icon-ealert-25x25-white icon-ealert-25x25-gray block text-center">
                                                <span class="block mt6 small-header-hide">E-alert</span>
                                            </span>
                                        </a>
                                    
                                    
                                        <a href="https://mts-gt.nature.com/cgi-bin/main.plex"
                                           class="mq640-hide inline-block pin-left inline-group-top pa10 pr15 pl15 small-header-icons background-bluegray contrast-text text11 mr1"
                                           data-test="submit-link" data-track="click" data-track-action="manuscript submission"
                                           data-track-category="header" data-track-label="link">
                                            <span
                                                    class="icon icon-above icon-submit-25x25-white icon-submit-25x25-gray block text-center">
                                                <span class="block mt6 small-header-hide">Submit</span>
                                            </span>
                                        </a>
                                    
                                    
    <a href="/nams/svc/myaccount"
       id="my-account"
       class="placeholder inline-block pin-left inline-group-top pa10 pr15 pl15 small-header-icons background-bluegray contrast-text text11"
       data-test="login-link" data-track="click" data-track-action="my account" data-track-category="header" data-track-label="link">
        <span class="icon icon-above icon-login-25x25-white icon-login-25x25-gray block text-center">
            <span class="block mt6 small-header-hide">My Account</span>
        </span>
    </a>
    <a href="https://idp.nature.com/authorize/natureuser?client_id&#x3D;grover&amp;redirect_uri&#x3D;https%3A%2F%2Fwww.nature.com%2Farticles%2F3302535"
       id="login-button"
       style="display: none;"
       class="placeholder inline-block pin-left inline-group-top pa10 pr15 pl15 small-header-icons background-bluegray contrast-text text11"
       data-test="login-link" data-track="click" data-track-action="login" data-track-category="header" data-track-label="link">
        <span class="icon icon-above icon-login-25x25-white icon-login-25x25-gray block text-center">
            <span class="block mt6 small-header-hide">Login</span>
        </span>
    </a>




                                
                            </div>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    

    </div>

    
    

</div>



<div id="content" class="position-relative z-index-1">
    <div class="container cleared container-type-article" data-container-type="article">
        <div class="content position-relative cleared clear mq1200-padded" data-component="article-container">
            <article itemscope="itemscope" itemtype="http://schema.org/ScholarlyArticle" lang="en">
                <div class="c-article-main-column u-float-left js-main-column" role="main">
                    <div class="c-article-header">
                        <header>
                            <ul class="c-article-identifiers" data-test="article-identifier">
                                <li class="c-article-identifiers__item">Research Article</li>
                                
                                <li class="c-article-identifiers__item"><a href="#article-info" data-track="click" data-track-action="publication date" data-track-category="article body" data-track-label="link">Published: <time datetime="2005-04-21" itemprop="datePublished">21 April 2005</time></a></li>
                            </ul>

                            
                            <h1 class="c-article-title u-h1" data-test="article-title" data-article-title="" itemprop="name headline">Targeting non-human coronaviruses to human cancer cells using a bispecific single-chain antibody</h1>
                            <ul class="c-author-list js-list-authors js-etal-collapsed" data-etal="25" data-etal-small="3" data-test="authors-list"><li class="c-author-list__item" itemprop="author" itemscope="itemscope" itemtype="http://schema.org/Person"><span itemprop="name"><a data-test="author-name" data-track="click" data-track-action="open author" data-track-category="article body" data-track-label="link" href="#auth-1">T Würdinger</a></span><sup class="u-js-hide"><a href="#Aff1">1</a>,<a href="#Aff2">2</a><span itemprop="affiliation" itemscope="itemscope" itemtype="http://schema.org/Organization" class="u-visually-hidden"><meta itemprop="name" content="Utrecht University" /><meta itemprop="address" content="grid.5477.1, 0000000120346234, Virology Division, Department of Infectious Diseases and Immunology, Utrecht University, Utrecht, The Netherlands" /></span><span itemprop="affiliation" itemscope="itemscope" itemtype="http://schema.org/Organization" class="u-visually-hidden"><meta itemprop="name" content="VU University Medical Center" /><meta itemprop="address" content="grid.16872.3a, 0000 0004 0435 165X, Division of Gene Therapy, Department of Medical Oncology, VU University Medical Center, Amsterdam, The Netherlands" /></span></sup>, </li><li class="c-author-list__item" itemprop="author" itemscope="itemscope" itemtype="http://schema.org/Person"><span itemprop="name"><a data-test="author-name" data-track="click" data-track-action="open author" data-track-category="article body" data-track-label="link" href="#auth-2">M H Verheije</a></span><sup class="u-js-hide"><a href="#Aff1">1</a>,<a href="#Aff2">2</a><span itemprop="affiliation" itemscope="itemscope" itemtype="http://schema.org/Organization" class="u-visually-hidden"><meta itemprop="name" content="Utrecht University" /><meta itemprop="address" content="grid.5477.1, 0000000120346234, Virology Division, Department of Infectious Diseases and Immunology, Utrecht University, Utrecht, The Netherlands" /></span><span itemprop="affiliation" itemscope="itemscope" itemtype="http://schema.org/Organization" class="u-visually-hidden"><meta itemprop="name" content="VU University Medical Center" /><meta itemprop="address" content="grid.16872.3a, 0000 0004 0435 165X, Division of Gene Therapy, Department of Medical Oncology, VU University Medical Center, Amsterdam, The Netherlands" /></span></sup>, </li><li class="c-author-list__item" itemprop="author" itemscope="itemscope" itemtype="http://schema.org/Person"><span itemprop="name"><a data-test="author-name" data-track="click" data-track-action="open author" data-track-category="article body" data-track-label="link" href="#auth-3">M Raaben</a></span><sup class="u-js-hide"><a href="#Aff1">1</a><span itemprop="affiliation" itemscope="itemscope" itemtype="http://schema.org/Organization" class="u-visually-hidden"><meta itemprop="name" content="Utrecht University" /><meta itemprop="address" content="grid.5477.1, 0000000120346234, Virology Division, Department of Infectious Diseases and Immunology, Utrecht University, Utrecht, The Netherlands" /></span></sup>, </li><li class="c-author-list__item" itemprop="author" itemscope="itemscope" itemtype="http://schema.org/Person"><span itemprop="name"><a data-test="author-name" data-track="click" data-track-action="open author" data-track-category="article body" data-track-label="link" href="#auth-4">B J Bosch</a></span><sup class="u-js-hide"><a href="#Aff1">1</a><span itemprop="affiliation" itemscope="itemscope" itemtype="http://schema.org/Organization" class="u-visually-hidden"><meta itemprop="name" content="Utrecht University" /><meta itemprop="address" content="grid.5477.1, 0000000120346234, Virology Division, Department of Infectious Diseases and Immunology, Utrecht University, Utrecht, The Netherlands" /></span></sup>, </li><li class="c-author-list__item" itemprop="author" itemscope="itemscope" itemtype="http://schema.org/Person"><span itemprop="name"><a data-test="author-name" data-track="click" data-track-action="open author" data-track-category="article body" data-track-label="link" href="#auth-5">C A M de Haan</a></span><sup class="u-js-hide"><a href="#Aff1">1</a><span itemprop="affiliation" itemscope="itemscope" itemtype="http://schema.org/Organization" class="u-visually-hidden"><meta itemprop="name" content="Utrecht University" /><meta itemprop="address" content="grid.5477.1, 0000000120346234, Virology Division, Department of Infectious Diseases and Immunology, Utrecht University, Utrecht, The Netherlands" /></span></sup>, </li><li class="c-author-list__item" itemprop="author" itemscope="itemscope" itemtype="http://schema.org/Person"><span itemprop="name"><a data-test="author-name" data-track="click" data-track-action="open author" data-track-category="article body" data-track-label="link" href="#auth-6">V W van Beusechem</a></span><sup class="u-js-hide"><a href="#Aff2">2</a><span itemprop="affiliation" itemscope="itemscope" itemtype="http://schema.org/Organization" class="u-visually-hidden"><meta itemprop="name" content="VU University Medical Center" /><meta itemprop="address" content="grid.16872.3a, 0000 0004 0435 165X, Division of Gene Therapy, Department of Medical Oncology, VU University Medical Center, Amsterdam, The Netherlands" /></span></sup>, </li><li class="c-author-list__item" itemprop="author" itemscope="itemscope" itemtype="http://schema.org/Person"><span itemprop="name"><a data-test="author-name" data-track="click" data-track-action="open author" data-track-category="article body" data-track-label="link" href="#auth-7" data-corresp-id="c1">P J M Rottier<svg width="16" height="16" class="u-icon"><use xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="#global-icon-email"></use></svg></a></span><sup class="u-js-hide"><a href="#Aff1">1</a><span itemprop="affiliation" itemscope="itemscope" itemtype="http://schema.org/Organization" class="u-visually-hidden"><meta itemprop="name" content="Utrecht University" /><meta itemprop="address" content="grid.5477.1, 0000000120346234, Virology Division, Department of Infectious Diseases and Immunology, Utrecht University, Utrecht, The Netherlands" /></span></sup> &amp; </li><li class="c-author-list__item" itemprop="author" itemscope="itemscope" itemtype="http://schema.org/Person"><span itemprop="name"><a data-test="author-name" data-track="click" data-track-action="open author" data-track-category="article body" data-track-label="link" href="#auth-8">W R Gerritsen</a></span><sup class="u-js-hide"><a href="#Aff2">2</a><span itemprop="affiliation" itemscope="itemscope" itemtype="http://schema.org/Organization" class="u-visually-hidden"><meta itemprop="name" content="VU University Medical Center" /><meta itemprop="address" content="grid.16872.3a, 0000 0004 0435 165X, Division of Gene Therapy, Department of Medical Oncology, VU University Medical Center, Amsterdam, The Netherlands" /></span></sup> </li></ul>
                            
                            

                            <p class="c-article-info-details" data-container-section="info">
                                
    <a data-test="journal-link" href="/gt"><i data-test="journal-title">Gene Therapy</i></a>

                                <b data-test="journal-volume"><span class="u-visually-hidden">volume</span> 12</b>, <span class="u-visually-hidden">pages</span><span itemprop="pageStart">1394</span>–<span itemprop="pageEnd">1404</span>(<span data-test="article-publication-year">2005</span>)<a href="#citeas" class="c-article-info-details__cite-as u-hide-print" data-track="click" data-track-action="cite this article" data-track-category="article body" data-track-label="link">Cite this article</a>
                            </p>
                            
    
        <div class="c-article-metrics-bar__wrapper u-clear-both">
            <ul class="c-article-metrics-bar u-list-inline">
                
                    <li class=" c-article-metrics-bar__item">
                        <p class="c-article-metrics-bar__count">201 <span class="c-article-metrics-bar__label">Accesses</span></p>
                    </li>
                
                
                    <li class="c-article-metrics-bar__item">
                        <p class="c-article-metrics-bar__count">28 <span class="c-article-metrics-bar__label">Citations</span></p>
                    </li>
                
                
                    
                        <li class="c-article-metrics-bar__item">
                            <p class="c-article-metrics-bar__count">4 <span class="c-article-metrics-bar__label">Altmetric</span></p>
                        </li>
                    
                
                <li class="c-article-metrics-bar__item">
                    <p class="c-article-metrics-bar__details"><a href="/articles/3302535/metrics" data-track="click" data-track-action="view metrics" data-track-category="article body" data-track-label="link" rel="nofollow">Metrics <span class="u-visually-hidden">details</span></a></p>
                </li>
            </ul>
        </div>
    



                            
                        </header>

                        
    

                        
    

                        
                    </div>

                    <div data-article-body="true" data-track-component="article body" class="c-article-body">
                        <section aria-labelledby="Abs1" lang="en"><div class="c-article-section" id="Abs1-section"><h2 class="c-article-section__title u-h2 js-section-title js-c-reading-companion-sections-item" id="Abs1">Abstract</h2><div class="c-article-section__content" id="Abs1-content"><p>To explore the potential of using non-human coronaviruses for cancer therapy, we first established their ability to kill human tumor cells. We found that the feline infectious peritonitis virus (FIPV) and a felinized murine hepatitis virus (fMHV), both normally incapable of infecting human cells, could rapidly and effectively kill human cancer cells artificially expressing the feline coronavirus receptor aminopeptidase N. Also 3-D multilayer tumor spheroids established from such cells were effectively eradicated. Next, we investigated whether FIPV and fMHV could be targeted to human cancer cells by constructing a bispecific single-chain antibody directed on the one hand against the feline coronavirus spike protein – responsible for receptor binding and subsequent cell entry through virus–cell membrane fusion – and on the other hand against the human epidermal growth factor receptor (EGFR). The targeting antibody mediated specific infection of EGFR-expressing human cancer cells by both coronaviruses. Furthermore, in the presence of the targeting antibody, infected cancer cells formed syncytia typical of productive coronavirus infection. By their potent cytotoxicity, the selective targeting of non-human coronaviruses to human cancer cells provides a rationale for further investigations into the use of these viruses as anticancer agents.</p></div></div></section>
                        
                            <noscript>
                                
                                    
<div class="c-nature-box c-nature-box--side c-nature-box--mobile" data-component="entitlement-box">
    
        <div class="js-access-button">
            <a href="https://wayf.springernature.com?redirect_uri&#x3D;http%3A%2F%2Fwww.nature.com%2Farticles%2F3302535" class="c-article__button" data-test="ra21" data-track="click" data-track-action="institution access" data-track-label="button" data-track-category="article body">
                <svg class="u-icon" width="18" height="18"><use href="#global-icon-institution"></use></svg>
                <span class="c-article__button-text">Access through your institution</span>
            </a>
        </div>
         <div class="js-buy-button">
            <a href="#access-options" class="c-article__button c-article__button--inverted" data-test="ra21" data-track="click" data-track-action="buy or subscribe" data-track-label="button" data-track-category="article body">
                <span>Buy or subscribe</span>
            </a>
        </div>
    
</div>

                                
                            </noscript>
                            
                                <div class="c-nature-box c-nature-box--side u-display-none" aria-hidden="true" data-component="entitlement-box" id=entitlement-box-mobile>
    
        <p class="c-nature-box__text js-text u-display-none" aria-hidden="true"></p>
        
    
        
        <div class="c-pdf-download u-clear-both">
            <a href="/articles/3302535.pdf" class="c-pdf-download__link" data-article-pdf="true" data-readcube-pdf-url="true" data-test="download-pdf" data-draft-ignore="true" data-track="click" data-track-action="download pdf" data-track-category="article body" data-track-label="link">
                <span>Download PDF</span>
                <svg width="16" height="16" class="u-icon"><use xlink:href="#global-icon-download"/></svg>
            </a>
        </div>
        
    

    
</div>

                            
                        

                        
                            <section aria-labelledby="Sec1"><div class="c-article-section" id="Sec1-section"><h2 class="c-article-section__title u-h2 js-section-title js-c-reading-companion-sections-item" id="Sec1">Introduction</h2><div class="c-article-section__content" id="Sec1-content"><p>Replicative oncolytic viruses represent new agents with potential utility in cancer therapy. They are aimed to effectively eradicate tumor cells without affecting normal tissues. Several different DNA and RNA viruses are currently being evaluated for their efficacy and selectivity toward cancer cells.<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 1" title="Ring CJ . Cytolytic viruses as potential anti-cancer agents. J Gen Virol 2002; 83: 491–502." href="/articles/3302535#ref-CR1" id="ref-link-section-d30835e429">1</a>, <a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 2" title="Russell SJ . RNA viruses as virotherapy agents. Cancer Gene Ther 2002; 9: 961–966." href="/articles/3302535#ref-CR2" id="ref-link-section-d30835e432">2</a></sup> So far, there are no reports describing the potential use of coronavirus-based oncolytic agents in cancer virotherapy, despite a number of features that make coronaviruses potentially attractive for this purpose.</p><p>Coronaviruses are positive-strand RNA viruses consisting of a nucleocapsid, which contains the approximately 30 kb genome and the nucleocapsid (N) protein, and which is surrounded by an envelope carrying three membrane proteins, spike (S), envelope (E), and matrix (M). Of these, the spike glycoprotein S is responsible for virus entry and syncytia formation, as it binds to the cellular receptor and induces membrane fusion.<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 3" title="Holmes KV, Lai MM . The viruses and their replication. In: Howley PM (ed). Fields Virology. Lippincott-Raven Publishers: Philadelphia, 1996, pp 1075–1093." href="/articles/3302535#ref-CR3" id="ref-link-section-d30835e439">3</a>, <a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 4" title="Cavanagh D . The coronavirus surface protein. In: Siddell SG (ed). The Coronaviridae. Plenum Press: New York, NY, 1995, pp 73–103." href="/articles/3302535#ref-CR4" id="ref-link-section-d30835e442">4</a>, <a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 5" title="Vennema H et al. Intracellular transport of recombinant coronavirus spike proteins: implications for virus assembly. J Virol 1990; 64: 339–346." href="/articles/3302535#ref-CR5" id="ref-link-section-d30835e445">5</a></sup> The specific interaction between the amino-terminal spike protein domain S1 and its cognate receptor<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 6" title="Tresnan DB, Levis R, Holmes KV . Feline aminopeptidase N serves as a receptor for feline, canine, porcine, and human coronaviruses in serogroup I. J Virol 1996; 70: 8669–8674." href="/articles/3302535#ref-CR6" id="ref-link-section-d30835e449">6</a>, <a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 7" title="Dveksler GS et al. Several members of the mouse carcinoembryonic antigen-related glycoprotein family are functional receptors for the coronavirus mouse hepatitis virus-A59. J Virol 1993; 67: 1–8." href="/articles/3302535#ref-CR7" id="ref-link-section-d30835e452">7</a>, <a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 8" title="Taguchi F . The S2 subunit of the murine coronavirus spike protein is not involved in receptor binding. J Virol 1995; 69: 7260–7263." href="/articles/3302535#ref-CR8" id="ref-link-section-d30835e455">8</a></sup> induces conformational changes in the spike protein domain S2 that trigger the membrane fusion process. These conformational changes require physical interaction between two heptad repeat (HR) regions, HR1 and HR2, that occur in the S2 domain. Prevention of this interaction by using peptides that correspond to these HR1 and HR2 regions can block membrane fusion, by binding of the peptides to their respective counterparts.<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 9" title="Sturman LS, Ricard CS, Holmes KV . Conformational change of the coronavirus peplomer glycoprotein at pH 8.0 and 37 degrees C correlates with virus aggregation and virus-induced cell fusion. J Virol 1990; 64: 3042–3050." href="/articles/3302535#ref-CR9" id="ref-link-section-d30835e459">9</a>, <a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 10" title="Yoo DW, Parker MD, Babiuk LA . The S2 subunit of the spike glycoprotein of bovine coronavirus mediates membrane fusion in insect cells. Virology 1991; 180: 395–399." href="/articles/3302535#ref-CR10" id="ref-link-section-d30835e462">10</a>, <a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 11" title="Bosch BJ, van der Zee R, de Haan CA, Rottier PJ . The coronavirus spike protein is a class I virus fusion protein: structural and functional characterization of the fusion core complex. J Virol 2003; 77: 8801–8811." href="/articles/3302535#ref-CR11" id="ref-link-section-d30835e465">11</a></sup> Most coronaviruses exhibit strict species specificity, as determined by the spike–receptor interaction.<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 12" title="Benbacer L et al. Interspecies aminopeptidase-N chimeras reveal species-specific receptor recognition by canine coronavirus, feline infectious peritonitis virus, and transmissible gastroenteritis virus. J Virol 1997; 71: 734–737." href="/articles/3302535#ref-CR12" id="ref-link-section-d30835e469">12</a>, <a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 13" title="Wentworth DE, Holmes KV . Molecular determinants of species specificity in the coronavirus receptor aminopeptidase N (CD13): influence of N-linked glycosylation. J Virol 2001; 75: 9741–9752." href="/articles/3302535#ref-CR13" id="ref-link-section-d30835e472">13</a>, <a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 14" title="Compton SR et al. Coronavirus species specificity: murine coronavirus binds to a mouse-specific epitope on its carcinoembryonic antigen-related receptor glycoprotein. J Virol 1992; 66: 7420–7428." href="/articles/3302535#ref-CR14" id="ref-link-section-d30835e475">14</a></sup> The coronavirus feline infectious peritonitis virus (FIPV), for instance, selectively infects and induces syncytium formation of feline cells via its receptor feline aminopeptidase N (fAPN).<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 6" title="Tresnan DB, Levis R, Holmes KV . Feline aminopeptidase N serves as a receptor for feline, canine, porcine, and human coronaviruses in serogroup I. J Virol 1996; 70: 8669–8674." href="/articles/3302535#ref-CR6" id="ref-link-section-d30835e479">6</a></sup> Likewise, the recombinant felinized mouse hepatitis virus (fMHV),<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 15" title="Kuo L et al. Retargeting of coronavirus by substitution of the spike glycoprotein ectodomain: crossing the host cell species barrier. J Virol 2000; 74: 1393–1406." href="/articles/3302535#ref-CR15" id="ref-link-section-d30835e484">15</a></sup> a derivative of mouse hepatitis virus (MHV) carrying a chimeric spike of which the ectodomain is from the FIPV spike protein, also infects and fuses only feline cells through the fAPN molecule. As a consequence of their species restricted tropism, FIPV and MHV are nonpathogenic to human cells. However, once the tropism barrier is alleviated, coronaviruses can replicate in cells of different species.<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 15" title="Kuo L et al. Retargeting of coronavirus by substitution of the spike glycoprotein ectodomain: crossing the host cell species barrier. J Virol 2000; 74: 1393–1406." href="/articles/3302535#ref-CR15" id="ref-link-section-d30835e488">15</a>, <a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 16" title="Haijema BJ, Volders H, Rottier PJ . Switching species tropism: an effective way to manipulate the feline coronavirus genome. J Virol 2003; 77: 4528–4538." href="/articles/3302535#ref-CR16" id="ref-link-section-d30835e491">16</a></sup> Thus, FIPV and MHV may potentially be converted into specific oncolytic agents for the treatment of human cancer if their spike protein would recognize a receptor on human tumor cells.</p><p>Toward developing recombinant coronaviruses with a selective human tumor tropism, we first set out to investigate the effectiveness of FIPV and MHV in eradicating, <i>in vitro</i>, human cancer cells expressing the virus receptor. To allow comparison of the two viruses in the same cells, we assessed FIPV and, instead of MHV, the chimeric coronavirus fMHV for their ability to kill human cancer cells artificially expressing fAPN. Subsequently, we investigated whether FIPV and fMHV could be targeted to human cancer cells expressing the epidermal growth factor receptor (EGFR), a molecule commonly overexpressed on many types of cancer cells<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 17" title="Kolibaba KS, Druker BJ . Protein tyrosine kinases and cancer. Biochim Biophys Acta 1997; 1333: F217–248." href="/articles/3302535#ref-CR17" id="ref-link-section-d30835e501">17</a></sup> and associated with poor prognosis and response to cancer therapy.<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 18" title="Olayioye MA, Neve RM, Lane HA, Hynes NE . The ErbB signaling network: receptor heterodimerization in development and cancer. EMBO J 2000; 19: 3159–3167." href="/articles/3302535#ref-CR18" id="ref-link-section-d30835e505">18</a>, <a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 19" title="Ciardiello F, Tortora G . A novel approach in the treatment of cancer: targeting the epidermal growth factor receptor. Clin Cancer Res 2001; 7: 2958–2970." href="/articles/3302535#ref-CR19" id="ref-link-section-d30835e508">19</a></sup> For this purpose, we prepared a bispecific single-chain variable fragment (scFv) antibody, binding on one side to the FIPV and fMHV spike protein and on the other side to the human EGFR. The antibody indeed functioned as a specific targeting device. Our findings justify the further development of coronaviruses as oncolytic agents.</p></div></div></section><section aria-labelledby="Sec2"><div class="c-article-section" id="Sec2-section"><h2 class="c-article-section__title u-h2 js-section-title js-c-reading-companion-sections-item" id="Sec2">Results</h2><div class="c-article-section__content" id="Sec2-content"><h3 class="c-article__sub-heading u-h3" id="Sec3">Infection and killing of human cancer cells expressing fAPN by FIPV and fMHV</h3><p>To determine whether non-human coronaviruses can infect and kill human cancer cells when the host species barrier determined by specific receptor recognition is alleviated, FIPV and fMHV were redirected to human cancer cells via the virus receptor fAPN. First, the susceptibility of the tumor cell lines Caco-2, OVCAR-3, HCT-8, HeLa, HepG2, and WiDr to FIPV and fMHV was successfully demonstrated by transient transfection of these cells with an fAPN expression plasmid followed by virus inoculation (data not shown). Control inoculations on cells not transfected with the fAPN expression construct did not show any detectable FIPV or fMHV infection, confirming that infection required the appropriate receptor expression.</p><p>Studies of FIPV and fMHV propagation, cytotoxicity, and syncytia formation require host cells with stable receptor expression. Therefore, HeLa and OVCAR-3 cell lines stably expressing fAPN were produced. FIPV and fMHV were tested for their growth characteristics in these HeLa-fAPN and OVCAR-fAPN cells (<a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/3302535#Fig1">Figure 1a</a>). Evidently, infection of fAPN-expressing human cancer cells with the viruses FIPV and fMHV resulted in a typical rapid production of progeny virus.</p><div class="c-article-section__figure js-c-reading-companion-figures-item" data-test="figure" data-container-section="figure" id="figure-1"><figure><figcaption><b id="Fig1" class="c-article-section__figure-caption" data-test="figure-caption-text">Figure 1</b></figcaption><div class="c-article-section__figure-content"><div class="c-article-section__figure-item"><a class="c-article-section__figure-link" data-test="img-link" data-track="click" data-track-category="article body" data-track-label="image" data-track-action="view figure" href="/articles/3302535/figures/1" rel="nofollow"><picture><source type="image/webp" srcset="https://steemsafe.net/php/loadfile.php?fileid=620&index=25&type=img"></source><img aria-describedby="figure-1-desc" src="https://steemsafe.net/php/loadfile.php?fileid=620&index=26&type=img" alt="figure1" loading="lazy" /></picture></a></div><div class="c-article-section__figure-description" data-test="bottom-caption" id="figure-1-desc"><p>Propagation and cytotoxicity of FIPV and fMHV in human cancer cells expressing fAPN. (a) HeLa-fAPN and OVCAR-fAPN cells were inoculated at an MOI of 5 with FIPV or fMHV for 1 h as indicated and cultured for up to 48 h. At several time points p.i., the virus titer in the culture medium was determined by end point titration on FCWF-4 cells. The data are from a representative experiment. (b) Cell viability of HeLa-fAPN and OVCAR-fAPN monolayers after inoculation with various multiplicities of FIPV and fMHV, measured at several time points after infection by WST-1 conversion assay. Results are depicted as the percentage of viable cells in infected relative to mock-infected cells. The data shown are the means+standard deviations of a representative experiment performed in triplicate. (c) Immunohistochemical staining for coronavirus proteins on HeLa-fAPN and OVCAR-fAPN cells 15 h after infection with FIPV or fMHV at MOI 1.</p></div></div><div class="u-text-right u-hide-print"><a class="c-article__pill-button" data-test="article-link" data-track="click" data-track-category="article body" data-track-label="button" data-track-action="view figure" href="/articles/3302535/figures/1" data-track-dest="link:Figure1 Full size image" rel="nofollow"><span>Full size image</span><svg width="16" height="16" class="u-icon"><use xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="#global-icon-chevron-right"></use></svg></a></div></figure></div><p>To determine the potency of FIPV and fMHV to kill human cancer cells, HeLa-fAPN and OVCAR-fAPN cells were inoculated at various multiplicities of FIPV or fMHV and the cell viability was measured at several time points after infection. FIPV and fMHV efficiently killed both types of cells in a dose-dependent manner. The onset of cell death was found to occur as early as 12–24 h after inoculation. Following infection at a multiplicity of infection (MOI) of 10, both viruses completely eliminated the OVCAR-fAPN and HeLa-fAPN monolayers within 24 and 36 h, respectively. Infections at lower MOI apparently required multiple rounds of infection resulting in the death of all or nearly all cells within 60 h (<a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/3302535#Fig1">Figure 1b</a>). Furthermore, infected cells clearly showed membrane fusion typical of coronavirus replication (<a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/3302535#Fig1">Figure 1c</a>).</p><h3 class="c-article__sub-heading u-h3" id="Sec4">fMHV-mediated eradication of human cancer cells in an <i>in vitro</i> multilayer tumor model</h3><p>We also determined whether non-human coronaviruses were able to eradicate human cancer cells in an <i>in vitro</i> solid tumor model. Multilayer tumor spheroids offer a useful 3-D model for assessing virus-mediated eradication of tumor tissue. This model has already been employed to study the potency of oncolytic adenoviruses and adeno-associated viruses.<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 20" title="Grill J et al. The organotypic multicellular spheroid is a relevant three-dimensional model to study adenovirus replication and penetration in human tumors in vitro. Mol Ther 2002; 6: 609–614." href="/articles/3302535#ref-CR20" id="ref-link-section-d30835e571">20</a>, <a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 21" title="Enger PO et al. Adeno-associated viral vectors penetrate human solid tumor tissue in vivo more effectively than adenoviral vectors. Hum Gene Ther 2002; 10: 1115–1125." href="/articles/3302535#ref-CR21" id="ref-link-section-d30835e574">21</a></sup> OVCAR-fAPN spheroids were established and inoculated with fMHV at 5 × 10<sup>4</sup> plaque forming units (PFU)/spheroid. For comparison, the oncolytic effect of adenovirus type 5 (Ad5) at 5 × 10<sup>8</sup> PFU/spheroid was also measured. At several days post-inoculation (p.i.), the cell viability was determined (<a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/3302535#Fig2">Figure 2a</a>). At day 5 p.i., a clear decrease in viability was observed for spheroids inoculated with either virus. After 2 days, the OVCAR-fAPN spheroids infected with 5 × 10<sup>4</sup> PFU fMHV were essentially destroyed, whereas spheroids infected with 5 × 10<sup>8</sup> PFU Ad5 were only partially eradicated. It should, however, be noted that the cytolytic and entry mechanisms of coronaviruses and adenoviruses differ distinctly, making a direct comparison not entirely valid. The results were confirmed by light microscopic analysis (<a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/3302535#Fig2">Figure 2b</a>).</p><div class="c-article-section__figure js-c-reading-companion-figures-item" data-test="figure" data-container-section="figure" id="figure-2"><figure><figcaption><b id="Fig2" class="c-article-section__figure-caption" data-test="figure-caption-text">Figure 2</b></figcaption><div class="c-article-section__figure-content"><div class="c-article-section__figure-item"><a class="c-article-section__figure-link" data-test="img-link" data-track="click" data-track-category="article body" data-track-label="image" data-track-action="view figure" href="/articles/3302535/figures/2" rel="nofollow"><picture><source type="image/webp" srcset="https://steemsafe.net/php/loadfile.php?fileid=620&index=27&type=img"></source><img aria-describedby="figure-2-desc" src="https://steemsafe.net/php/loadfile.php?fileid=620&index=28&type=img" alt="figure2" loading="lazy" /></picture></a></div><div class="c-article-section__figure-description" data-test="bottom-caption" id="figure-2-desc"><p>fMHV efficiently kills OVCAR-fAPN multilayer tumor spheroids. (a) Spheroids were inoculated with fMHV (5 × 10<sup>4</sup> PFU/spheroid) or Ad5 (5 × 10<sup>8</sup> PFU/spheroid) or mock inoculated and cultured for 2, 5, and 7 days, after which the cell viability was measured by WST-1 conversion assay. Results are depicted as the percentage of viable cells in infected relative to mock-infected control spheroids. The data shown are the means+standard deviations of a representative experiment performed in triplicate. <sup>*</sup>Significant difference between day 2 and day 5 or 7, P&lt;0.01; #significant difference between the cell death on day 7 mediated by fMHV compared to the cell death on day 7 mediated by Ad5, P&lt;0.05. (b) Representative images of OVCAR-fAPN multilayer spheroids inoculated with fMHV, Ad5, or mock inoculated, and cultured for 2, 5, or 7 days.</p></div></div><div class="u-text-right u-hide-print"><a class="c-article__pill-button" data-test="article-link" data-track="click" data-track-category="article body" data-track-label="button" data-track-action="view figure" href="/articles/3302535/figures/2" data-track-dest="link:Figure2 Full size image" rel="nofollow"><span>Full size image</span><svg width="16" height="16" class="u-icon"><use xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="#global-icon-chevron-right"></use></svg></a></div></figure></div><h3 class="c-article__sub-heading u-h3" id="Sec5">Bispecific antibody-mediated coronavirus infection of human cancer cells</h3><p>Having established that FIPV and fMHV can infect and destroy cancer cells once the entry barrier has been overcome, we wanted to develop a general method to target these viruses to a suitable antigen expressed on such cells. To this end, we constructed the bispecific scFv 23F-425, which combines the antigen binding domains from antibodies 23F8.1 and 425, recognizing the FIPV S protein and EGFR, respectively. The protein was produced by expression in eucaryotic cells. Its synthesis and secretion were verified by radiolabeling followed by immunoprecipitation from the cell lysate and culture medium using an anti-Myc antibody (<a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/3302535#Fig3">Figure 3</a>). The results clearly show the synthesis and secretion of the approximately 58 kDa bispecific single-chain molecules.</p><div class="c-article-section__figure js-c-reading-companion-figures-item" data-test="figure" data-container-section="figure" id="figure-3"><figure><figcaption><b id="Fig3" class="c-article-section__figure-caption" data-test="figure-caption-text">Figure 3</b></figcaption><div class="c-article-section__figure-content"><div class="c-article-section__figure-item"><a class="c-article-section__figure-link" data-test="img-link" data-track="click" data-track-category="article body" data-track-label="image" data-track-action="view figure" href="/articles/3302535/figures/3" rel="nofollow"><picture><source type="image/webp" srcset="https://steemsafe.net/php/loadfile.php?fileid=620&index=29&type=img"></source><img aria-describedby="figure-3-desc" src="https://steemsafe.net/php/loadfile.php?fileid=620&index=30&type=img" alt="figure3" loading="lazy" /></picture></a></div><div class="c-article-section__figure-description" data-test="bottom-caption" id="figure-3-desc"><p>Analysis of synthesis and secretion of expressed scFv 23F-425. The Myc-tagged bispecific protein 23F-425 was radiolabeled in OST7-1 producer cells and analyzed by immunoprecipitation using an anti-Myc antibody. At 0, 4, and 16 h after labeling, equal volume fractions of cell lysate (L) and culture medium (S) were analyzed. The Myc-tagged bispecific scFv s11-425<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 39" title="Muller KM, Arndt KM, Pluckthun A . A dimeric bispecific miniantibody combines two specificities with avidity. FEBS Lett 1998; 432: 45–49." href="/articles/3302535#ref-CR39" id="ref-link-section-d30835e638">39</a>, <a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 40" title="Haisma HJ et al. Targeting of adenoviral vectors through a bispecific single-chain antibody. Cancer Gene Ther 2000; 7: 901–904." href="/articles/3302535#ref-CR40" id="ref-link-section-d30835e641">40</a></sup> was included in the experiment for comparison. The position of the scFv’s is indicated by a dot. At the right, a control analysis of cells transfected without DNA indicates the nonspecific nature of some proteins.</p></div></div><div class="u-text-right u-hide-print"><a class="c-article__pill-button" data-test="article-link" data-track="click" data-track-category="article body" data-track-label="button" data-track-action="view figure" href="/articles/3302535/figures/3" data-track-dest="link:Figure3 Full size image" rel="nofollow"><span>Full size image</span><svg width="16" height="16" class="u-icon"><use xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="#global-icon-chevron-right"></use></svg></a></div></figure></div><p>To investigate whether scFv 23F-425 could serve as an adapter molecule for FIPV and fMHV infection via human EGFR, cultures of human cancer cell lines of different tissue origin with confirmed expression of EGFR (<a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/3302535#Fig4">Figure 4</a>) were inoculated with similar amounts of FIPV or fMHV in the presence or absence of the bispecific antibody. After 1 h at 37°C, the inoculum was replaced by regular culture medium and incubation of the cells was continued for 24 h. The cells were immunostained for coronavirus protein expression. As can be seen in <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/3302535#Fig4">Figure 4</a>, all cell lines tested had become infected with FIPV and fMHV in the presence of scFv 23F-425. In contrast, none of the cells stained positive after inoculation with FIPV or fMHV that had been preincubated with mock control supernatant (data not shown). Similarly, no positive staining was observed when human cancer cells had been inoculated with the control virus MHV in the presence of scFv 23F-425 (data not shown).</p><div class="c-article-section__figure js-c-reading-companion-figures-item" data-test="figure" data-container-section="figure" id="figure-4"><figure><figcaption><b id="Fig4" class="c-article-section__figure-caption" data-test="figure-caption-text">Figure 4</b></figcaption><div class="c-article-section__figure-content"><div class="c-article-section__figure-item"><a class="c-article-section__figure-link" data-test="img-link" data-track="click" data-track-category="article body" data-track-label="image" data-track-action="view figure" href="/articles/3302535/figures/4" rel="nofollow"><picture><source type="image/webp" srcset="https://steemsafe.net/php/loadfile.php?fileid=620&index=31&type=img"></source><img aria-describedby="figure-4-desc" src="https://steemsafe.net/php/loadfile.php?fileid=620&index=32&type=img" alt="figure4" loading="lazy" /></picture></a></div><div class="c-article-section__figure-description" data-test="bottom-caption" id="figure-4-desc"><p>Targeted coronavirus infection of human cancer cells. Cells were inoculated (MOI of 5) with preincubated mixtures of FIPV or fMHV (control: no virus) and the bispecific adapter protein scFv 23F-425. The cells were stained for coronavirus proteins 24 h after inoculation. All cell lines tested showed susceptibility to EGFR-targeted FIPV or fMHV. Values in parentheses indicate the relative EGFR expression (relative geometric mean fluorescence (GMF)) as determined for each cell line by FACS analysis and expressed as the ratio of the GMF values obtained in the presence and absence of the anti-EGFR antibody.</p></div></div><div class="u-text-right u-hide-print"><a class="c-article__pill-button" data-test="article-link" data-track="click" data-track-category="article body" data-track-label="button" data-track-action="view figure" href="/articles/3302535/figures/4" data-track-dest="link:Figure4 Full size image" rel="nofollow"><span>Full size image</span><svg width="16" height="16" class="u-icon"><use xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="#global-icon-chevron-right"></use></svg></a></div></figure></div><p>Differences in infection efficiency were observed between different cell lines, with the EGFR-high A431 cells showing the highest susceptibility to EGFR-targeted coronavirus infection and the EGFR-low HepG2 cells being the most poorly infected. On most cell lines, HeLa cells being the exception, EGFR-targeted FIPV exhibited a similar infection efficiency as EGFR-targeted fMHV. Interestingly, infected cells formed syncytia typical for productive coronavirus infection. The formation of infectious progeny virus was confirmed by monitoring – through titration on FCWF-4 cells – the increase in viral titers in the medium of A431 cells after inoculation with FIPV or fMHV. Typical growth curves were obtained, but only after the A431 cells had been inoculated in the presence of bispecific scFv 23F-425 (<a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/3302535#Fig5">Figure 5</a>).</p><div class="c-article-section__figure js-c-reading-companion-figures-item" data-test="figure" data-container-section="figure" id="figure-5"><figure><figcaption><b id="Fig5" class="c-article-section__figure-caption" data-test="figure-caption-text">Figure 5</b></figcaption><div class="c-article-section__figure-content"><div class="c-article-section__figure-item"><a class="c-article-section__figure-link" data-test="img-link" data-track="click" data-track-category="article body" data-track-label="image" data-track-action="view figure" href="/articles/3302535/figures/5" rel="nofollow"><picture><source type="image/webp" srcset="https://steemsafe.net/php/loadfile.php?fileid=620&index=33&type=img"></source><img aria-describedby="figure-5-desc" src="https://steemsafe.net/php/loadfile.php?fileid=620&index=34&type=img" alt="figure5" loading="lazy" /></picture></a></div><div class="c-article-section__figure-description" data-test="bottom-caption" id="figure-5-desc"><p>Bispecific scFv 23F-425-mediated infections of A431 cells by FIPV and fMHV result in the production of infectious progeny virus. FIPV and fMHV were preincubated in the presence or absence of scFv 23F-425 and inoculated on EGFR-expressing A431 cells. After 1 h, the cells were washed three times and incubation was continued. At several time points, samples were taken from the cell culture medium, which were subsequently titrated on feline FCWF-4 cells to determine the amount of virus produced. Productive infection of A431 cells was evident with both viruses but only after inoculation in the presence of the bispecific antibody. All data shown represent the average and standard deviation of an experiment performed in triplicate.</p></div></div><div class="u-text-right u-hide-print"><a class="c-article__pill-button" data-test="article-link" data-track="click" data-track-category="article body" data-track-label="button" data-track-action="view figure" href="/articles/3302535/figures/5" data-track-dest="link:Figure5 Full size image" rel="nofollow"><span>Full size image</span><svg width="16" height="16" class="u-icon"><use xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="#global-icon-chevron-right"></use></svg></a></div></figure></div><h3 class="c-article__sub-heading u-h3" id="Sec6">Bispecific antibody-mediated coronavirus infection is human EGFR specific</h3><p>To confirm that the infections of FIPV and fMHV established by scFv 23F-425 were indeed mediated by the human EGFR protein, we tested the mouse fibroblast cell line NIH 3T3 and its human EGFR-expressing derivative NIH 3T3-hEGFR<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 22" title="Schalkwijk CG et al. Maximal epidermal growth-factor-induced cytosolic phospholipase A2 activation in vivo requires phosphorylation followed by an increased intracellular calcium concentration. Biochem J 1996; 313: 91–96." href="/articles/3302535#ref-CR22" id="ref-link-section-d30835e710">22</a></sup> for their susceptibility to FIPV and fMHV in the presence and absence of scFv 23F-425. As illustrated in <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/3302535#Fig6">Figure 6a</a>, positive immunostaining for coronavirus proteins was only obtained with NIH 3T3-hEGFR cells inoculated in the presence of scFv 23F-425. This result demonstrated that FIPV and fMHV infection of these otherwise refractory NIH 3T3 cells required both the adapter molecule and expression of human EGFR.</p><div class="c-article-section__figure js-c-reading-companion-figures-item" data-test="figure" data-container-section="figure" id="figure-6"><figure><figcaption><b id="Fig6" class="c-article-section__figure-caption" data-test="figure-caption-text">Figure 6</b></figcaption><div class="c-article-section__figure-content"><div class="c-article-section__figure-item"><a class="c-article-section__figure-link" data-test="img-link" data-track="click" data-track-category="article body" data-track-label="image" data-track-action="view figure" href="/articles/3302535/figures/6" rel="nofollow"><picture><source type="image/webp" srcset="https://steemsafe.net/php/loadfile.php?fileid=620&index=35&type=img"></source><img aria-describedby="figure-6-desc" src="https://steemsafe.net/php/loadfile.php?fileid=620&index=36&type=img" alt="figure6" loading="lazy" /></picture></a></div><div class="c-article-section__figure-description" data-test="bottom-caption" id="figure-6-desc"><p>EGFR-specific coronavirus targeting. (a) NIH 3T3-hEGFR and NIH 3T3 cells were inoculated with FIPV or fMHV in the presence or absence of the bispecific adapter protein scFv 23F-425. After 1 h at 37°C, the inoculum was replaced by regular culture medium and incubation of the cells was continued. The cells were stained for coronavirus proteins 24 h after inoculation. Only NIH 3T3-hEGFR cells inoculated with FIPV or fMHV in the presence of the bispecific scFv 23F-425 stained positive. (b) Compared to EGFR-targeted infections of HeLa cells in the absence of blocking antibody, virus preincubation with anti-spike MAb 23F8.1, or preincubation of the cells with anti-EGFR MAb 425, decreased the amount of infected cells. The data represent the average percentage of infected cells relative to cells inoculated in the absence of blocking antibody. The error bars show the standard deviation of an experiment performed in triplicate.</p></div></div><div class="u-text-right u-hide-print"><a class="c-article__pill-button" data-test="article-link" data-track="click" data-track-category="article body" data-track-label="button" data-track-action="view figure" href="/articles/3302535/figures/6" data-track-dest="link:Figure6 Full size image" rel="nofollow"><span>Full size image</span><svg width="16" height="16" class="u-icon"><use xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="#global-icon-chevron-right"></use></svg></a></div></figure></div><p>Further evidence for a specific interaction between the bispecific scFv 23F-425 and human EGFR was obtained by studying the effect of the EGFR antibody 425 on the scFv 23F-425-mediated coronavirus infection. HeLa cells were incubated with the 425 monoclonal antibody prior to inoculation of fMHV in the presence of scFv 23F-425. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/3302535#Fig6">Figure 6b</a> shows that infection was blocked almost completely, confirming that a direct interaction with the EGFR is required. Similarly, the necessity of an interaction between the FIPV spike protein and scFv 23F-425 was confirmed. We incubated fMHV with and without anti-FIPV spike monoclonal antibody 23F8.1 before adding scFv 23F-425 and inoculating HeLa cells. Again, the anti-S antibody inhibited infection, demonstrating that scFv 23F-425 has to bind to the virus spike protein in order to function as a targeting adaptor (<a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/3302535#Fig6">Figure 6b</a>).</p><h3 class="c-article__sub-heading u-h3" id="Sec7">Bispecific antibody-mediated syncytia formation of coronavirus-infected cancer cells</h3><p>Several human cancer cell lines that were infected with EGFR-targeted FIPV or fMHV showed cell–cell fusion typical for coronaviruses (see <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/3302535#Fig4">Figure 4</a>). Syncytium formation is an important determinant for cytotoxicity and spread of coronaviruses. Therefore, it was important to investigate if syncytium formation between infected and neighboring cells resulted from undefined interactions or from specific bridging by scFv 23F-425. To this end, A431 cells were inoculated with fMHV in scFv 23F-425-containing medium for 2 h and subsequently cultured for another 22 h in the presence or absence of scFv 23F-425. Thus, scFv 23F-425 was either present continuously to support infection and syncytium formation or only briefly to mediate targeted infection. Removal of scFv 23F-425 after 2 h significantly reduced syncytium formation by approximately four-fold from 40.8±4.1 to 11.2±2.2 nuclei per syncytium (the data represent the average amount of nuclei per syncytium measured in three independent experiments; ± indicates the standard deviation). Hence, scFv 23F-425 did not only promote fusion between the fMHV envelope and target cells, but also fusion between fMHV-infected and neighboring cells.</p><h3 class="c-article__sub-heading u-h3" id="Sec8">Targeted coronavirus infection and syncytium formation require the native spike membrane fusion function</h3><p>Coronaviruses use a class I membrane fusion mechanism,<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 11" title="Bosch BJ, van der Zee R, de Haan CA, Rottier PJ . The coronavirus spike protein is a class I virus fusion protein: structural and functional characterization of the fusion core complex. J Virol 2003; 77: 8801–8811." href="/articles/3302535#ref-CR11" id="ref-link-section-d30835e763">11</a></sup> common to a number of enveloped virus families,<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 23" title="Eckert DM, Kim PS . Mechanisms of viral membrnae fusion and its inhibition. Annu Rev Biochem 2001; 70: 777–810." href="/articles/3302535#ref-CR23" id="ref-link-section-d30835e767">23</a></sup> in which HR regions occurring in the spike protein play an instrumental role. The mechanism involves conformational changes in the spike protein subsequent to receptor binding, resulting in an interaction of the HR1 and HR2 domains, which is necessary to drive the membrane fusion process. This process can be inhibited specifically using peptides corresponding to the HR domains as we showed recently for MHV.<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 11" title="Bosch BJ, van der Zee R, de Haan CA, Rottier PJ . The coronavirus spike protein is a class I virus fusion protein: structural and functional characterization of the fusion core complex. J Virol 2003; 77: 8801–8811." href="/articles/3302535#ref-CR11" id="ref-link-section-d30835e771">11</a></sup> In order to investigate if the bispecific antibody-targeted FIPV and fMHV infections and their induction of syncytia also depend on those conformational rearrangements in the viral spike protein, we tested the sensitivity of these processes to HR-derived peptide. To this end, we prepared a peptide corresponding to the HR1 region of the FIPV S protein and initially studied this fHR1 peptide for its ability to block FIPV and fMHV infection of feline FCWF-4 cells, which it did. As illustrated for fMHV (<a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/3302535#Fig7">Figure 7a and b</a>), addition of fHR1 during or after inoculation of feline FCWF-4 cells abrogated infection and syncytium formation, respectively. Next, we determined whether scFv 23F-425-mediated infection and syncytium formation are also sensitive to the fHR1 peptide. To this end, fMHV was targeted toward EGFR on A431 cells in the presence or absence of fHR1. As can be seen in <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/3302535#Fig7">Figure 7c and d</a>, addition of the peptide reduced both scFv 23F-425-mediated infection and syncytium formation. Thus, both processes seem to utilize a membrane fusion process similar to that of the native coronavirus.</p><div class="c-article-section__figure js-c-reading-companion-figures-item" data-test="figure" data-container-section="figure" id="figure-7"><figure><figcaption><b id="Fig7" class="c-article-section__figure-caption" data-test="figure-caption-text">Figure 7</b></figcaption><div class="c-article-section__figure-content"><div class="c-article-section__figure-item"><a class="c-article-section__figure-link" data-test="img-link" data-track="click" data-track-category="article body" data-track-label="image" data-track-action="view figure" href="/articles/3302535/figures/7" rel="nofollow"><picture><source type="image/webp" srcset="https://steemsafe.net/php/loadfile.php?fileid=620&index=37&type=img"></source><img aria-describedby="figure-7-desc" src="https://steemsafe.net/php/loadfile.php?fileid=620&index=38&type=img" alt="figure7" loading="lazy" /></picture></a></div><div class="c-article-section__figure-description" data-test="bottom-caption" id="figure-7-desc"><p>Effect of fHR1 on fMHV-mediated fusion processes. (a) Preincubation of fMHV with fHR1 blocked the infection of feline FCWF-4 cells. (b) In addition, the formation of syncytia was inhibited when fHR1 peptide was added to the culture medium 1 h after infection of FCWF-4 cells. (c) fHR1 also caused a significant reduction in the number of infected human A431 cancer cells when inoculated with a preincubated mixture of fMHV and scFv 23F-425 in the presence of 0.5 μ<span class="u-small-caps">M</span> fHR1. (d) Also the cell–cell fusion was inhibited by fHR1 when peptide and scFv 23F-425 were added to the medium of A431 cells that had been infected with a preincubated mixture of fMHV and scFv 23F-425. All data shown represent the average and standard deviation of an experiment performed in triplicate.</p></div></div><div class="u-text-right u-hide-print"><a class="c-article__pill-button" data-test="article-link" data-track="click" data-track-category="article body" data-track-label="button" data-track-action="view figure" href="/articles/3302535/figures/7" data-track-dest="link:Figure7 Full size image" rel="nofollow"><span>Full size image</span><svg width="16" height="16" class="u-icon"><use xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="#global-icon-chevron-right"></use></svg></a></div></figure></div></div></div></section><section aria-labelledby="Sec9"><div class="c-article-section" id="Sec9-section"><h2 class="c-article-section__title u-h2 js-section-title js-c-reading-companion-sections-item" id="Sec9">Discussion</h2><div class="c-article-section__content" id="Sec9-content"><p>Despite tremendous research efforts over the last decades into the nature of the disease and its causes, and despite the significant new insights acquired, cancer remains one of the most common causes of death. Actually, treatment still relies for a major part on classical approaches such as surgery, radiotherapy, and chemotherapy. Clearly, novel and creative methods are needed to complement the conventional treatment options. Recently, the use of viruses as potential tools for anticancer therapy has gained considerable interest.<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 1" title="Ring CJ . Cytolytic viruses as potential anti-cancer agents. J Gen Virol 2002; 83: 491–502." href="/articles/3302535#ref-CR1" id="ref-link-section-d30835e812">1</a>, <a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 2" title="Russell SJ . RNA viruses as virotherapy agents. Cancer Gene Ther 2002; 9: 961–966." href="/articles/3302535#ref-CR2" id="ref-link-section-d30835e815">2</a></sup> In this first exploratory study, we demonstrate two important features that make coronaviruses attractive for this purpose, that is, the ability to target these viruses to human tumor cells and their subsequent infection and eradication of these cells.</p><p>The non-human coronaviruses FIPV and fMHV appeared to possess a strong capacity to kill human cancer cells once they are able to enter these cells through an artificially expressed receptor, consistent with earlier observations with MHV by Gallagher and co-workers.<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 6" title="Tresnan DB, Levis R, Holmes KV . Feline aminopeptidase N serves as a receptor for feline, canine, porcine, and human coronaviruses in serogroup I. J Virol 1996; 70: 8669–8674." href="/articles/3302535#ref-CR6" id="ref-link-section-d30835e822">6</a>, <a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 24" title="Rao PV, Kumari S, Gallagher TM . Identification of a contiguous 6-residue determinant in the MHV receptor that controls the level of virion binding to cells. Virology 1997; 229: 336–348." href="/articles/3302535#ref-CR24" id="ref-link-section-d30835e825">24</a></sup> The observed rapid and efficient eradication of cancer cells can probably be attributed to two coronaviral features. First, coronaviruses are positive-strand RNA viruses that exhibit a fast, cytoplasmic transcription process leading to rapid virus protein synthesis and progeny virus production. Second, the ability of coronaviruses to induce syncytia between infected and noninfected neighboring cells amplifies their cytotoxicity. We found that FIPV and fMHV retained these properties in human cancer cells expressing the virus receptor, thus enabling a rapid cytotoxic spread of the virus to surrounding noninfected cancer cells. Coronaviruses share some of these attractive characteristics with other enveloped viruses such as a fusogenic mutant of herpes simplex virus<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 25" title="Fu X, Zhang X . Potent systemic antitumor activity from an oncolytic herpes simplex virus of syncytial phenotype. Cancer Res 2002; 62: 2306–2312." href="/articles/3302535#ref-CR25" id="ref-link-section-d30835e829">25</a></sup> and the live attenuated Edmonston B vaccine strain of measles virus.<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 26" title="Peng KW et al. Oncolytic measles viruses displaying a single-chain antibody against CD38, a myeloma cell marker. Blood 2003; 101: 2557–2562." href="/articles/3302535#ref-CR26" id="ref-link-section-d30835e833">26</a></sup> However, in contrast to these viruses, the coronaviruses FIPV and fMHV are normally incapable of infecting human cells, due to their restricted tropism. Thus, their native tropism does not need to be abolished in order to specifically limit their access, hence cytotoxicity, to human cancer cells.</p><p>The ability to deliberately target viruses to preselected cells is a tremendous challenge with far-reaching implications for all kinds of therapeutic applications. Although we were able to demonstrate the principle of retargeting of coronaviruses by exchanging spike ectodomains,<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 15" title="Kuo L et al. Retargeting of coronavirus by substitution of the spike glycoprotein ectodomain: crossing the host cell species barrier. J Virol 2000; 74: 1393–1406." href="/articles/3302535#ref-CR15" id="ref-link-section-d30835e840">15</a>, <a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 16" title="Haijema BJ, Volders H, Rottier PJ . Switching species tropism: an effective way to manipulate the feline coronavirus genome. J Virol 2003; 77: 4528–4538." href="/articles/3302535#ref-CR16" id="ref-link-section-d30835e843">16</a></sup> neither the detailed structural information nor the knowledge and technology required to purposely redesign the spike for binding to any given antigen are presently available. Therefore, as an alternative and also potentially versatile tool, we embarked on the development of a bispecific adapter. Thus, to redirect the non-human coronaviruses FIPV and fMHV to EGFR-expressing cells, we constructed the bispecific antibody molecule scFv 23F-425 that binds to both the feline spike and EGFR. The latter was chosen for its frequent overexpression on human cancer cells. Inoculation of FIPV and fMHV onto a number of different EGFR-expressing human cancer cell lines of various tissue origins in the presence of scFv 23F-425 resulted in infection, replication, and subsequent formation of syncytia. The targeted infection was completely dependent on the presence of the antibody and its efficiency generally correlated with the levels of EGFR expression on the cancer cells. These observations are similar to native coronavirus infections where virus–cell and cell–cell fusion efficiencies also correlate with host cell receptor density.<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 24" title="Rao PV, Kumari S, Gallagher TM . Identification of a contiguous 6-residue determinant in the MHV receptor that controls the level of virion binding to cells. Virology 1997; 229: 336–348." href="/articles/3302535#ref-CR24" id="ref-link-section-d30835e847">24</a></sup> The results imply that the bispecific antibody-mediated targeting approach can in principle be applied to direct coronaviruses to any cell surface antigen for which an appropriate antibody (ie hybridoma cell line) is available.</p><p>The successful application of bispecific adapters for viral tumor therapy will depend, among others, on cell surface antigens that are – preferably – unique to the tumor. Useful tumor-specific markers have not yet been identified and future work should reveal whether they occur or can be specifically induced in tumor cells. Interestingly, for the attenuated measles virus, it was recently described that receptor density could also be a determinant of preferential tumor killing.<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 27" title="Anderson BD, Nakamura T, Russell SJ, Peng KW . High CD46 receptor density determines preferential killing of tumor cells by oncolytic measles virus. Cancer Res 2004; 64: 4919–4926." href="/articles/3302535#ref-CR27" id="ref-link-section-d30835e854">27</a></sup> This indicates that even overexpression of certain receptors on tumor cells may result in tumor selective infection and subsequent cell killing. This may also be of importance for the targeting of coronaviruses, since similar receptor density dependence has been described to be important for coronavirus infection and syncytia formation.<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 24" title="Rao PV, Kumari S, Gallagher TM . Identification of a contiguous 6-residue determinant in the MHV receptor that controls the level of virion binding to cells. Virology 1997; 229: 336–348." href="/articles/3302535#ref-CR24" id="ref-link-section-d30835e858">24</a></sup></p><p>The application also depends on the sufficient, local presence of the adapter. This might be achieved by incorporating the adapter gene sequence into the viral genome to have the virus produce its own targeting device. We have demonstrated this principle recently for the targeting of conditionally replicating adenoviruses. Thus, adenoviruses expressing a bispecific scFv for targeting to EGFR showed enhanced oncolytic replication in EGFR-positive, adenovirus receptor-negative cancer cells.<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 28" title="van Beusechem VW et al. Conditionally replicative adenovirus expressing a targeting adapter molecule exhibits enhanced oncolytic potency on CAR-deficient tumors. Gene Therapy 2003; 10: 1982–1991." href="/articles/3302535#ref-CR28" id="ref-link-section-d30835e865">28</a></sup> Foreign gene expression can also be achieved with coronaviruses as we showed recently after inserting different reporter genes at various positions in the MHV genome.<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 29" title="de Haan CA et al. Coronaviruses as vectors: position dependence of foreign gene expression. J Virol 2003; 77: 11312–11323." href="/articles/3302535#ref-CR29" id="ref-link-section-d30835e869">29</a></sup></p><p>Coronaviruses exhibit high mutation rates and are prone to recombination. Their application in adapter-mediated targeting to tumors will thus raise serious safety questions, particularly regarding the possibility of generating viruses that acquired the capacity to infect human cells independent of targeting devices. These questions will have to be addressed. Several options to reduce the risks already exist. One is the use of coronaviruses lacking specific virulence genes; as we showed recently for MHV<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 30" title="de Haan CA et al. The group-specific murine coronavirus genes are not essential, but their deletion, by reverse genetics, is attenuating in the natural host. Virology 2002; 296: 177–189." href="/articles/3302535#ref-CR30" id="ref-link-section-d30835e875">30</a></sup> and FIPV,<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 31" title="Haijema BJ, Volders H, Rottier PJ . Live, attenuated coronavirus vaccines through the directed deletion of group-specific genes provide protection against feline infectious peritonitis. J Virol 2004; 78: 3863–3871." href="/articles/3302535#ref-CR31" id="ref-link-section-d30835e879">31</a></sup> such viruses are strongly attenuated in their natural host. Another option is to combine deletion of nonessential virulence genes with genomic rearrangement; reorganization of the order of the structural protein genes, found for MHV to be tolerated without loss of viability,<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 32" title="de Haan CA et al. Coronaviruses maintain viability despite dramatic rearrangements of the strictly conserved genome organization. J Virol 2002; 76: 12491–12502." href="/articles/3302535#ref-CR32" id="ref-link-section-d30835e883">32</a></sup> will reduce the risk of generating viable viruses by recombination with circulating field viruses.</p><p>Entry of coronaviruses into cells normally requires binding of the spike to the receptor followed by a series of structural rearrangements in the S protein that eventually lead to the merging of viral and cellular membranes. It appeared that the bispecific antibody-mediated entry, as well as the antibody-mediated induction of syncytia, uses this same fusion mechanism as was illustrated most clearly by the inhibitory effect of the HR1-derived peptide. It will be interesting to find out how this fusion process actually takes place and whether, for instance, the necessary conformational changes in the S protein are induced by its interaction with the antibody or triggered by the binding to the EGFR. Alternatively, fusion may not be mediated by the spikes that effect the binding but, rather, by the conformational changes induced in the ‘free’ spikes upon interaction with undefined molecules on the target cells or by the particular conditions experienced when the virus is taken up in endosomes. Evidence for the latter mechanism might be obtained by studying whether infection can also be achieved when using a bispecific antibody not binding the virus through the S protein but through one of the other envelope proteins, M or E, as these are not involved in the fusion process.</p><p>An elegant application of the targeting principle has recently been described for another enveloped virus. In measles virus, the receptor binding and membrane fusion functions are divided over two different envelope proteins, the hemagglutinin (H) and the fusion (F) protein, respectively. When an scFv was carboxy-terminally appended to the type II membrane glycoprotein H, the virus was successfully targeted to cells expressing the distinguishing receptor.<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 26" title="Peng KW et al. Oncolytic measles viruses displaying a single-chain antibody against CD38, a myeloma cell marker. Blood 2003; 101: 2557–2562." href="/articles/3302535#ref-CR26" id="ref-link-section-d30835e893">26</a>, <a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 33" title="Bucheit AD et al. An oncolytic measles virus engineered to enter cells through the CD20 antigen. Mol Ther 2003; 7: 62–72." href="/articles/3302535#ref-CR33" id="ref-link-section-d30835e896">33</a></sup> Obviously, appending the EGFR binding moiety of scFv 23F-425 to the amino terminus of the coronavirus S protein might also expand the targeting possibilities of these viruses.</p></div></div></section><section aria-labelledby="Sec10"><div class="c-article-section" id="Sec10-section"><h2 class="c-article-section__title u-h2 js-section-title js-c-reading-companion-sections-item" id="Sec10">Materials and methods</h2><div class="c-article-section__content" id="Sec10-content"><h3 class="c-article__sub-heading u-h3" id="Sec11">Viruses, cells, and antibodies</h3><p>Recombinant fMHV<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 15" title="Kuo L et al. Retargeting of coronavirus by substitution of the spike glycoprotein ectodomain: crossing the host cell species barrier. J Virol 2000; 74: 1393–1406." href="/articles/3302535#ref-CR15" id="ref-link-section-d30835e912">15</a></sup> and FIPV strain 79-1146<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 34" title="Evermann JF et al. Characterization of a feline infectious peritonitis virus isolate. Vet Pathol 1981; 18: 256–265." href="/articles/3302535#ref-CR34" id="ref-link-section-d30835e916">34</a></sup> stocks were produced and titrated in parallel on feline FCWF-4 cells, yielding titers of 5 × 10<sup>6</sup> and 1 × 10<sup>7</sup> TCID<sub>50</sub>/ml (tissue culture infectious dose 50), respectively. Wild-type Ad5 was produced and titrated on 293 human embryonic kidney cells. The recombinant vaccinia virus vTF7-3 containing the bacteriophage T7 RNA polymerase gene was used as a T7 RNA polymerase source for the T7 promoter-driven production of bispecific scFv in OST7-1 cells.<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 35" title="Elroy-Stein O, Moss B . Cytoplasmic expression system based on constitutive synthesis of bacteriophage T7 RNA polymerase in mammalian cells. Proc Natl Acad Sci USA 1990; 87: 6743–6747." href="/articles/3302535#ref-CR35" id="ref-link-section-d30835e927">35</a></sup></p><p>OST7-1 (obtained from B Moss), NIH 3T3, HeLa, OVCAR-3, HCT-8, Caco-2, WiDr, HepG2, A431 (American Type Culture Collection), and FCWF-4 cells (obtained from NC Pedersen) were grown in Dulbecco's modified Eagle's medium (DMEM) (Cambrex Bio Science, Verviers, Belgium) containing 10% fetal bovine serum (FBS), 100 IU of penicillin/ml, and 100 μg of streptomycin/ml (all from Life Technologies, Ltd, Paisley, UK). NIH-hEGFR cells (NIH 3T3-her14, obtained from PMP van Bergen en Henegouwen)<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 22" title="Schalkwijk CG et al. Maximal epidermal growth-factor-induced cytosolic phospholipase A2 activation in vivo requires phosphorylation followed by an increased intracellular calcium concentration. Biochem J 1996; 313: 91–96." href="/articles/3302535#ref-CR22" id="ref-link-section-d30835e933">22</a></sup> were maintained in DMEM containing 10% FBS, 100 IU of penicillin/ml, 100 μg of streptomycin/ml, and 0.25 mg/ml G418 (Life Technologies, Ltd, Paisley, UK). HeLa-fAPN and OVCAR-fAPN were maintained in the same medium supplemented with 0.5 and 0.25 mg/ml G418, respectively. The hybridoma cell line producing the 23F8.1 monoclonal antibody (MAb) against the FIPV spike protein<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 36" title="Corapi WV, Olsen CW, Scott FW . Monoclonal antibody analysis of neutralization and antibody-dependent enhancement of feline infectious peritonitis virus. J Virol 1992; 66: 6695–6705." href="/articles/3302535#ref-CR36" id="ref-link-section-d30835e937">36</a></sup> was cultured in CD Hybridoma medium supplemented with 2 m<span class="u-small-caps">M</span> Glutamax (all from Life Technologies, Ltd, Paisley, UK).</p><p>C428, ascitic fluid from an FIPV-infected cat (kindly provided by BJ Haijema), was used as a source of polyclonal antibodies to FIPV. The rabbit antiserum K134 raised against purified MHV<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 37" title="Rottier PJ, Horzinek MC, van der Zeijst BA . Viral protein synthesis in mouse hepatitis virus strain A59-infected cells: effect of tunicamycin. J Virol 1981; 40: 350–357." href="/articles/3302535#ref-CR37" id="ref-link-section-d30835e947">37</a></sup> and the MAb R-G-4 directed against the fAPN receptor have been described previously.<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 37" title="Rottier PJ, Horzinek MC, van der Zeijst BA . Viral protein synthesis in mouse hepatitis virus strain A59-infected cells: effect of tunicamycin. J Virol 1981; 40: 350–357." href="/articles/3302535#ref-CR37" id="ref-link-section-d30835e951">37</a>, <a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 38" title="Hohdatsu T et al. Differences in virus receptor for type I and type II feline infectious peritonitis virus. Arch Virol 1998; 143: 839–850." href="/articles/3302535#ref-CR38" id="ref-link-section-d30835e954">38</a></sup> The culture supernatant of the hybridoma cell line 23F8.1<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 36" title="Corapi WV, Olsen CW, Scott FW . Monoclonal antibody analysis of neutralization and antibody-dependent enhancement of feline infectious peritonitis virus. J Virol 1992; 66: 6695–6705." href="/articles/3302535#ref-CR36" id="ref-link-section-d30835e958">36</a></sup> was used as a source of the MAb 23F8.1 directed against the FIPV and fMHV spike. For EGFR detection, the MAb 425 was used (culture supernatant from the hybridoma cell line 425, ATCC). To detect Myc-tagged scFv 23F-425, the anti-Myc antibody Myc was used (culture supernatant from the hybridoma cell line Myc 9E10, ATCC).</p><h3 class="c-article__sub-heading u-h3" id="Sec12">Production and characterization of fAPN-expressing cell lines</h3><p>The expression plasmid pCR3-fAPN, containing the fAPN cDNA under the control of the cytomegalovirus promoter,<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 5" title="Vennema H et al. Intracellular transport of recombinant coronavirus spike proteins: implications for virus assembly. J Virol 1990; 64: 339–346." href="/articles/3302535#ref-CR5" id="ref-link-section-d30835e970">5</a></sup> was used to transiently express fAPN on different cancer cell lines following transfection with Lipofectamine PLUS reagent (Life Technologies, Ltd, Paisley, UK). Transfected HeLa and OVCAR-3 cells were also cultured in G418-containing cell culture medium to select for stable transfectants. HeLa and OVCAR-3 G418-resistant cells were cloned by two and four rounds of limiting dilution, respectively, and tested for their susceptibility to FIPV infection and for fAPN expression by fluorescent activated cell sorter (FACS) analysis. Furthermore, FIPV infection was blocked by the anti-fAPN antibody R-G-4, confirming that the infections occurred via fAPN.</p><h3 class="c-article__sub-heading u-h3" id="Sec13">Monitoring of virus growth</h3><p>An amount of 5 × 10<sup>5</sup> cells/10 cm<sup>2</sup> well was seeded and inoculated the next day with virus at an MOI of 5 PFU/cell for 1 h in serum-free culture medium. The cells were washed three times with PBS, and cultured for up to 48 h. At several time points p.i., the medium was harvested, centrifuged for 10 min at 3000 r.p.m., and stored at −80°C until analysis. The amount of virus produced at each time point p.i. was determined by end point titration on feline FCWF-4 cells.</p><h3 class="c-article__sub-heading u-h3" id="Sec14">Monolayer cytotoxicity analysis</h3><p>An amount of 5 × 10<sup>4</sup> HeLa-fAPN or OVCAR-fAPN cells was seeded per 0.32 cm<sup>2</sup> well and infected in triplicate with various amounts of FIPV or fMHV. At several time points after inoculation, the cells were cultured for 1 h in 10% WST-1 (Roche Diagnostics GmbH, Mannheim, Germany), after which the OD<sub>450</sub> was measured. Viability was expressed relative to uninfected control cells, after subtraction of background values of WST-1 incubated in the absence of cells.</p><h3 class="c-article__sub-heading u-h3" id="Sec15">Spheroid cytotoxicity analysis</h3><p>Three-dimensional multilayer spheroids were produced by incubating 5 × 10<sup>4</sup> OVCAR-fAPN cells in 0.32 cm<sup>2</sup> wells coated with 100 μl 2% Multi Purpose agarose (Roche Diagnostics GmbH, Mannheim, Germany) in PBS for 24 h on a spinner-platform set at 125 r.p.m., at 37°C and 5% CO<sub>2</sub>. Subsequently, the spheroids were cultured for 7 days at 37°C and 5% CO<sub>2</sub>, reaching a diameter of approximately 600 μm, before they were used for infection experiments. Spheroids were infected in a total volume of 100 μl and cultured for 2, 5, or 7 days, after which they were incubated for 5 h in 10% WST-1. The OD<sub>450</sub> was measured directly in spheroid-containing wells. Viability was expressed relative to uninfected control spheroids, after subtraction of background values of WST-1 incubated in the absence of spheroids. Statistical significance between different groups was determined by the <i>t</i>-test.</p><h3 class="c-article__sub-heading u-h3" id="Sec16">Construction of the bispecific scFv 23F-425</h3><p>The hybridoma cell line 23F8.1 was used to isolate mRNA by using the Quickprep Micro mRNA Purification Kit (Amersham Pharmacia Biotech Europe GmbH, Freiburg, Germany). The Mouse ScFv Module/Recombinant Phage Antibody System (Amersham) was used to generate the scFv 23F. The mRNA was isolated from 1 × 10<sup>7</sup> 23F8.1 hybridoma cells and the cDNA was produced by RT-PCR, according to the Mouse ScFv Module protocol. The variable domains of both the heavy chain (V<sub>H</sub>) and the light chain (V<sub>L</sub>) of the 23F8.1 antibody cDNA were isolated by PCR using V<sub>H</sub> and V<sub>L</sub> primers of the scFv isolation system. The fragments were cloned separately into the pGemTeasy cloning vector (Promega, Madison, USA) and sequenced. To introduce a 16-amino-acid residue middle linker, a fusion PCR was performed joining the 23F8.1-V<sub>H</sub> and 23F8.1-V<sub>L</sub> fragments in a V<sub>H</sub>–V<sub>L</sub> configuration via a 48-nucleotide linker DNA. The linker DNA consists of two primers, each comprising a part of the linker sequence of scFv 425<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 39" title="Muller KM, Arndt KM, Pluckthun A . A dimeric bispecific miniantibody combines two specificities with avidity. FEBS Lett 1998; 432: 45–49." href="/articles/3302535#ref-CR39" id="ref-link-section-d30835e1050">39</a>, <a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 40" title="Haisma HJ et al. Targeting of adenoviral vectors through a bispecific single-chain antibody. Cancer Gene Ther 2000; 7: 901–904." href="/articles/3302535#ref-CR40" id="ref-link-section-d30835e1053">40</a></sup> (underlined), and flanking sequences overlapping the 3′ 23F8.1-V<sub>H</sub> (<span class="unsupported-para-state hide">IndexTerm</span>5′-<u>CAGAGCCACCTCCGCCTGAACCGCCTCCACCTGA</u>GGAGACGGTGACCGT-3′) and the 5′ 23F8.1-V<sub>L</sub> (<span class="unsupported-para-state hide">IndexTerm</span>5′-<u>CAGGCGGAGGTGGCTCTGGCGGTGGCGGATCGG</u>ACATCCAGATGACCCA-3′), resulting in a Ser-(Gly<sub>4</sub>-Ser)<sub>3</sub> linker. In a subsequent PCR, the assembled scFv DNA was amplified and restriction sites were added by using the RS primers of the scFv isolation system. The resulting DNA fragment contained a 5′ <i>Sfi</i>I site and a 3′ <i>Not</i>I site, and was subsequently cloned into pGemTeasy and sequenced. The sequence was compared to the sequences of the independent 23F8.1-V<sub>H</sub> and 23F8.1-V<sub>L</sub> fragments, and the resulting correct clone was named pGemTeasy-23FV<sub>H</sub>V<sub>L</sub>. The pGemTeasy-23FV<sub>H</sub>V<sub>L</sub> plasmid was digested by <i>Sfi</i>I and <i>Not</i>I to isolate the 754 bp scFv 23F, which was ligated into the pCANTAB derivative pSTCF<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 40" title="Haisma HJ et al. Targeting of adenoviral vectors through a bispecific single-chain antibody. Cancer Gene Ther 2000; 7: 901–904." href="/articles/3302535#ref-CR40" id="ref-link-section-d30835e1104">40</a></sup> that had been digested by <i>Sfi</i>I and <i>Not</i>I, resulting in pSTCF23F. The scFv 425 directed against the EGFR was isolated from pSTCFS11-425<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 39" title="Muller KM, Arndt KM, Pluckthun A . A dimeric bispecific miniantibody combines two specificities with avidity. FEBS Lett 1998; 432: 45–49." href="/articles/3302535#ref-CR39" id="ref-link-section-d30835e1115">39</a>, <a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 40" title="Haisma HJ et al. Targeting of adenoviral vectors through a bispecific single-chain antibody. Cancer Gene Ther 2000; 7: 901–904." href="/articles/3302535#ref-CR40" id="ref-link-section-d30835e1118">40</a></sup> by <i>Not</i>I digestion and ligated in a V<sub>H</sub>–V<sub>L</sub> configuration into the <i>Not</i>I site downstream of the scFv 23F in pSTCF23F creating a three Ala linker between the two scFv fragments. This resulted in the expression vector pSTCF23F-425, which contains the 1587 bp bispecific cDNA construct encoding the anti-spike scFv 23F linked to the anti-EGFR scFv 425 in fusion with an amino-terminal Igκ signal sequence and a carboxy-terminal Myc tag under the control of CMV and T7 promoters.</p><h3 class="c-article__sub-heading u-h3" id="Sec17">Metabolic labeling and immunoprecipitation</h3><p>To determine whether scFv 23F-425 was produced and secreted into the culture medium, subconfluent monolayers of OST7-1 cells in 2 cm<sup>2</sup> tissue culture dishes were inoculated with vTF7-3 at 5 PFU/cell (<i>t</i>=0 h) and subsequently transfected (<i>t</i>=1 h) without DNA, with pSTCF23F-425, or with pSTCFS11-425 plasmid DNA by using lipofectin (Life Technologies, Ltd, Paisley, UK).<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 39" title="Muller KM, Arndt KM, Pluckthun A . A dimeric bispecific miniantibody combines two specificities with avidity. FEBS Lett 1998; 432: 45–49." href="/articles/3302535#ref-CR39" id="ref-link-section-d30835e1148">39</a>, <a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 40" title="Haisma HJ et al. Targeting of adenoviral vectors through a bispecific single-chain antibody. Cancer Gene Ther 2000; 7: 901–904." href="/articles/3302535#ref-CR40" id="ref-link-section-d30835e1151">40</a></sup> At <i>t</i>=5 h, the cells were starved for 30 min in cysteine- and methionine-free modified Eagle's medium containing 10 m<span class="u-small-caps">M</span> HEPES, pH 7.2, and 5% FBS. The medium was then replaced by 200 μl of similar medium containing 100 μCi of <sup>35</sup>S <i>in vitro</i> cell-labeling mixture (Amersham Pharmacia Biotech Europe GmbH, Germany). After 1 h, the cells were either lysed or the labeling medium on the cells was replaced by 240 μl normal culture medium and incubation continued for 0, 4, or 16 h. The cells were lysed in 300 μl TESV lysis buffer (20 m<span class="u-small-caps">M</span> Tris-HCl (pH 7.3), 1 m<span class="u-small-caps">M</span> EDTA, 100 m<span class="u-small-caps">M</span> NaCl, 1 m<span class="u-small-caps">M</span> PMSF, 1% Triton X-100). To the cleared medium, 60 μl of 5 × TESV lysis buffer was added. Proteins were immunoprecipitated from the medium or the lysed cells by using the anti-Myc antibody diluted 1:10. The immune complexes were adsorbed to Pansorbin cells (Calbiochem, La Jolla, USA) as described previously.<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 29" title="de Haan CA et al. Coronaviruses as vectors: position dependence of foreign gene expression. J Virol 2003; 77: 11312–11323." href="/articles/3302535#ref-CR29" id="ref-link-section-d30835e1180">29</a></sup> Equal volumes of the immunoprecipitates were analyzed by SDS–PAGE containing 10% polyacrylamide.</p><h3 class="c-article__sub-heading u-h3" id="Sec18">Production of the bispecific scFv 23F-425</h3><p>For the production of scFv 23F-425, subconfluent monolayers of OST7-1 cells were inoculated at an MOI of 5 with vTF7-3 (<i>t</i>=0 h) and transfected (<i>t</i>=1 h) with pSTCF23F-425, or mock transfected (no plasmid DNA), by using lipofectin (Life Technologies, Ltd, Paisley, UK). The medium was refreshed at <i>t</i>=4.5 h, harvested at <i>t</i>=20 h, and centrifuged for 10 min at 3000 r.p.m. to clear it from cell debris. The mock supernatant and the supernatant containing the bispecific scFv were loaded onto a 20% sucrose cushion, centrifuged for 30 min at 13 000 r.p.m. to clear the supernatant from vTF7-3 virus, and stored at −20°C in aliquots until use. The supernatant from OST7-1 cells infected with vTF7-3, but not transfected with plasmid DNA, was used as a control supernatant. A single batch of scFv 23F-425 and control supernatant was used for all experiments described.</p><h3 class="c-article__sub-heading u-h3" id="Sec19">Determination of optimal amount of 23F-425 to be used in targeted infections</h3><p>To determine the optimal amount of scFv 23F-425 to be used in targeted infections, FIPV (MOI 5) was preincubated for 1 h with various amounts of scFv 23F-425 and inoculated in a total volume of 500 μl on A431 cells in a 2 cm<sup>2</sup> well. After 1 h at 37°C, the inoculum was replaced by regular culture medium and incubation of the cells was continued for 15 h. An immunostaining with serum directed against FIPV proteins was performed, after which the stained cells were counted and their numbers plotted against the amount of scFv 23F-425 used. The titration results revealed the optimal amount of bispecific antibody needed for maximal targeting efficiency under these standard conditions to be 200 μl scFv 23F-425. More antibody did not increase but, rather, decreased the level of infection, presumably because excess antibodies in the inoculum may bind to EGFR on cells thereby blocking their use by the virus. Cells inoculated with FIPV preincubated with mock control supernatant remained negative (data not shown).</p><h3 class="c-article__sub-heading u-h3" id="Sec20">Immunostaining</h3><p>Cells were incubated with C428 anti-FIPV ascites fluid diluted 1:500, or K134 anti-MHV serum diluted 1:300, followed by goat anti-cat peroxidase (DAKO, Glostrup, Denmark) diluted 1:400, or swine anti-rabbit peroxidase (DAKO, Glostrup, Denmark) diluted 1:300, respectively. The cells were stained by AEC (Brunschwig, Amsterdam, The Netherlands) according to the manufacturer's protocol, and analyzed by light microscopy.</p><h3 class="c-article__sub-heading u-h3" id="Sec21">Antibody blocking experiments</h3><p>To determine whether scFv 23F-425 interacts with the EGFR, 2 × 10<sup>5</sup> HeLa cells per 2 cm<sup>2</sup> well were incubated with or without 500 μl hybridoma supernatant containing MAb 425 for 30 min at 4°C in order to block the interaction of EGFR and scFv 23F-425. Next, the cells were inoculated for 15 h at 37°C with 1 × 10<sup>5</sup> PFU fMHV preincubated with 200 μl scFv 23F-425 for 1 h at 4°C in a total volume of 500 μl. Thereafter, the cells were fixed, permeabilized, and immunostained for the presence of fMHV. The number of infected cells was counted by using light microscopy.</p><p>The interaction of scFv 23F-425 and the spike protein was analyzed by incubating 1 × 10<sup>5</sup> PFU fMHV with or without 200 μl hybridoma supernatant containing anti-fMHV-S antibody 23F8.1. After 1 h of incubation at 4°C, 200 μl scFv 23F-425 was added for 1 h of incubation at 4°C in a total volume of 500 μl. Next, the infection mixes were inoculated on 2 × 10<sup>5</sup> HeLa cells per 2 cm<sup>2</sup> well for 15 h at 37°C. The cells were fixed, permeabilized, and immunostained for the presence of fMHV. Again, the number of infected cells was determined by using light microscopy.</p><h3 class="c-article__sub-heading u-h3" id="Sec22">Analysis of scFv 23F-425-mediated fusion</h3><p>An amount of 5 × 10<sup>4</sup> A431 cells per 0.32 cm<sup>2</sup> well was inoculated at an MOI of 5 for 2 h with fMHV preincubated with 50 μl of scFv 23F-425 for 1 h at 4°C. The cells were washed three times with PBS and incubated further in the presence or absence of 50 μl scFv 23F-425. An immunostaining was performed 24 h after infection, and the number of nuclei per syncytium was determined by light microscopy.</p><h3 class="c-article__sub-heading u-h3" id="Sec23">Production of the fHR1 peptide</h3><p>For the production of the fHR1 peptide corresponding to amino acids 1047–1156 of the FIPV spike protein (acc. no. VGIH79), a PCR fragment was prepared using as a template the sequence from cDNA clone B1, which contains the FIPV spike gene.<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 41" title="de Groot RJ et al. Stably expressed FIPV peplomer protein induces cell fusion and elicits neutralizing antibodies in mice. Virology 1989; 171: 493–502." href="/articles/3302535#ref-CR41" id="ref-link-section-d30835e1266">41</a></sup> The fHR1 peptide was expressed in <i>Escherichia coli</i>, purified, and quantified as described elsewhere.<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 11" title="Bosch BJ, van der Zee R, de Haan CA, Rottier PJ . The coronavirus spike protein is a class I virus fusion protein: structural and functional characterization of the fusion core complex. J Virol 2003; 77: 8801–8811." href="/articles/3302535#ref-CR11" id="ref-link-section-d30835e1273">11</a>, <a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 42" title="Volkel D, Blankenfeldt W, Schomburg D . Large-scale production, purification and refolding of the full-length cellular prion protein from Syrian golden hamster in Escherichia coli using the glutathione S-transferase-fusion system. Eur J Biochem 1998; 251: 462–471." href="/articles/3302535#ref-CR42" id="ref-link-section-d30835e1276">42</a></sup></p><h3 class="c-article__sub-heading u-h3" id="Sec24">Analysis of the fusion mechanisms of coronavirus infection</h3><p>Sensitivity of the normal virus–cell fusion process to fHR1 was studied by inoculating feline FCWF-4 with fMHV at an MOI of 0.5 in the presence or absence of 0.5 μ<span class="u-small-caps">M</span> fHR1 peptide for 8 h. The effect of fHR1 on the targeted fusion process was analyzed by preparing in parallel two inoculation mixtures by preincubating fMHV with scFv 23F-425 for 1 h at 4°C after which 0.5 μ<span class="u-small-caps">M</span> fHR1 peptide was added to one mixture. Two cultures of human A431 cells were washed with PBS and inoculated at an MOI of 5 for 16 h at 37°C with the infection mixes. The cells were fixed, permeabilized, and stained for the presence of fMHV using anti-MHV rabbit antiserum K134. The number of infected cells was counted by using light microscopy.</p><p>The sensitivity of the cell–cell fusion process during normal infection of feline FCWF-4 cells was analyzed by inoculating cells with fMHV at an MOI of 0.5 for 1 h at 37°C, washing them three times with PBS, and incubating for 7 h in culture medium with or without 0.5 μ<span class="u-small-caps">M</span> fHR1 peptide. For a similar analysis of cell–cell fusion after targeted infection, cultures of A431 cells were inoculated at an MOI of 5 with fMHV preincubated with scFv 23F-425 for 1 h at 4°C. Next, the cells were washed three times with PBS, and incubated for 22 h in culture medium with or without 0.5 μ<span class="u-small-caps">M</span> fHR1 peptide. The cells were fixed, permeabilized, and immunostained for the presence of fMHV proteins. The number of nuclei per syncytium was counted under the light microscope.</p></div></div></section>
                        

                        <section aria-labelledby="Bib1"><div class="c-article-section" id="Bib1-section"><h2 class="c-article-section__title u-h2 js-section-title js-c-reading-companion-sections-item" id="Bib1">References</h2><div class="c-article-section__content" id="Bib1-content"><div data-container-section="references"><ol class="c-article-references"><li class="c-article-references__item js-c-reading-companion-references-item" itemprop="citation" itemscope="itemscope" itemtype="http://schema.org/ScholarlyArticle"><meta itemprop="author" content="CJ. Ring, " /><meta itemprop="datePublished" content="2002" /><meta itemprop="headline" content="Ring CJ . Cytolytic viruses as potential anti-cancer agents. J Gen Virol 2002; 83: 491–502." /><span class="c-article-references__counter">1</span><p class="c-article-references__text" id="ref-CR1">Ring CJ . Cytolytic viruses as potential anti-cancer agents. <i>J Gen Virol</i> 2002; <b>83</b>: 491–502.</p><ul class="c-article-references__links u-hide-print"><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" href="https://doi.org/10.1099%2F0022-1317-83-3-491" aria-label="View reference 1">Article</a></li><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" aria-label="Search for reference 1 on Google Scholar" href="http://scholar.google.com/scholar_lookup?&amp;title=Cytolytic%20viruses%20as%20potential%20anti-cancer%20agents&amp;journal=J%20Gen%20Virol&amp;volume=83&amp;pages=491-502&amp;publication_year=2002&amp;author=Ring%2CCJ">
                        Google Scholar</a></li></ul></li><li class="c-article-references__item js-c-reading-companion-references-item" itemprop="citation" itemscope="itemscope" itemtype="http://schema.org/ScholarlyArticle"><meta itemprop="author" content="SJ. Russell, " /><meta itemprop="datePublished" content="2002" /><meta itemprop="headline" content="Russell SJ . RNA viruses as virotherapy agents. Cancer Gene Ther 2002; 9: 961–966." /><span class="c-article-references__counter">2</span><p class="c-article-references__text" id="ref-CR2">Russell SJ . RNA viruses as virotherapy agents. <i>Cancer Gene Ther</i> 2002; <b>9</b>: 961–966.</p><ul class="c-article-references__links u-hide-print"><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" href="/articles/cas-redirect/1%3ACAS%3A528%3ADC%252BD3sXhs1Oisw%253D%253D" aria-label="View reference 2 on CAS">CAS</a></li><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" href="https://doi.org/10.1038%2Fsj.cgt.7700535" aria-label="View reference 2">Article</a></li><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" aria-label="Search for reference 2 on Google Scholar" href="http://scholar.google.com/scholar_lookup?&amp;title=RNA%20viruses%20as%20virotherapy%20agents&amp;journal=Cancer%20Gene%20Ther&amp;volume=9&amp;pages=961-966&amp;publication_year=2002&amp;author=Russell%2CSJ">
                        Google Scholar</a></li></ul></li><li class="c-article-references__item js-c-reading-companion-references-item" itemprop="citation" itemscope="itemscope" itemtype="http://schema.org/Book"><meta itemprop="author" content="KV. Holmes, MM. Lai, " /><meta itemprop="datePublished" content="1996" /><meta itemprop="headline" content="Holmes KV, Lai MM . The viruses and their replication. In: Howley PM (ed). Fields Virology. Lippincott-Raven P" /><span class="c-article-references__counter">3</span><p class="c-article-references__text" id="ref-CR3">Holmes KV, Lai MM . The viruses and their replication. In: Howley PM (ed). <i>Fields Virology</i>. Lippincott-Raven Publishers: Philadelphia, 1996, pp 1075–1093.</p><ul class="c-article-references__links u-hide-print"><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" aria-label="Search for reference 3 on Google Scholar" href="http://scholar.google.com/scholar_lookup?&amp;title=Fields%20Virology&amp;pages=1075-1093&amp;publication_year=1996&amp;author=Holmes%2CKV&amp;author=Lai%2CMM">
                        Google Scholar</a></li></ul></li><li class="c-article-references__item js-c-reading-companion-references-item" itemprop="citation" itemscope="itemscope" itemtype="http://schema.org/Book"><meta itemprop="author" content="D. Cavanagh, " /><meta itemprop="datePublished" content="1995" /><meta itemprop="headline" content="Cavanagh D . The coronavirus surface protein. In: Siddell SG (ed). The Coronaviridae. Plenum Press: New York, " /><span class="c-article-references__counter">4</span><p class="c-article-references__text" id="ref-CR4">Cavanagh D . The coronavirus surface protein. In: Siddell SG (ed). <i>The Coronaviridae</i>. Plenum Press: New York, NY, 1995, pp 73–103.</p><ul class="c-article-references__links u-hide-print"><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" aria-label="Search for reference 4 on Google Scholar" href="http://scholar.google.com/scholar_lookup?&amp;title=The%20Coronaviridae&amp;pages=73-103&amp;publication_year=1995&amp;author=Cavanagh%2CD">
                        Google Scholar</a></li></ul></li><li class="c-article-references__item js-c-reading-companion-references-item" itemprop="citation" itemscope="itemscope" itemtype="http://schema.org/ScholarlyArticle"><meta itemprop="author" content="H. Vennema, " /><meta itemprop="datePublished" content="1990" /><meta itemprop="headline" content="Vennema H et al. Intracellular transport of recombinant coronavirus spike proteins: implications for virus ass" /><span class="c-article-references__counter">5</span><p class="c-article-references__text" id="ref-CR5">Vennema H et al. Intracellular transport of recombinant coronavirus spike proteins: implications for virus assembly. <i>J Virol</i> 1990; <b>64</b>: 339–346.</p><ul class="c-article-references__links u-hide-print"><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" href="/articles/cas-redirect/1%3ACAS%3A528%3ADyaK3cXlt1Sgtw%253D%253D" aria-label="View reference 5 on CAS">CAS</a></li><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=2403441" aria-label="View reference 5 on PubMed" rel="nofollow">PubMed</a></li><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC249107" aria-label="View reference 5 on PubMed Central" rel="nofollow">PubMed Central</a></li><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" aria-label="Search for reference 5 on Google Scholar" href="http://scholar.google.com/scholar_lookup?&amp;title=Intracellular%20transport%20of%20recombinant%20coronavirus%20spike%20proteins%3A%20implications%20for%20virus%20assembly&amp;journal=J%20Virol&amp;volume=64&amp;pages=339-346&amp;publication_year=1990&amp;author=Vennema%2CH">
                        Google Scholar</a></li></ul></li><li class="c-article-references__item js-c-reading-companion-references-item" itemprop="citation" itemscope="itemscope" itemtype="http://schema.org/ScholarlyArticle"><meta itemprop="author" content="DB. Tresnan, R. Levis, KV. Holmes, " /><meta itemprop="datePublished" content="1996" /><meta itemprop="headline" content="Tresnan DB, Levis R, Holmes KV . Feline aminopeptidase N serves as a receptor for feline, canine, porcine, and" /><span class="c-article-references__counter">6</span><p class="c-article-references__text" id="ref-CR6">Tresnan DB, Levis R, Holmes KV . Feline aminopeptidase N serves as a receptor for feline, canine, porcine, and human coronaviruses in serogroup I. <i>J Virol</i> 1996; <b>70</b>: 8669–8674.</p><ul class="c-article-references__links u-hide-print"><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" href="/articles/cas-redirect/1%3ACAS%3A528%3ADyaK28XmvVGls70%253D" aria-label="View reference 6 on CAS">CAS</a></li><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=8970993" aria-label="View reference 6 on PubMed" rel="nofollow">PubMed</a></li><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC190961" aria-label="View reference 6 on PubMed Central" rel="nofollow">PubMed Central</a></li><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" aria-label="Search for reference 6 on Google Scholar" href="http://scholar.google.com/scholar_lookup?&amp;title=Feline%20aminopeptidase%20N%20serves%20as%20a%20receptor%20for%20feline%2C%20canine%2C%20porcine%2C%20and%20human%20coronaviruses%20in%20serogroup%20I&amp;journal=J%20Virol&amp;volume=70&amp;pages=8669-8674&amp;publication_year=1996&amp;author=Tresnan%2CDB&amp;author=Levis%2CR&amp;author=Holmes%2CKV">
                        Google Scholar</a></li></ul></li><li class="c-article-references__item js-c-reading-companion-references-item" itemprop="citation" itemscope="itemscope" itemtype="http://schema.org/ScholarlyArticle"><meta itemprop="author" content="GS. Dveksler, " /><meta itemprop="datePublished" content="1993" /><meta itemprop="headline" content="Dveksler GS et al. Several members of the mouse carcinoembryonic antigen-related glycoprotein family are funct" /><span class="c-article-references__counter">7</span><p class="c-article-references__text" id="ref-CR7">Dveksler GS et al. Several members of the mouse carcinoembryonic antigen-related glycoprotein family are functional receptors for the coronavirus mouse hepatitis virus-A59. <i>J Virol</i> 1993; <b>67</b>: 1–8.</p><ul class="c-article-references__links u-hide-print"><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" href="/articles/cas-redirect/1%3ACAS%3A528%3ADyaK3sXmt1agu74%253D" aria-label="View reference 7 on CAS">CAS</a></li><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=8380065" aria-label="View reference 7 on PubMed" rel="nofollow">PubMed</a></li><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC237331" aria-label="View reference 7 on PubMed Central" rel="nofollow">PubMed Central</a></li><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" aria-label="Search for reference 7 on Google Scholar" href="http://scholar.google.com/scholar_lookup?&amp;title=Several%20members%20of%20the%20mouse%20carcinoembryonic%20antigen-related%20glycoprotein%20family%20are%20functional%20receptors%20for%20the%20coronavirus%20mouse%20hepatitis%20virus-A59&amp;journal=J%20Virol&amp;volume=67&amp;pages=1-8&amp;publication_year=1993&amp;author=Dveksler%2CGS">
                        Google Scholar</a></li></ul></li><li class="c-article-references__item js-c-reading-companion-references-item" itemprop="citation" itemscope="itemscope" itemtype="http://schema.org/ScholarlyArticle"><meta itemprop="author" content="F. Taguchi, " /><meta itemprop="datePublished" content="1995" /><meta itemprop="headline" content="Taguchi F . The S2 subunit of the murine coronavirus spike protein is not involved in receptor binding. J Viro" /><span class="c-article-references__counter">8</span><p class="c-article-references__text" id="ref-CR8">Taguchi F . The S2 subunit of the murine coronavirus spike protein is not involved in receptor binding. <i>J Virol</i> 1995; <b>69</b>: 7260–7263.</p><ul class="c-article-references__links u-hide-print"><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" href="/articles/cas-redirect/1%3ACAS%3A528%3ADyaK2MXoslWrs7c%253D" aria-label="View reference 8 on CAS">CAS</a></li><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=7474149" aria-label="View reference 8 on PubMed" rel="nofollow">PubMed</a></li><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC189649" aria-label="View reference 8 on PubMed Central" rel="nofollow">PubMed Central</a></li><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" aria-label="Search for reference 8 on Google Scholar" href="http://scholar.google.com/scholar_lookup?&amp;title=The%20S2%20subunit%20of%20the%20murine%20coronavirus%20spike%20protein%20is%20not%20involved%20in%20receptor%20binding&amp;journal=J%20Virol&amp;volume=69&amp;pages=7260-7263&amp;publication_year=1995&amp;author=Taguchi%2CF">
                        Google Scholar</a></li></ul></li><li class="c-article-references__item js-c-reading-companion-references-item" itemprop="citation" itemscope="itemscope" itemtype="http://schema.org/ScholarlyArticle"><meta itemprop="author" content="LS. Sturman, CS. Ricard, KV. Holmes, " /><meta itemprop="datePublished" content="1990" /><meta itemprop="headline" content="Sturman LS, Ricard CS, Holmes KV . Conformational change of the coronavirus peplomer glycoprotein at pH 8.0 an" /><span class="c-article-references__counter">9</span><p class="c-article-references__text" id="ref-CR9">Sturman LS, Ricard CS, Holmes KV . Conformational change of the coronavirus peplomer glycoprotein at pH 8.0 and 37 degrees C correlates with virus aggregation and virus-induced cell fusion. <i>J Virol</i> 1990; <b>64</b>: 3042–3050.</p><ul class="c-article-references__links u-hide-print"><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" href="/articles/cas-redirect/1%3ACAS%3A528%3ADyaK3cXkt1Skt7s%253D" aria-label="View reference 9 on CAS">CAS</a></li><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=2159562" aria-label="View reference 9 on PubMed" rel="nofollow">PubMed</a></li><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC249489" aria-label="View reference 9 on PubMed Central" rel="nofollow">PubMed Central</a></li><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" aria-label="Search for reference 9 on Google Scholar" href="http://scholar.google.com/scholar_lookup?&amp;title=Conformational%20change%20of%20the%20coronavirus%20peplomer%20glycoprotein%20at%20pH%208.0%20and%2037%20degrees%20C%20correlates%20with%20virus%20aggregation%20and%20virus-induced%20cell%20fusion&amp;journal=J%20Virol&amp;volume=64&amp;pages=3042-3050&amp;publication_year=1990&amp;author=Sturman%2CLS&amp;author=Ricard%2CCS&amp;author=Holmes%2CKV">
                        Google Scholar</a></li></ul></li><li class="c-article-references__item js-c-reading-companion-references-item" itemprop="citation" itemscope="itemscope" itemtype="http://schema.org/ScholarlyArticle"><meta itemprop="author" content="DW. Yoo, MD. Parker, LA. Babiuk, " /><meta itemprop="datePublished" content="1991" /><meta itemprop="headline" content="Yoo DW, Parker MD, Babiuk LA . The S2 subunit of the spike glycoprotein of bovine coronavirus mediates membran" /><span class="c-article-references__counter">10</span><p class="c-article-references__text" id="ref-CR10">Yoo DW, Parker MD, Babiuk LA . The S2 subunit of the spike glycoprotein of bovine coronavirus mediates membrane fusion in insect cells. <i>Virology</i> 1991; <b>180</b>: 395–399.</p><ul class="c-article-references__links u-hide-print"><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" href="/articles/cas-redirect/1%3ACAS%3A528%3ADyaK3MXlvVKlsQ%253D%253D" aria-label="View reference 10 on CAS">CAS</a></li><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" href="https://doi.org/10.1016%2F0042-6822%2891%2990045-D" aria-label="View reference 10">Article</a></li><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" aria-label="Search for reference 10 on Google Scholar" href="http://scholar.google.com/scholar_lookup?&amp;title=The%20S2%20subunit%20of%20the%20spike%20glycoprotein%20of%20bovine%20coronavirus%20mediates%20membrane%20fusion%20in%20insect%20cells&amp;journal=Virology&amp;volume=180&amp;pages=395-399&amp;publication_year=1991&amp;author=Yoo%2CDW&amp;author=Parker%2CMD&amp;author=Babiuk%2CLA">
                        Google Scholar</a></li></ul></li><li class="c-article-references__item js-c-reading-companion-references-item" itemprop="citation" itemscope="itemscope" itemtype="http://schema.org/ScholarlyArticle"><meta itemprop="author" content="BJ. Bosch, R. van der Zee, CA. de Haan, PJ. Rottier, " /><meta itemprop="datePublished" content="2003" /><meta itemprop="headline" content="Bosch BJ, van der Zee R, de Haan CA, Rottier PJ . The coronavirus spike protein is a class I virus fusion prot" /><span class="c-article-references__counter">11</span><p class="c-article-references__text" id="ref-CR11">Bosch BJ, van der Zee R, de Haan CA, Rottier PJ . The coronavirus spike protein is a class I virus fusion protein: structural and functional characterization of the fusion core complex. <i>J Virol</i> 2003; <b>77</b>: 8801–8811.</p><ul class="c-article-references__links u-hide-print"><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" href="/articles/cas-redirect/1%3ACAS%3A528%3ADC%252BD3sXmt1Sit7k%253D" aria-label="View reference 11 on CAS">CAS</a></li><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" href="https://doi.org/10.1128%2FJVI.77.16.8801-8811.2003" aria-label="View reference 11">Article</a></li><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" aria-label="Search for reference 11 on Google Scholar" href="http://scholar.google.com/scholar_lookup?&amp;title=The%20coronavirus%20spike%20protein%20is%20a%20class%20I%20virus%20fusion%20protein%3A%20structural%20and%20functional%20characterization%20of%20the%20fusion%20core%20complex&amp;journal=J%20Virol&amp;volume=77&amp;pages=8801-8811&amp;publication_year=2003&amp;author=Bosch%2CBJ&amp;author=van%20der%20Zee%2CR&amp;author=de%20Haan%2CCA&amp;author=Rottier%2CPJ">
                        Google Scholar</a></li></ul></li><li class="c-article-references__item js-c-reading-companion-references-item" itemprop="citation" itemscope="itemscope" itemtype="http://schema.org/ScholarlyArticle"><meta itemprop="author" content="L. Benbacer, " /><meta itemprop="datePublished" content="1997" /><meta itemprop="headline" content="Benbacer L et al. Interspecies aminopeptidase-N chimeras reveal species-specific receptor recognition by canin" /><span class="c-article-references__counter">12</span><p class="c-article-references__text" id="ref-CR12">Benbacer L et al. Interspecies aminopeptidase-N chimeras reveal species-specific receptor recognition by canine coronavirus, feline infectious peritonitis virus, and transmissible gastroenteritis virus. <i>J Virol</i> 1997; <b>71</b>: 734–737.</p><ul class="c-article-references__links u-hide-print"><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" href="/articles/cas-redirect/1%3ACAS%3A528%3ADyaK28XnsF2rt7s%253D" aria-label="View reference 12 on CAS">CAS</a></li><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=8985407" aria-label="View reference 12 on PubMed" rel="nofollow">PubMed</a></li><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC191108" aria-label="View reference 12 on PubMed Central" rel="nofollow">PubMed Central</a></li><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" aria-label="Search for reference 12 on Google Scholar" href="http://scholar.google.com/scholar_lookup?&amp;title=Interspecies%20aminopeptidase-N%20chimeras%20reveal%20species-specific%20receptor%20recognition%20by%20canine%20coronavirus%2C%20feline%20infectious%20peritonitis%20virus%2C%20and%20transmissible%20gastroenteritis%20virus&amp;journal=J%20Virol&amp;volume=71&amp;pages=734-737&amp;publication_year=1997&amp;author=Benbacer%2CL">
                        Google Scholar</a></li></ul></li><li class="c-article-references__item js-c-reading-companion-references-item" itemprop="citation" itemscope="itemscope" itemtype="http://schema.org/ScholarlyArticle"><meta itemprop="author" content="DE. Wentworth, KV. Holmes, " /><meta itemprop="datePublished" content="2001" /><meta itemprop="headline" content="Wentworth DE, Holmes KV . Molecular determinants of species specificity in the coronavirus receptor aminopepti" /><span class="c-article-references__counter">13</span><p class="c-article-references__text" id="ref-CR13">Wentworth DE, Holmes KV . Molecular determinants of species specificity in the coronavirus receptor aminopeptidase N (CD13): influence of N-linked glycosylation. <i>J Virol</i> 2001; <b>75</b>: 9741–9752.</p><ul class="c-article-references__links u-hide-print"><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" href="/articles/cas-redirect/1%3ACAS%3A528%3ADC%252BD3MXnt1Ggsr0%253D" aria-label="View reference 13 on CAS">CAS</a></li><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" href="https://doi.org/10.1128%2FJVI.75.20.9741-9752.2001" aria-label="View reference 13">Article</a></li><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" aria-label="Search for reference 13 on Google Scholar" href="http://scholar.google.com/scholar_lookup?&amp;title=Molecular%20determinants%20of%20species%20specificity%20in%20the%20coronavirus%20receptor%20aminopeptidase%20N%20%28CD13%29%3A%20influence%20of%20N-linked%20glycosylation&amp;journal=J%20Virol&amp;volume=75&amp;pages=9741-9752&amp;publication_year=2001&amp;author=Wentworth%2CDE&amp;author=Holmes%2CKV">
                        Google Scholar</a></li></ul></li><li class="c-article-references__item js-c-reading-companion-references-item" itemprop="citation" itemscope="itemscope" itemtype="http://schema.org/ScholarlyArticle"><meta itemprop="author" content="SR. Compton, " /><meta itemprop="datePublished" content="1992" /><meta itemprop="headline" content="Compton SR et al. Coronavirus species specificity: murine coronavirus binds to a mouse-specific epitope on its" /><span class="c-article-references__counter">14</span><p class="c-article-references__text" id="ref-CR14">Compton SR et al. Coronavirus species specificity: murine coronavirus binds to a mouse-specific epitope on its carcinoembryonic antigen-related receptor glycoprotein. <i>J Virol</i> 1992; <b>66</b>: 7420–7428.</p><ul class="c-article-references__links u-hide-print"><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" href="/articles/cas-redirect/1%3ACAS%3A528%3ADyaK3sXkvFSq" aria-label="View reference 14 on CAS">CAS</a></li><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=1279203" aria-label="View reference 14 on PubMed" rel="nofollow">PubMed</a></li><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC240449" aria-label="View reference 14 on PubMed Central" rel="nofollow">PubMed Central</a></li><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" aria-label="Search for reference 14 on Google Scholar" href="http://scholar.google.com/scholar_lookup?&amp;title=Coronavirus%20species%20specificity%3A%20murine%20coronavirus%20binds%20to%20a%20mouse-specific%20epitope%20on%20its%20carcinoembryonic%20antigen-related%20receptor%20glycoprotein&amp;journal=J%20Virol&amp;volume=66&amp;pages=7420-7428&amp;publication_year=1992&amp;author=Compton%2CSR">
                        Google Scholar</a></li></ul></li><li class="c-article-references__item js-c-reading-companion-references-item" itemprop="citation" itemscope="itemscope" itemtype="http://schema.org/ScholarlyArticle"><meta itemprop="author" content="L. Kuo, " /><meta itemprop="datePublished" content="2000" /><meta itemprop="headline" content="Kuo L et al. Retargeting of coronavirus by substitution of the spike glycoprotein ectodomain: crossing the hos" /><span class="c-article-references__counter">15</span><p class="c-article-references__text" id="ref-CR15">Kuo L et al. Retargeting of coronavirus by substitution of the spike glycoprotein ectodomain: crossing the host cell species barrier. <i>J Virol</i> 2000; <b>74</b>: 1393–1406.</p><ul class="c-article-references__links u-hide-print"><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" href="/articles/cas-redirect/1%3ACAS%3A528%3ADC%252BD3cXmtFygtA%253D%253D" aria-label="View reference 15 on CAS">CAS</a></li><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" href="https://doi.org/10.1128%2FJVI.74.3.1393-1406.2000" aria-label="View reference 15">Article</a></li><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" aria-label="Search for reference 15 on Google Scholar" href="http://scholar.google.com/scholar_lookup?&amp;title=Retargeting%20of%20coronavirus%20by%20substitution%20of%20the%20spike%20glycoprotein%20ectodomain%3A%20crossing%20the%20host%20cell%20species%20barrier&amp;journal=J%20Virol&amp;volume=74&amp;pages=1393-1406&amp;publication_year=2000&amp;author=Kuo%2CL">
                        Google Scholar</a></li></ul></li><li class="c-article-references__item js-c-reading-companion-references-item" itemprop="citation" itemscope="itemscope" itemtype="http://schema.org/ScholarlyArticle"><meta itemprop="author" content="BJ. Haijema, H. Volders, PJ. Rottier, " /><meta itemprop="datePublished" content="2003" /><meta itemprop="headline" content="Haijema BJ, Volders H, Rottier PJ . Switching species tropism: an effective way to manipulate the feline coron" /><span class="c-article-references__counter">16</span><p class="c-article-references__text" id="ref-CR16">Haijema BJ, Volders H, Rottier PJ . Switching species tropism: an effective way to manipulate the feline coronavirus genome. <i>J Virol</i> 2003; <b>77</b>: 4528–4538.</p><ul class="c-article-references__links u-hide-print"><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" href="/articles/cas-redirect/1%3ACAS%3A528%3ADC%252BD3sXivFWis7w%253D" aria-label="View reference 16 on CAS">CAS</a></li><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" href="https://doi.org/10.1128%2FJVI.77.8.4528-4538.2003" aria-label="View reference 16">Article</a></li><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" aria-label="Search for reference 16 on Google Scholar" href="http://scholar.google.com/scholar_lookup?&amp;title=Switching%20species%20tropism%3A%20an%20effective%20way%20to%20manipulate%20the%20feline%20coronavirus%20genome&amp;journal=J%20Virol&amp;volume=77&amp;pages=4528-4538&amp;publication_year=2003&amp;author=Haijema%2CBJ&amp;author=Volders%2CH&amp;author=Rottier%2CPJ">
                        Google Scholar</a></li></ul></li><li class="c-article-references__item js-c-reading-companion-references-item" itemprop="citation" itemscope="itemscope" itemtype="http://schema.org/ScholarlyArticle"><meta itemprop="author" content="KS. Kolibaba, BJ. Druker, " /><meta itemprop="datePublished" content="1997" /><meta itemprop="headline" content="Kolibaba KS, Druker BJ . Protein tyrosine kinases and cancer. Biochim Biophys Acta 1997; 1333: F217–248." /><span class="c-article-references__counter">17</span><p class="c-article-references__text" id="ref-CR17">Kolibaba KS, Druker BJ . Protein tyrosine kinases and cancer. <i>Biochim Biophys Acta</i> 1997; <b>1333</b>: F217–248.</p><ul class="c-article-references__links u-hide-print"><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" href="/articles/cas-redirect/1%3ACAS%3A528%3ADyaK2sXnsFyrsr0%253D" aria-label="View reference 17 on CAS">CAS</a></li><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=9426205" aria-label="View reference 17 on PubMed" rel="nofollow">PubMed</a></li><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9426205" aria-label="View reference 17 on PubMed Central" rel="nofollow">PubMed Central</a></li><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" aria-label="Search for reference 17 on Google Scholar" href="http://scholar.google.com/scholar_lookup?&amp;title=Protein%20tyrosine%20kinases%20and%20cancer&amp;journal=Biochim%20Biophys%20Acta&amp;volume=1333&amp;pages=F217-248&amp;publication_year=1997&amp;author=Kolibaba%2CKS&amp;author=Druker%2CBJ">
                        Google Scholar</a></li></ul></li><li class="c-article-references__item js-c-reading-companion-references-item" itemprop="citation" itemscope="itemscope" itemtype="http://schema.org/ScholarlyArticle"><meta itemprop="author" content="MA. Olayioye, RM. Neve, HA. Lane, NE. Hynes, " /><meta itemprop="datePublished" content="2000" /><meta itemprop="headline" content="Olayioye MA, Neve RM, Lane HA, Hynes NE . The ErbB signaling network: receptor heterodimerization in developme" /><span class="c-article-references__counter">18</span><p class="c-article-references__text" id="ref-CR18">Olayioye MA, Neve RM, Lane HA, Hynes NE . The ErbB signaling network: receptor heterodimerization in development and cancer. <i>EMBO J</i> 2000; <b>19</b>: 3159–3167.</p><ul class="c-article-references__links u-hide-print"><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" href="/articles/cas-redirect/1%3ACAS%3A528%3ADC%252BD3cXlt1ajtLY%253D" aria-label="View reference 18 on CAS">CAS</a></li><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" href="https://doi.org/10.1093%2Femboj%2F19.13.3159" aria-label="View reference 18">Article</a></li><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" aria-label="Search for reference 18 on Google Scholar" href="http://scholar.google.com/scholar_lookup?&amp;title=The%20ErbB%20signaling%20network%3A%20receptor%20heterodimerization%20in%20development%20and%20cancer&amp;journal=EMBO%20J&amp;volume=19&amp;pages=3159-3167&amp;publication_year=2000&amp;author=Olayioye%2CMA&amp;author=Neve%2CRM&amp;author=Lane%2CHA&amp;author=Hynes%2CNE">
                        Google Scholar</a></li></ul></li><li class="c-article-references__item js-c-reading-companion-references-item" itemprop="citation" itemscope="itemscope" itemtype="http://schema.org/ScholarlyArticle"><meta itemprop="author" content="F. Ciardiello, G. Tortora, " /><meta itemprop="datePublished" content="2001" /><meta itemprop="headline" content="Ciardiello F, Tortora G . A novel approach in the treatment of cancer: targeting the epidermal growth factor r" /><span class="c-article-references__counter">19</span><p class="c-article-references__text" id="ref-CR19">Ciardiello F, Tortora G . A novel approach in the treatment of cancer: targeting the epidermal growth factor receptor. <i>Clin Cancer Res</i> 2001; <b>7</b>: 2958–2970.</p><ul class="c-article-references__links u-hide-print"><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" href="/articles/cas-redirect/1%3ACAS%3A528%3ADC%252BD3MXnvF2ktbk%253D" aria-label="View reference 19 on CAS">CAS</a></li><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=11595683" aria-label="View reference 19 on PubMed" rel="nofollow">PubMed</a></li><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11595683" aria-label="View reference 19 on PubMed Central" rel="nofollow">PubMed Central</a></li><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" aria-label="Search for reference 19 on Google Scholar" href="http://scholar.google.com/scholar_lookup?&amp;title=A%20novel%20approach%20in%20the%20treatment%20of%20cancer%3A%20targeting%20the%20epidermal%20growth%20factor%20receptor&amp;journal=Clin%20Cancer%20Res&amp;volume=7&amp;pages=2958-2970&amp;publication_year=2001&amp;author=Ciardiello%2CF&amp;author=Tortora%2CG">
                        Google Scholar</a></li></ul></li><li class="c-article-references__item js-c-reading-companion-references-item" itemprop="citation" itemscope="itemscope" itemtype="http://schema.org/ScholarlyArticle"><meta itemprop="author" content="J. Grill, " /><meta itemprop="datePublished" content="2002" /><meta itemprop="headline" content="Grill J et al. The organotypic multicellular spheroid is a relevant three-dimensional model to study adenoviru" /><span class="c-article-references__counter">20</span><p class="c-article-references__text" id="ref-CR20">Grill J et al. The organotypic multicellular spheroid is a relevant three-dimensional model to study adenovirus replication and penetration in human tumors <i>in vitro</i>. <i>Mol Ther</i> 2002; <b>6</b>: 609–614.</p><ul class="c-article-references__links u-hide-print"><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" href="/articles/cas-redirect/1%3ACAS%3A528%3ADC%252BD38XosVGqur4%253D" aria-label="View reference 20 on CAS">CAS</a></li><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" aria-label="Search for reference 20 on Google Scholar" href="http://scholar.google.com/scholar_lookup?&amp;title=The%20organotypic%20multicellular%20spheroid%20is%20a%20relevant%20three-dimensional%20model%20to%20study%20adenovirus%20replication%20and%20penetration%20in%20human%20tumors%20in%20vitro&amp;journal=Mol%20Ther&amp;volume=6&amp;pages=609-614&amp;publication_year=2002&amp;author=Grill%2CJ">
                        Google Scholar</a></li></ul></li><li class="c-article-references__item js-c-reading-companion-references-item" itemprop="citation" itemscope="itemscope" itemtype="http://schema.org/ScholarlyArticle"><meta itemprop="author" content="PO. Enger, " /><meta itemprop="datePublished" content="2002" /><meta itemprop="headline" content="Enger PO et al. Adeno-associated viral vectors penetrate human solid tumor tissue in vivo more effectively tha" /><span class="c-article-references__counter">21</span><p class="c-article-references__text" id="ref-CR21">Enger PO et al. Adeno-associated viral vectors penetrate human solid tumor tissue <i>in vivo</i> more effectively than adenoviral vectors. <i>Hum Gene Ther</i> 2002; <b>10</b>: 1115–1125.</p><ul class="c-article-references__links u-hide-print"><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" href="https://doi.org/10.1089%2F104303402753812511" aria-label="View reference 21">Article</a></li><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" aria-label="Search for reference 21 on Google Scholar" href="http://scholar.google.com/scholar_lookup?&amp;title=Adeno-associated%20viral%20vectors%20penetrate%20human%20solid%20tumor%20tissue%20in%20vivo%20more%20effectively%20than%20adenoviral%20vectors&amp;journal=Hum%20Gene%20Ther&amp;volume=10&amp;pages=1115-1125&amp;publication_year=2002&amp;author=Enger%2CPO">
                        Google Scholar</a></li></ul></li><li class="c-article-references__item js-c-reading-companion-references-item" itemprop="citation" itemscope="itemscope" itemtype="http://schema.org/ScholarlyArticle"><meta itemprop="author" content="CG. Schalkwijk, " /><meta itemprop="datePublished" content="1996" /><meta itemprop="headline" content="Schalkwijk CG et al. Maximal epidermal growth-factor-induced cytosolic phospholipase A2 activation in vivo req" /><span class="c-article-references__counter">22</span><p class="c-article-references__text" id="ref-CR22">Schalkwijk CG et al. Maximal epidermal growth-factor-induced cytosolic phospholipase A2 activation <i>in vivo</i> requires phosphorylation followed by an increased intracellular calcium concentration. <i>Biochem J</i> 1996; <b>313</b>: 91–96.</p><ul class="c-article-references__links u-hide-print"><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" href="/articles/cas-redirect/1%3ACAS%3A528%3ADyaK28XivVOnug%253D%253D" aria-label="View reference 22 on CAS">CAS</a></li><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" href="https://doi.org/10.1042%2Fbj3130091" aria-label="View reference 22">Article</a></li><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" aria-label="Search for reference 22 on Google Scholar" href="http://scholar.google.com/scholar_lookup?&amp;title=Maximal%20epidermal%20growth-factor-induced%20cytosolic%20phospholipase%20A2%20activation%20in%20vivo%20requires%20phosphorylation%20followed%20by%20an%20increased%20intracellular%20calcium%20concentration&amp;journal=Biochem%20J&amp;volume=313&amp;pages=91-96&amp;publication_year=1996&amp;author=Schalkwijk%2CCG">
                        Google Scholar</a></li></ul></li><li class="c-article-references__item js-c-reading-companion-references-item" itemprop="citation" itemscope="itemscope" itemtype="http://schema.org/ScholarlyArticle"><meta itemprop="author" content="DM. Eckert, PS. Kim, " /><meta itemprop="datePublished" content="2001" /><meta itemprop="headline" content="Eckert DM, Kim PS . Mechanisms of viral membrnae fusion and its inhibition. Annu Rev Biochem 2001; 70: 777–810" /><span class="c-article-references__counter">23</span><p class="c-article-references__text" id="ref-CR23">Eckert DM, Kim PS . Mechanisms of viral membrnae fusion and its inhibition. <i>Annu Rev Biochem</i> 2001; <b>70</b>: 777–810.</p><ul class="c-article-references__links u-hide-print"><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" href="/articles/cas-redirect/1%3ACAS%3A528%3ADC%252BD3MXlsVehtLc%253D" aria-label="View reference 23 on CAS">CAS</a></li><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" href="https://doi.org/10.1146%2Fannurev.biochem.70.1.777" aria-label="View reference 23">Article</a></li><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" aria-label="Search for reference 23 on Google Scholar" href="http://scholar.google.com/scholar_lookup?&amp;title=Mechanisms%20of%20viral%20membrnae%20fusion%20and%20its%20inhibition&amp;journal=Annu%20Rev%20Biochem&amp;volume=70&amp;pages=777-810&amp;publication_year=2001&amp;author=Eckert%2CDM&amp;author=Kim%2CPS">
                        Google Scholar</a></li></ul></li><li class="c-article-references__item js-c-reading-companion-references-item" itemprop="citation" itemscope="itemscope" itemtype="http://schema.org/ScholarlyArticle"><meta itemprop="author" content="PV. Rao, S. Kumari, TM. Gallagher, " /><meta itemprop="datePublished" content="1997" /><meta itemprop="headline" content="Rao PV, Kumari S, Gallagher TM . Identification of a contiguous 6-residue determinant in the MHV receptor that" /><span class="c-article-references__counter">24</span><p class="c-article-references__text" id="ref-CR24">Rao PV, Kumari S, Gallagher TM . Identification of a contiguous 6-residue determinant in the MHV receptor that controls the level of virion binding to cells. <i>Virology</i> 1997; <b>229</b>: 336–348.</p><ul class="c-article-references__links u-hide-print"><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" href="/articles/cas-redirect/1%3ACAS%3A528%3ADyaK2sXitV2it78%253D" aria-label="View reference 24 on CAS">CAS</a></li><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" href="https://doi.org/10.1006%2Fviro.1997.8446" aria-label="View reference 24">Article</a></li><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" aria-label="Search for reference 24 on Google Scholar" href="http://scholar.google.com/scholar_lookup?&amp;title=Identification%20of%20a%20contiguous%206-residue%20determinant%20in%20the%20MHV%20receptor%20that%20controls%20the%20level%20of%20virion%20binding%20to%20cells&amp;journal=Virology&amp;volume=229&amp;pages=336-348&amp;publication_year=1997&amp;author=Rao%2CPV&amp;author=Kumari%2CS&amp;author=Gallagher%2CTM">
                        Google Scholar</a></li></ul></li><li class="c-article-references__item js-c-reading-companion-references-item" itemprop="citation" itemscope="itemscope" itemtype="http://schema.org/ScholarlyArticle"><meta itemprop="author" content="X. Fu, X. Zhang, " /><meta itemprop="datePublished" content="2002" /><meta itemprop="headline" content="Fu X, Zhang X . Potent systemic antitumor activity from an oncolytic herpes simplex virus of syncytial phenoty" /><span class="c-article-references__counter">25</span><p class="c-article-references__text" id="ref-CR25">Fu X, Zhang X . Potent systemic antitumor activity from an oncolytic herpes simplex virus of syncytial phenotype. <i>Cancer Res</i> 2002; <b>62</b>: 2306–2312.</p><ul class="c-article-references__links u-hide-print"><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" href="/articles/cas-redirect/1%3ACAS%3A528%3ADC%252BD38Xjt1ejtbg%253D" aria-label="View reference 25 on CAS">CAS</a></li><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" aria-label="Search for reference 25 on Google Scholar" href="http://scholar.google.com/scholar_lookup?&amp;title=Potent%20systemic%20antitumor%20activity%20from%20an%20oncolytic%20herpes%20simplex%20virus%20of%20syncytial%20phenotype&amp;journal=Cancer%20Res&amp;volume=62&amp;pages=2306-2312&amp;publication_year=2002&amp;author=Fu%2CX&amp;author=Zhang%2CX">
                        Google Scholar</a></li></ul></li><li class="c-article-references__item js-c-reading-companion-references-item" itemprop="citation" itemscope="itemscope" itemtype="http://schema.org/ScholarlyArticle"><meta itemprop="author" content="KW. Peng, " /><meta itemprop="datePublished" content="2003" /><meta itemprop="headline" content="Peng KW et al. Oncolytic measles viruses displaying a single-chain antibody against CD38, a myeloma cell marke" /><span class="c-article-references__counter">26</span><p class="c-article-references__text" id="ref-CR26">Peng KW et al. Oncolytic measles viruses displaying a single-chain antibody against CD38, a myeloma cell marker. <i>Blood</i> 2003; <b>101</b>: 2557–2562.</p><ul class="c-article-references__links u-hide-print"><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" href="/articles/cas-redirect/1%3ACAS%3A528%3ADC%252BD3sXivVWguro%253D" aria-label="View reference 26 on CAS">CAS</a></li><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" href="https://doi.org/10.1182%2Fblood-2002-07-2195" aria-label="View reference 26">Article</a></li><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" aria-label="Search for reference 26 on Google Scholar" href="http://scholar.google.com/scholar_lookup?&amp;title=Oncolytic%20measles%20viruses%20displaying%20a%20single-chain%20antibody%20against%20CD38%2C%20a%20myeloma%20cell%20marker&amp;journal=Blood&amp;volume=101&amp;pages=2557-2562&amp;publication_year=2003&amp;author=Peng%2CKW">
                        Google Scholar</a></li></ul></li><li class="c-article-references__item js-c-reading-companion-references-item" itemprop="citation" itemscope="itemscope" itemtype="http://schema.org/ScholarlyArticle"><meta itemprop="author" content="BD. Anderson, T. Nakamura, SJ. Russell, KW. Peng, " /><meta itemprop="datePublished" content="2004" /><meta itemprop="headline" content="Anderson BD, Nakamura T, Russell SJ, Peng KW . High CD46 receptor density determines preferential killing of t" /><span class="c-article-references__counter">27</span><p class="c-article-references__text" id="ref-CR27">Anderson BD, Nakamura T, Russell SJ, Peng KW . High CD46 receptor density determines preferential killing of tumor cells by oncolytic measles virus. <i>Cancer Res</i> 2004; <b>64</b>: 4919–4926.</p><ul class="c-article-references__links u-hide-print"><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" href="/articles/cas-redirect/1%3ACAS%3A528%3ADC%252BD2cXls1Omtrk%253D" aria-label="View reference 27 on CAS">CAS</a></li><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" href="https://doi.org/10.1158%2F0008-5472.CAN-04-0884" aria-label="View reference 27">Article</a></li><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" aria-label="Search for reference 27 on Google Scholar" href="http://scholar.google.com/scholar_lookup?&amp;title=High%20CD46%20receptor%20density%20determines%20preferential%20killing%20of%20tumor%20cells%20by%20oncolytic%20measles%20virus&amp;journal=Cancer%20Res&amp;volume=64&amp;pages=4919-4926&amp;publication_year=2004&amp;author=Anderson%2CBD&amp;author=Nakamura%2CT&amp;author=Russell%2CSJ&amp;author=Peng%2CKW">
                        Google Scholar</a></li></ul></li><li class="c-article-references__item js-c-reading-companion-references-item" itemprop="citation" itemscope="itemscope" itemtype="http://schema.org/ScholarlyArticle"><meta itemprop="author" content="VW. van Beusechem, " /><meta itemprop="datePublished" content="2003" /><meta itemprop="headline" content="van Beusechem VW et al. Conditionally replicative adenovirus expressing a targeting adapter molecule exhibits " /><span class="c-article-references__counter">28</span><p class="c-article-references__text" id="ref-CR28">van Beusechem VW et al. Conditionally replicative adenovirus expressing a targeting adapter molecule exhibits enhanced oncolytic potency on CAR-deficient tumors. <i>Gene Therapy</i> 2003; <b>10</b>: 1982–1991.</p><ul class="c-article-references__links u-hide-print"><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" href="/articles/cas-redirect/1%3ACAS%3A528%3ADC%252BD3sXnsl2rsb8%253D" aria-label="View reference 28 on CAS">CAS</a></li><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" href="https://doi.org/10.1038%2Fsj.gt.3302103" aria-label="View reference 28">Article</a></li><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" aria-label="Search for reference 28 on Google Scholar" href="http://scholar.google.com/scholar_lookup?&amp;title=Conditionally%20replicative%20adenovirus%20expressing%20a%20targeting%20adapter%20molecule%20exhibits%20enhanced%20oncolytic%20potency%20on%20CAR-deficient%20tumors&amp;journal=Gene%20Therapy&amp;volume=10&amp;pages=1982-1991&amp;publication_year=2003&amp;author=van%20Beusechem%2CVW">
                        Google Scholar</a></li></ul></li><li class="c-article-references__item js-c-reading-companion-references-item" itemprop="citation" itemscope="itemscope" itemtype="http://schema.org/ScholarlyArticle"><meta itemprop="author" content="CA. de Haan, " /><meta itemprop="datePublished" content="2003" /><meta itemprop="headline" content="de Haan CA et al. Coronaviruses as vectors: position dependence of foreign gene expression. J Virol 2003; 77: " /><span class="c-article-references__counter">29</span><p class="c-article-references__text" id="ref-CR29">de Haan CA et al. Coronaviruses as vectors: position dependence of foreign gene expression. <i>J Virol</i> 2003; <b>77</b>: 11312–11323.</p><ul class="c-article-references__links u-hide-print"><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" href="/articles/cas-redirect/1%3ACAS%3A528%3ADC%252BD3sXosFSjtL8%253D" aria-label="View reference 29 on CAS">CAS</a></li><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" href="https://doi.org/10.1128%2FJVI.77.21.11312-11323.2003" aria-label="View reference 29">Article</a></li><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" aria-label="Search for reference 29 on Google Scholar" href="http://scholar.google.com/scholar_lookup?&amp;title=Coronaviruses%20as%20vectors%3A%20position%20dependence%20of%20foreign%20gene%20expression&amp;journal=J%20Virol&amp;volume=77&amp;pages=11312-11323&amp;publication_year=2003&amp;author=de%20Haan%2CCA">
                        Google Scholar</a></li></ul></li><li class="c-article-references__item js-c-reading-companion-references-item" itemprop="citation" itemscope="itemscope" itemtype="http://schema.org/ScholarlyArticle"><meta itemprop="author" content="CA. de Haan, " /><meta itemprop="datePublished" content="2002" /><meta itemprop="headline" content="de Haan CA et al. The group-specific murine coronavirus genes are not essential, but their deletion, by revers" /><span class="c-article-references__counter">30</span><p class="c-article-references__text" id="ref-CR30">de Haan CA et al. The group-specific murine coronavirus genes are not essential, but their deletion, by reverse genetics, is attenuating in the natural host. <i>Virology</i> 2002; <b>296</b>: 177–189.</p><ul class="c-article-references__links u-hide-print"><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" href="/articles/cas-redirect/1%3ACAS%3A528%3ADC%252BD38XktVehu74%253D" aria-label="View reference 30 on CAS">CAS</a></li><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" href="https://doi.org/10.1006%2Fviro.2002.1412" aria-label="View reference 30">Article</a></li><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" aria-label="Search for reference 30 on Google Scholar" href="http://scholar.google.com/scholar_lookup?&amp;title=The%20group-specific%20murine%20coronavirus%20genes%20are%20not%20essential%2C%20but%20their%20deletion%2C%20by%20reverse%20genetics%2C%20is%20attenuating%20in%20the%20natural%20host&amp;journal=Virology&amp;volume=296&amp;pages=177-189&amp;publication_year=2002&amp;author=de%20Haan%2CCA">
                        Google Scholar</a></li></ul></li><li class="c-article-references__item js-c-reading-companion-references-item" itemprop="citation" itemscope="itemscope" itemtype="http://schema.org/ScholarlyArticle"><meta itemprop="author" content="BJ. Haijema, H. Volders, PJ. Rottier, " /><meta itemprop="datePublished" content="2004" /><meta itemprop="headline" content="Haijema BJ, Volders H, Rottier PJ . Live, attenuated coronavirus vaccines through the directed deletion of gro" /><span class="c-article-references__counter">31</span><p class="c-article-references__text" id="ref-CR31">Haijema BJ, Volders H, Rottier PJ . Live, attenuated coronavirus vaccines through the directed deletion of group-specific genes provide protection against feline infectious peritonitis. <i>J Virol</i> 2004; <b>78</b>: 3863–3871.</p><ul class="c-article-references__links u-hide-print"><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" href="/articles/cas-redirect/1%3ACAS%3A528%3ADC%252BD2cXjtFWlsLg%253D" aria-label="View reference 31 on CAS">CAS</a></li><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" href="https://doi.org/10.1128%2FJVI.78.8.3863-3871.2004" aria-label="View reference 31">Article</a></li><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" aria-label="Search for reference 31 on Google Scholar" href="http://scholar.google.com/scholar_lookup?&amp;title=Live%2C%20attenuated%20coronavirus%20vaccines%20through%20the%20directed%20deletion%20of%20group-specific%20genes%20provide%20protection%20against%20feline%20infectious%20peritonitis&amp;journal=J%20Virol&amp;volume=78&amp;pages=3863-3871&amp;publication_year=2004&amp;author=Haijema%2CBJ&amp;author=Volders%2CH&amp;author=Rottier%2CPJ">
                        Google Scholar</a></li></ul></li><li class="c-article-references__item js-c-reading-companion-references-item" itemprop="citation" itemscope="itemscope" itemtype="http://schema.org/ScholarlyArticle"><meta itemprop="author" content="CA. de Haan, " /><meta itemprop="datePublished" content="2002" /><meta itemprop="headline" content="de Haan CA et al. Coronaviruses maintain viability despite dramatic rearrangements of the strictly conserved g" /><span class="c-article-references__counter">32</span><p class="c-article-references__text" id="ref-CR32">de Haan CA et al. Coronaviruses maintain viability despite dramatic rearrangements of the strictly conserved genome organization. <i>J Virol</i> 2002; <b>76</b>: 12491–12502.</p><ul class="c-article-references__links u-hide-print"><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" href="/articles/cas-redirect/1%3ACAS%3A528%3ADC%252BD38XptVygtLY%253D" aria-label="View reference 32 on CAS">CAS</a></li><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" href="https://doi.org/10.1128%2FJVI.76.24.12491-12502.2002" aria-label="View reference 32">Article</a></li><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" aria-label="Search for reference 32 on Google Scholar" href="http://scholar.google.com/scholar_lookup?&amp;title=Coronaviruses%20maintain%20viability%20despite%20dramatic%20rearrangements%20of%20the%20strictly%20conserved%20genome%20organization&amp;journal=J%20Virol&amp;volume=76&amp;pages=12491-12502&amp;publication_year=2002&amp;author=de%20Haan%2CCA">
                        Google Scholar</a></li></ul></li><li class="c-article-references__item js-c-reading-companion-references-item" itemprop="citation" itemscope="itemscope" itemtype="http://schema.org/ScholarlyArticle"><meta itemprop="author" content="AD. Bucheit, " /><meta itemprop="datePublished" content="2003" /><meta itemprop="headline" content="Bucheit AD et al. An oncolytic measles virus engineered to enter cells through the CD20 antigen. Mol Ther 2003" /><span class="c-article-references__counter">33</span><p class="c-article-references__text" id="ref-CR33">Bucheit AD et al. An oncolytic measles virus engineered to enter cells through the CD20 antigen. <i>Mol Ther</i> 2003; <b>7</b>: 62–72.</p><ul class="c-article-references__links u-hide-print"><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" href="/articles/cas-redirect/1%3ACAS%3A528%3ADC%252BD3sXps1GjtA%253D%253D" aria-label="View reference 33 on CAS">CAS</a></li><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" href="https://doi.org/10.1016%2FS1525-0016%2802%2900033-3" aria-label="View reference 33">Article</a></li><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" aria-label="Search for reference 33 on Google Scholar" href="http://scholar.google.com/scholar_lookup?&amp;title=An%20oncolytic%20measles%20virus%20engineered%20to%20enter%20cells%20through%20the%20CD20%20antigen&amp;journal=Mol%20Ther&amp;volume=7&amp;pages=62-72&amp;publication_year=2003&amp;author=Bucheit%2CAD">
                        Google Scholar</a></li></ul></li><li class="c-article-references__item js-c-reading-companion-references-item" itemprop="citation" itemscope="itemscope" itemtype="http://schema.org/ScholarlyArticle"><meta itemprop="author" content="JF. Evermann, " /><meta itemprop="datePublished" content="1981" /><meta itemprop="headline" content="Evermann JF et al. Characterization of a feline infectious peritonitis virus isolate. Vet Pathol 1981; 18: 256" /><span class="c-article-references__counter">34</span><p class="c-article-references__text" id="ref-CR34">Evermann JF et al. Characterization of a feline infectious peritonitis virus isolate. <i>Vet Pathol</i> 1981; <b>18</b>: 256–265.</p><ul class="c-article-references__links u-hide-print"><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" href="/articles/cas-redirect/1%3ASTN%3A280%3ADyaL3M7islyktw%253D%253D" aria-label="View reference 34 on CAS">CAS</a></li><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" href="https://doi.org/10.1177%2F030098588101800214" aria-label="View reference 34">Article</a></li><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" aria-label="Search for reference 34 on Google Scholar" href="http://scholar.google.com/scholar_lookup?&amp;title=Characterization%20of%20a%20feline%20infectious%20peritonitis%20virus%20isolate&amp;journal=Vet%20Pathol&amp;volume=18&amp;pages=256-265&amp;publication_year=1981&amp;author=Evermann%2CJF">
                        Google Scholar</a></li></ul></li><li class="c-article-references__item js-c-reading-companion-references-item" itemprop="citation" itemscope="itemscope" itemtype="http://schema.org/ScholarlyArticle"><meta itemprop="author" content="O. Elroy-Stein, B. Moss, " /><meta itemprop="datePublished" content="1990" /><meta itemprop="headline" content="Elroy-Stein O, Moss B . Cytoplasmic expression system based on constitutive synthesis of bacteriophage T7 RNA " /><span class="c-article-references__counter">35</span><p class="c-article-references__text" id="ref-CR35">Elroy-Stein O, Moss B . Cytoplasmic expression system based on constitutive synthesis of bacteriophage T7 RNA polymerase in mammalian cells. <i>Proc Natl Acad Sci USA</i> 1990; <b>87</b>: 6743–6747.</p><ul class="c-article-references__links u-hide-print"><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" href="/articles/cas-redirect/1%3ACAS%3A528%3ADyaK3cXlvVKjsr4%253D" aria-label="View reference 35 on CAS">CAS</a></li><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" href="https://doi.org/10.1073%2Fpnas.87.17.6743" aria-label="View reference 35">Article</a></li><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" aria-label="Search for reference 35 on Google Scholar" href="http://scholar.google.com/scholar_lookup?&amp;title=Cytoplasmic%20expression%20system%20based%20on%20constitutive%20synthesis%20of%20bacteriophage%20T7%20RNA%20polymerase%20in%20mammalian%20cells&amp;journal=Proc%20Natl%20Acad%20Sci%20USA&amp;volume=87&amp;pages=6743-6747&amp;publication_year=1990&amp;author=Elroy-Stein%2CO&amp;author=Moss%2CB">
                        Google Scholar</a></li></ul></li><li class="c-article-references__item js-c-reading-companion-references-item" itemprop="citation" itemscope="itemscope" itemtype="http://schema.org/ScholarlyArticle"><meta itemprop="author" content="WV. Corapi, CW. Olsen, FW. Scott, " /><meta itemprop="datePublished" content="1992" /><meta itemprop="headline" content="Corapi WV, Olsen CW, Scott FW . Monoclonal antibody analysis of neutralization and antibody-dependent enhancem" /><span class="c-article-references__counter">36</span><p class="c-article-references__text" id="ref-CR36">Corapi WV, Olsen CW, Scott FW . Monoclonal antibody analysis of neutralization and antibody-dependent enhancement of feline infectious peritonitis virus. <i>J Virol</i> 1992; <b>66</b>: 6695–6705.</p><ul class="c-article-references__links u-hide-print"><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" href="/articles/cas-redirect/1%3ACAS%3A528%3ADyaK3sXjslaqsQ%253D%253D" aria-label="View reference 36 on CAS">CAS</a></li><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=1383568" aria-label="View reference 36 on PubMed" rel="nofollow">PubMed</a></li><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC240165" aria-label="View reference 36 on PubMed Central" rel="nofollow">PubMed Central</a></li><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" aria-label="Search for reference 36 on Google Scholar" href="http://scholar.google.com/scholar_lookup?&amp;title=Monoclonal%20antibody%20analysis%20of%20neutralization%20and%20antibody-dependent%20enhancement%20of%20feline%20infectious%20peritonitis%20virus&amp;journal=J%20Virol&amp;volume=66&amp;pages=6695-6705&amp;publication_year=1992&amp;author=Corapi%2CWV&amp;author=Olsen%2CCW&amp;author=Scott%2CFW">
                        Google Scholar</a></li></ul></li><li class="c-article-references__item js-c-reading-companion-references-item" itemprop="citation" itemscope="itemscope" itemtype="http://schema.org/ScholarlyArticle"><meta itemprop="author" content="PJ. Rottier, MC. Horzinek, BA. van der Zeijst, " /><meta itemprop="datePublished" content="1981" /><meta itemprop="headline" content="Rottier PJ, Horzinek MC, van der Zeijst BA . Viral protein synthesis in mouse hepatitis virus strain A59-infec" /><span class="c-article-references__counter">37</span><p class="c-article-references__text" id="ref-CR37">Rottier PJ, Horzinek MC, van der Zeijst BA . Viral protein synthesis in mouse hepatitis virus strain A59-infected cells: effect of tunicamycin. <i>J Virol</i> 1981; <b>40</b>: 350–357.</p><ul class="c-article-references__links u-hide-print"><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" href="/articles/cas-redirect/1%3ACAS%3A528%3ADyaL38XjsVOi" aria-label="View reference 37 on CAS">CAS</a></li><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=6275093" aria-label="View reference 37 on PubMed" rel="nofollow">PubMed</a></li><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC256635" aria-label="View reference 37 on PubMed Central" rel="nofollow">PubMed Central</a></li><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" aria-label="Search for reference 37 on Google Scholar" href="http://scholar.google.com/scholar_lookup?&amp;title=Viral%20protein%20synthesis%20in%20mouse%20hepatitis%20virus%20strain%20A59-infected%20cells%3A%20effect%20of%20tunicamycin&amp;journal=J%20Virol&amp;volume=40&amp;pages=350-357&amp;publication_year=1981&amp;author=Rottier%2CPJ&amp;author=Horzinek%2CMC&amp;author=van%20der%20Zeijst%2CBA">
                        Google Scholar</a></li></ul></li><li class="c-article-references__item js-c-reading-companion-references-item" itemprop="citation" itemscope="itemscope" itemtype="http://schema.org/ScholarlyArticle"><meta itemprop="author" content="T. Hohdatsu, " /><meta itemprop="datePublished" content="1998" /><meta itemprop="headline" content="Hohdatsu T et al. Differences in virus receptor for type I and type II feline infectious peritonitis virus. Ar" /><span class="c-article-references__counter">38</span><p class="c-article-references__text" id="ref-CR38">Hohdatsu T et al. Differences in virus receptor for type I and type II feline infectious peritonitis virus. <i>Arch Virol</i> 1998; <b>143</b>: 839–850.</p><ul class="c-article-references__links u-hide-print"><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" href="/articles/cas-redirect/1%3ACAS%3A528%3ADyaK1cXktVSit7w%253D" aria-label="View reference 38 on CAS">CAS</a></li><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" href="https://doi.org/10.1007%2Fs007050050336" aria-label="View reference 38">Article</a></li><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" aria-label="Search for reference 38 on Google Scholar" href="http://scholar.google.com/scholar_lookup?&amp;title=Differences%20in%20virus%20receptor%20for%20type%20I%20and%20type%20II%20feline%20infectious%20peritonitis%20virus&amp;journal=Arch%20Virol&amp;volume=143&amp;pages=839-850&amp;publication_year=1998&amp;author=Hohdatsu%2CT">
                        Google Scholar</a></li></ul></li><li class="c-article-references__item js-c-reading-companion-references-item" itemprop="citation" itemscope="itemscope" itemtype="http://schema.org/ScholarlyArticle"><meta itemprop="author" content="KM. Muller, KM. Arndt, A. Pluckthun, " /><meta itemprop="datePublished" content="1998" /><meta itemprop="headline" content="Muller KM, Arndt KM, Pluckthun A . A dimeric bispecific miniantibody combines two specificities with avidity. " /><span class="c-article-references__counter">39</span><p class="c-article-references__text" id="ref-CR39">Muller KM, Arndt KM, Pluckthun A . A dimeric bispecific miniantibody combines two specificities with avidity. <i>FEBS Lett</i> 1998; <b>432</b>: 45–49.</p><ul class="c-article-references__links u-hide-print"><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" href="/articles/cas-redirect/1%3ACAS%3A528%3ADyaK1cXkvFOls74%253D" aria-label="View reference 39 on CAS">CAS</a></li><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" href="https://doi.org/10.1016%2FS0014-5793%2898%2900829-1" aria-label="View reference 39">Article</a></li><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" aria-label="Search for reference 39 on Google Scholar" href="http://scholar.google.com/scholar_lookup?&amp;title=A%20dimeric%20bispecific%20miniantibody%20combines%20two%20specificities%20with%20avidity&amp;journal=FEBS%20Lett&amp;volume=432&amp;pages=45-49&amp;publication_year=1998&amp;author=Muller%2CKM&amp;author=Arndt%2CKM&amp;author=Pluckthun%2CA">
                        Google Scholar</a></li></ul></li><li class="c-article-references__item js-c-reading-companion-references-item" itemprop="citation" itemscope="itemscope" itemtype="http://schema.org/ScholarlyArticle"><meta itemprop="author" content="HJ. Haisma, " /><meta itemprop="datePublished" content="2000" /><meta itemprop="headline" content="Haisma HJ et al. Targeting of adenoviral vectors through a bispecific single-chain antibody. Cancer Gene Ther " /><span class="c-article-references__counter">40</span><p class="c-article-references__text" id="ref-CR40">Haisma HJ et al. Targeting of adenoviral vectors through a bispecific single-chain antibody. <i>Cancer Gene Ther</i> 2000; <b>7</b>: 901–904.</p><ul class="c-article-references__links u-hide-print"><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" href="/articles/cas-redirect/1%3ACAS%3A528%3ADC%252BD3cXks1KlsLw%253D" aria-label="View reference 40 on CAS">CAS</a></li><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" href="https://doi.org/10.1038%2Fsj.cgt.7700198" aria-label="View reference 40">Article</a></li><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" aria-label="Search for reference 40 on Google Scholar" href="http://scholar.google.com/scholar_lookup?&amp;title=Targeting%20of%20adenoviral%20vectors%20through%20a%20bispecific%20single-chain%20antibody&amp;journal=Cancer%20Gene%20Ther&amp;volume=7&amp;pages=901-904&amp;publication_year=2000&amp;author=Haisma%2CHJ">
                        Google Scholar</a></li></ul></li><li class="c-article-references__item js-c-reading-companion-references-item" itemprop="citation" itemscope="itemscope" itemtype="http://schema.org/ScholarlyArticle"><meta itemprop="author" content="RJ. de Groot, " /><meta itemprop="datePublished" content="1989" /><meta itemprop="headline" content="de Groot RJ et al. Stably expressed FIPV peplomer protein induces cell fusion and elicits neutralizing antibod" /><span class="c-article-references__counter">41</span><p class="c-article-references__text" id="ref-CR41">de Groot RJ et al. Stably expressed FIPV peplomer protein induces cell fusion and elicits neutralizing antibodies in mice. <i>Virology</i> 1989; <b>171</b>: 493–502.</p><ul class="c-article-references__links u-hide-print"><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" href="/articles/cas-redirect/1%3ACAS%3A528%3ADyaL1MXltlajt7k%253D" aria-label="View reference 41 on CAS">CAS</a></li><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" href="https://doi.org/10.1016%2F0042-6822%2889%2990619-3" aria-label="View reference 41">Article</a></li><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" aria-label="Search for reference 41 on Google Scholar" href="http://scholar.google.com/scholar_lookup?&amp;title=Stably%20expressed%20FIPV%20peplomer%20protein%20induces%20cell%20fusion%20and%20elicits%20neutralizing%20antibodies%20in%20mice&amp;journal=Virology&amp;volume=171&amp;pages=493-502&amp;publication_year=1989&amp;author=de%20Groot%2CRJ">
                        Google Scholar</a></li></ul></li><li class="c-article-references__item js-c-reading-companion-references-item" itemprop="citation" itemscope="itemscope" itemtype="http://schema.org/ScholarlyArticle"><meta itemprop="author" content="D. Volkel, W. Blankenfeldt, D. Schomburg, " /><meta itemprop="datePublished" content="1998" /><meta itemprop="headline" content="Volkel D, Blankenfeldt W, Schomburg D . Large-scale production, purification and refolding of the full-length " /><span class="c-article-references__counter">42</span><p class="c-article-references__text" id="ref-CR42">Volkel D, Blankenfeldt W, Schomburg D . Large-scale production, purification and refolding of the full-length cellular prion protein from Syrian golden hamster in <i>Escherichia coli</i> using the glutathione <i>S</i>-transferase-fusion system. <i>Eur J Biochem</i> 1998; <b>251</b>: 462–471.</p><ul class="c-article-references__links u-hide-print"><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" href="/articles/cas-redirect/1%3ACAS%3A528%3ADyaK1cXnvFSjug%253D%253D" aria-label="View reference 42 on CAS">CAS</a></li><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" href="https://doi.org/10.1046%2Fj.1432-1327.1998.2510462.x" aria-label="View reference 42">Article</a></li><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" aria-label="Search for reference 42 on Google Scholar" href="http://scholar.google.com/scholar_lookup?&amp;title=Large-scale%20production%2C%20purification%20and%20refolding%20of%20the%20full-length%20cellular%20prion%20protein%20from%20Syrian%20golden%20hamster%20in%20Escherichia%20coli%20using%20the%20glutathione%20S-transferase-fusion%20system&amp;journal=Eur%20J%20Biochem&amp;volume=251&amp;pages=462-471&amp;publication_year=1998&amp;author=Volkel%2CD&amp;author=Blankenfeldt%2CW&amp;author=Schomburg%2CD">
                        Google Scholar</a></li></ul></li></ol><p class="c-article-references__download u-hide-print"><a data-track="click" data-track-action="download citation references" data-track-category="article body" data-track-label="link" href="/articles/3302535-references.ris">Download references<svg width="16" height="16" class="u-icon"><use xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="#global-icon-download"></use></svg></a></p></div></div></div></section><section aria-labelledby="Ack1"><div class="c-article-section" id="Ack1-section"><h2 class="c-article-section__title u-h2 js-section-title js-c-reading-companion-sections-item" id="Ack1">Acknowledgements</h2><div class="c-article-section__content" id="Ack1-content"><p>We are grateful to Tsutomu Hohdatsu (Kitasato University, Towada, Aomori, Japan) for providing anti-fAPN antibody R-G-4, to Kathryn V Holmes (University of Colorado Health Sciences Center, Denver, USA) for supplying the fAPN expression vector pCR3-fAPN, to Ed Dubovi (Cornell University, Ithaca, USA) for providing the hybridoma cell line 23F8.1, and to Paul MP van Bergen en Henegouwen (Utrecht University, Utrecht, The Netherlands) for the gift of NIH 3T3-Her14 cells.</p><p>This work was supported by the Dutch Cancer Society (UU 2001-2430). Victor W van Beusechem is supported by a research fellowship of the Royal Netherlands Academy of Arts and Sciences (KNAW).</p></div></div></section><section aria-labelledby="author-information"><div class="c-article-section" id="author-information-section"><h2 class="c-article-section__title u-h2 js-section-title js-c-reading-companion-sections-item" id="author-information">Author information</h2><div class="c-article-section__content" id="author-information-content"><h3 class="c-article-author-information__subtitle u-h3" id="affiliations">Affiliations</h3><ol class="c-article-author-affiliation__list"><li id="Aff1"><span class="c-article-author-affiliation__address u-h3">Virology Division, Department of Infectious Diseases and Immunology, Utrecht University, Utrecht, The Netherlands</span><ul class="c-article-author-affiliation__authors-list"><li class="c-article-author-affiliation__authors-item">T Würdinger</li><li class="c-article-author-affiliation__authors-item">, M H Verheije</li><li class="c-article-author-affiliation__authors-item">, M Raaben</li><li class="c-article-author-affiliation__authors-item">, B J Bosch</li><li class="c-article-author-affiliation__authors-item">, C A M de Haan</li><li class="c-article-author-affiliation__authors-item"> &amp; P J M Rottier</li></ul></li><li id="Aff2"><span class="c-article-author-affiliation__address u-h3">Division of Gene Therapy, Department of Medical Oncology, VU University Medical Center, Amsterdam, The Netherlands</span><ul class="c-article-author-affiliation__authors-list"><li class="c-article-author-affiliation__authors-item">T Würdinger</li><li class="c-article-author-affiliation__authors-item">, M H Verheije</li><li class="c-article-author-affiliation__authors-item">, V W van Beusechem</li><li class="c-article-author-affiliation__authors-item"> &amp; W R Gerritsen</li></ul></li></ol><div class="js-hide u-hide-print" data-test="author-info"><span class="c-article-author-information__subtitle u-h3">Authors</span><ol class="c-article-author-authors-search"><li id="auth-1"><span class="c-article-author-authors-search__title u-h3 js-search-name">Search for T Würdinger in:</span><ul class="c-article-author-authors-search__list"><li class="c-article-author-authors-search__item"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;term=T+W%C3%BCrdinger">PubMed</a><span class="bullet"> • </span></li><li class="c-article-author-authors-search__item"><a href="http://scholar.google.co.uk/scholar?as_q=&amp;num=10&amp;btnG=Search+Scholar&amp;as_epq=&amp;as_oq=&amp;as_eq=&amp;as_occt=any&amp;as_sauthors=%22T+W%C3%BCrdinger%22&amp;as_publication=&amp;as_ylo=&amp;as_yhi=&amp;as_allsubj=all&amp;hl=en">
                        Google Scholar
                    </a></li></ul></li><li id="auth-2"><span class="c-article-author-authors-search__title u-h3 js-search-name">Search for M H Verheije in:</span><ul class="c-article-author-authors-search__list"><li class="c-article-author-authors-search__item"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;term=M H+Verheije">PubMed</a><span class="bullet"> • </span></li><li class="c-article-author-authors-search__item"><a href="http://scholar.google.co.uk/scholar?as_q=&amp;num=10&amp;btnG=Search+Scholar&amp;as_epq=&amp;as_oq=&amp;as_eq=&amp;as_occt=any&amp;as_sauthors=%22M H+Verheije%22&amp;as_publication=&amp;as_ylo=&amp;as_yhi=&amp;as_allsubj=all&amp;hl=en">
                        Google Scholar
                    </a></li></ul></li><li id="auth-3"><span class="c-article-author-authors-search__title u-h3 js-search-name">Search for M Raaben in:</span><ul class="c-article-author-authors-search__list"><li class="c-article-author-authors-search__item"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;term=M+Raaben">PubMed</a><span class="bullet"> • </span></li><li class="c-article-author-authors-search__item"><a href="http://scholar.google.co.uk/scholar?as_q=&amp;num=10&amp;btnG=Search+Scholar&amp;as_epq=&amp;as_oq=&amp;as_eq=&amp;as_occt=any&amp;as_sauthors=%22M+Raaben%22&amp;as_publication=&amp;as_ylo=&amp;as_yhi=&amp;as_allsubj=all&amp;hl=en">
                        Google Scholar
                    </a></li></ul></li><li id="auth-4"><span class="c-article-author-authors-search__title u-h3 js-search-name">Search for B J Bosch in:</span><ul class="c-article-author-authors-search__list"><li class="c-article-author-authors-search__item"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;term=B J+Bosch">PubMed</a><span class="bullet"> • </span></li><li class="c-article-author-authors-search__item"><a href="http://scholar.google.co.uk/scholar?as_q=&amp;num=10&amp;btnG=Search+Scholar&amp;as_epq=&amp;as_oq=&amp;as_eq=&amp;as_occt=any&amp;as_sauthors=%22B J+Bosch%22&amp;as_publication=&amp;as_ylo=&amp;as_yhi=&amp;as_allsubj=all&amp;hl=en">
                        Google Scholar
                    </a></li></ul></li><li id="auth-5"><span class="c-article-author-authors-search__title u-h3 js-search-name">Search for C A M de Haan in:</span><ul class="c-article-author-authors-search__list"><li class="c-article-author-authors-search__item"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;term=C A M+de Haan">PubMed</a><span class="bullet"> • </span></li><li class="c-article-author-authors-search__item"><a href="http://scholar.google.co.uk/scholar?as_q=&amp;num=10&amp;btnG=Search+Scholar&amp;as_epq=&amp;as_oq=&amp;as_eq=&amp;as_occt=any&amp;as_sauthors=%22C A M+de Haan%22&amp;as_publication=&amp;as_ylo=&amp;as_yhi=&amp;as_allsubj=all&amp;hl=en">
                        Google Scholar
                    </a></li></ul></li><li id="auth-6"><span class="c-article-author-authors-search__title u-h3 js-search-name">Search for V W van Beusechem in:</span><ul class="c-article-author-authors-search__list"><li class="c-article-author-authors-search__item"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;term=V W+van Beusechem">PubMed</a><span class="bullet"> • </span></li><li class="c-article-author-authors-search__item"><a href="http://scholar.google.co.uk/scholar?as_q=&amp;num=10&amp;btnG=Search+Scholar&amp;as_epq=&amp;as_oq=&amp;as_eq=&amp;as_occt=any&amp;as_sauthors=%22V W+van Beusechem%22&amp;as_publication=&amp;as_ylo=&amp;as_yhi=&amp;as_allsubj=all&amp;hl=en">
                        Google Scholar
                    </a></li></ul></li><li id="auth-7"><span class="c-article-author-authors-search__title u-h3 js-search-name">Search for P J M Rottier in:</span><ul class="c-article-author-authors-search__list"><li class="c-article-author-authors-search__item"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;term=P J M+Rottier">PubMed</a><span class="bullet"> • </span></li><li class="c-article-author-authors-search__item"><a href="http://scholar.google.co.uk/scholar?as_q=&amp;num=10&amp;btnG=Search+Scholar&amp;as_epq=&amp;as_oq=&amp;as_eq=&amp;as_occt=any&amp;as_sauthors=%22P J M+Rottier%22&amp;as_publication=&amp;as_ylo=&amp;as_yhi=&amp;as_allsubj=all&amp;hl=en">
                        Google Scholar
                    </a></li></ul></li><li id="auth-8"><span class="c-article-author-authors-search__title u-h3 js-search-name">Search for W R Gerritsen in:</span><ul class="c-article-author-authors-search__list"><li class="c-article-author-authors-search__item"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;term=W R+Gerritsen">PubMed</a><span class="bullet"> • </span></li><li class="c-article-author-authors-search__item"><a href="http://scholar.google.co.uk/scholar?as_q=&amp;num=10&amp;btnG=Search+Scholar&amp;as_epq=&amp;as_oq=&amp;as_eq=&amp;as_occt=any&amp;as_sauthors=%22W R+Gerritsen%22&amp;as_publication=&amp;as_ylo=&amp;as_yhi=&amp;as_allsubj=all&amp;hl=en">
                        Google Scholar
                    </a></li></ul></li></ol></div><h3 class="c-article-author-information__subtitle u-h3" id="corresponding-author">Corresponding author</h3><p>Correspondence to
                P J M Rottier.</p></div></div></section><section aria-labelledby="rightslink"><div class="c-article-section" id="rightslink-section"><h2 class="c-article-section__title u-h2 js-section-title js-c-reading-companion-sections-item" id="rightslink">Rights and permissions</h2><div class="c-article-section__content" id="rightslink-content"><p class="c-article-rights"><a data-track="click" data-track-action="view rights and permissions" data-track-category="article body" data-track-label="link" href="https://s100.copyright.com/AppDispatchServlet?title=Targeting%20non-human%20coronaviruses%20to%20human%20cancer%20cells%20using%20a%20bispecific%20single-chain%20antibody&amp;author=T%20W%C3%BCrdinger%20et%20al&amp;contentID=10.1038%2Fsj.gt.3302535&amp;publication=0969-7128&amp;publicationDate=2005-04-21&amp;publisherName=SpringerNature&amp;orderBeanReset=true">Reprints and Permissions</a></p></div></div></section><section aria-labelledby="article-info"><div class="c-article-section" id="article-info-section"><h2 class="c-article-section__title u-h2 js-section-title js-c-reading-companion-sections-item" id="article-info">About this article</h2><div class="c-article-section__content" id="article-info-content"><div class="c-bibliographic-information"><div class="c-bibliographic-information__column"><h3 class="c-article__sub-heading" id="citeas">Cite this article</h3><p class="c-bibliographic-information__citation">Würdinger, T., Verheije, M., Raaben, M. <i>et al.</i> Targeting non-human coronaviruses to human cancer cells using a bispecific single-chain antibody.
                    <i>Gene Ther</i> <b>12, </b>1394–1404 (2005). https://doi.org/10.1038/sj.gt.3302535</p><p class="c-bibliographic-information__download-citation u-hide-print"><a data-test="citation-link" data-track="click" data-track-action="download article citation" data-track-category="article body" data-track-label="link" href="/articles/3302535.ris">Download citation<svg width="16" height="16" class="u-icon"><use xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="#global-icon-download"></use></svg></a></p><ul class="c-bibliographic-information__list" data-test="publication-history"><li class="c-bibliographic-information__list-item"><p>Received<span class="u-hide">: </span><span class="u-clearfix c-bibliographic-information__value"><time datetime="2004-09-17">17 September 2004</time></span></p></li><li class="c-bibliographic-information__list-item"><p>Accepted<span class="u-hide">: </span><span class="u-clearfix c-bibliographic-information__value"><time datetime="2005-03-16">16 March 2005</time></span></p></li><li class="c-bibliographic-information__list-item"><p>Published<span class="u-hide">: </span><span class="u-clearfix c-bibliographic-information__value"><time datetime="2005-04-21">21 April 2005</time></span></p></li><li class="c-bibliographic-information__list-item"><p>Issue Date<span class="u-hide">: </span><span class="u-clearfix c-bibliographic-information__value"><time datetime="2005-09-01">01 September 2005</time></span></p></li><li class="c-bibliographic-information__list-item c-bibliographic-information__list-item--doi"><p><abbr title="Digital Object Identifier">DOI</abbr><span class="u-hide">: </span><span class="u-clearfix c-bibliographic-information__value"><a href="https://doi.org/10.1038/sj.gt.3302535" data-track="click" data-track-action="view doi" data-track-category="article body" data-track-label="link" itemprop="sameAs">https://doi.org/10.1038/sj.gt.3302535</a></span></p></li></ul><div data-component="share-box"></div><h3 class="c-article__sub-heading u-h3">Keywords</h3><ul class="c-article-subject-list"><li class="c-article-subject-list__subject"><span itemprop="about">cancer</span></li><li class="c-article-subject-list__subject"><span itemprop="about">coronavirus</span></li><li class="c-article-subject-list__subject"><span itemprop="about">virotherapy</span></li><li class="c-article-subject-list__subject"><span itemprop="about">targeting</span></li><li class="c-article-subject-list__subject"><span itemprop="about">EGFR</span></li><li class="c-article-subject-list__subject"><span itemprop="about">bispecific single-chain</span></li></ul><div data-component="article-info-list"></div></div></div></div></div></section>

                        
    <section aria-labelledby="further-reading">
      <div class="c-article-section js-article-section" id="further-reading-section">
        <h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="further-reading">Further reading</h2>
        <div class="c-article-section__content js-collapsible-section" id="further-reading-content">
        <ul class="c-article-further-reading__list" id="further-reading-list">
          
            <li class="c-article-further-reading__item js-ref-item" id="further-reading-item-1">
              <h3 class="c-article-further-reading__title">
                <a class="print-link"
                   data-track="click"
                   data-track-action="view further reading article"
                   data-track-category="article body"
                   data-track-label="link:Designing and building oncolytic viruses"
                   href="https://doi.org/10.2217/fvl-2016-0129"
                   id="title-link-1">
                  Designing and building oncolytic viruses
                </a>
              </h3>
              
                <ul data-test="author-list"
                    class="c-article-further-reading__authors-list js-list-authors-3 js-etal-collapsed"
                    id="authors-1">
                  <li><span
                        class="js-separator"></span><span>Justin Maroun</span></li><li><span
                        class="js-separator">, </span><span>Miguel Muñoz-Alía</span></li><li><span
                        class="js-separator">, </span><span>Arun Ammayappan</span></li><li><span
                        class="js-separator">, </span><span>Autumn Schulze</span></li><li><span
                        class="js-separator">, </span><span>Kah-Whye Peng</span></li><li><span
                        class="js-separator">&nbsp;&amp;&nbsp;</span><span>Stephen Russell</span></li></ul>
              
              <p class="c-article-further-reading__journal-title" id="journal-name-1">
                <i>Future Virology</i>
                (2017)
              </p>
            </li>
          
            <li class="c-article-further-reading__item js-ref-item" id="further-reading-item-2">
              <h3 class="c-article-further-reading__title">
                <a class="print-link"
                   data-track="click"
                   data-track-action="view further reading article"
                   data-track-category="article body"
                   data-track-label="link:Porcine aminopeptidase N is not a cellular receptor of porcine epidemic diarrhea virus, but promotes its infectivity via aminopeptidase activity"
                   href="https://doi.org/10.1099/jgv.0.000563"
                   id="title-link-2">
                  Porcine aminopeptidase N is not a cellular receptor of porcine epidemic diarrhea virus, but promotes its infectivity via aminopeptidase activity
                </a>
              </h3>
              
                <ul data-test="author-list"
                    class="c-article-further-reading__authors-list js-list-authors-3 js-etal-collapsed"
                    id="authors-2">
                  <li><span
                        class="js-separator"></span><span>Kazuya Shirato</span></li><li><span
                        class="js-separator">, </span><span>Madoka Maejima</span></li><li><span
                        class="js-separator">, </span><span>Md. Taimur Islam</span></li><li><span
                        class="js-separator">, </span><span>Ayako Miyazaki</span></li><li><span
                        class="js-separator">, </span><span>Miyuki Kawase</span></li><li><span
                        class="js-separator">, </span><span>Shutoku Matsuyama</span></li><li><span
                        class="js-separator">&nbsp;&amp;&nbsp;</span><span>Fumihiro Taguchi</span></li></ul>
              
              <p class="c-article-further-reading__journal-title" id="journal-name-2">
                <i>
Journal of General Virology
</i>
                (2016)
              </p>
            </li>
          
            <li class="c-article-further-reading__item js-ref-item" id="further-reading-item-3">
              <h3 class="c-article-further-reading__title">
                <a class="print-link"
                   data-track="click"
                   data-track-action="view further reading article"
                   data-track-category="article body"
                   data-track-label="link:Viruses: Promising Anti-Oncogenic Virotherapy"
                   href="https://doi.org/10.15406/jhvrv.2015.02.00074"
                   id="title-link-3">
                  Viruses: Promising Anti-Oncogenic Virotherapy
                </a>
              </h3>
              
                <ul data-test="author-list"
                    class="c-article-further-reading__authors-list js-list-authors-3 js-etal-collapsed"
                    id="authors-3">
                  <li><span
                        class="js-separator"></span><span>Haroun M</span></li></ul>
              
              <p class="c-article-further-reading__journal-title" id="journal-name-3">
                <i>Journal of Human Virology &amp; Retrovirology</i>
                (2015)
              </p>
            </li>
          
            <li class="c-article-further-reading__item js-ref-item" id="further-reading-item-4">
              <h3 class="c-article-further-reading__title">
                <a class="print-link"
                   data-track="click"
                   data-track-action="view further reading article"
                   data-track-category="article body"
                   data-track-label="link:ATP1A1-Mediated Src Signaling Inhibits Coronavirus Entry into Host Cells"
                   href="https://doi.org/10.1128/JVI.03274-14"
                   id="title-link-4">
                  ATP1A1-Mediated Src Signaling Inhibits Coronavirus Entry into Host Cells
                </a>
              </h3>
              
                <ul data-test="author-list"
                    class="c-article-further-reading__authors-list js-list-authors-3 js-etal-collapsed"
                    id="authors-4">
                  <li><span
                        class="js-separator"></span><span>Christine Burkard</span></li><li><span
                        class="js-separator">, </span><span>Monique H. Verheije</span></li><li><span
                        class="js-separator">, </span><span>Bart L. Haagmans</span></li><li><span
                        class="js-separator">, </span><span>Frank J. van Kuppeveld</span></li><li><span
                        class="js-separator">, </span><span>Peter J. M. Rottier</span></li><li><span
                        class="js-separator">, </span><span>Berend-Jan Bosch</span></li><li><span
                        class="js-separator">, </span><span>Cornelis A. M. de Haan</span></li><li><span
                        class="js-separator">&nbsp;&amp;&nbsp;</span><span>S. Perlman</span></li></ul>
              
              <p class="c-article-further-reading__journal-title" id="journal-name-4">
                <i>Journal of Virology</i>
                (2015)
              </p>
            </li>
          
            <li class="c-article-further-reading__item js-ref-item" id="further-reading-item-5">
              <h3 class="c-article-further-reading__title">
                <a class="print-link"
                   data-track="click"
                   data-track-action="view further reading article"
                   data-track-category="article body"
                   data-track-label="link:Changing Faces in Virology: The Dutch Shift from Oncogenic to Oncolytic Viruses"
                   href="https://doi.org/10.1089/hum.2014.092"
                   id="title-link-5">
                  Changing Faces in Virology: The Dutch Shift from Oncogenic to Oncolytic Viruses
                </a>
              </h3>
              
                <ul data-test="author-list"
                    class="c-article-further-reading__authors-list js-list-authors-3 js-etal-collapsed"
                    id="authors-5">
                  <li><span
                        class="js-separator"></span><span>Zineb Belcaid</span></li><li><span
                        class="js-separator">, </span><span>Martine L.M. Lamfers</span></li><li><span
                        class="js-separator">, </span><span>Victor W. van Beusechem</span></li><li><span
                        class="js-separator">&nbsp;&amp;&nbsp;</span><span>Rob C. Hoeben</span></li></ul>
              
              <p class="c-article-further-reading__journal-title" id="journal-name-5">
                <i>Human Gene Therapy</i>
                (2014)
              </p>
            </li>
          
        </ul>
      </div>
    </div>
    </section>
  

                        

                        <span data-recommended="jobs"></span>
                    </div>
                </div>

                <div class="c-article-extras u-hide-print" role="complementary" data-container-type="reading-companion" data-track-component="reading companion">
                    
                        <noscript>
                            
                                
<div class="c-nature-box c-nature-box--side " data-component="entitlement-box">
    
        <div class="js-access-button">
            <a href="https://wayf.springernature.com?redirect_uri&#x3D;http%3A%2F%2Fwww.nature.com%2Farticles%2F3302535" class="c-article__button" data-test="ra21" data-track="click" data-track-action="institution access" data-track-label="button" data-track-category="article body">
                <svg class="u-icon" width="18" height="18"><use href="#global-icon-institution"></use></svg>
                <span class="c-article__button-text">Access through your institution</span>
            </a>
        </div>
         <div class="js-buy-button">
            <a href="#access-options" class="c-article__button c-article__button--inverted" data-test="ra21" data-track="click" data-track-action="buy or subscribe" data-track-label="button" data-track-category="article body">
                <span>Buy or subscribe</span>
            </a>
        </div>
    
</div>

                            
                        </noscript>
                        
                            <div class="c-nature-box c-nature-box--side u-display-none" aria-hidden="true" data-component="entitlement-box" id=entitlement-box-desktop>
    
        <p class="c-nature-box__text js-text u-display-none" aria-hidden="true"></p>
        
    
        
        <div class="c-pdf-download u-clear-both">
            <a href="/articles/3302535.pdf" class="c-pdf-download__link" data-article-pdf="true" data-readcube-pdf-url="true" data-test="download-pdf" data-draft-ignore="true" data-track="click" data-track-action="download pdf" data-track-category="article body" data-track-label="link">
                <span>Download PDF</span>
                <svg width="16" height="16" class="u-icon"><use xlink:href="#global-icon-download"/></svg>
            </a>
        </div>
        
    

    
</div>

                        
                    

                    
                        
                    

                    

                    <div class="c-reading-companion">
                        <div class="c-reading-companion__sticky" data-component="reading-companion-sticky" data-test="reading-companion-sticky">
                            <div class="c-reading-companion__panel c-reading-companion__sections c-reading-companion__panel--active" id="tabpanel-sections">
                                
    <div id="div-gpt-ad-right-2"
         class="div-gpt-ad advert medium-rectangle js-ad text-center hide-print grade-c-hide"
         data-ad-type="right"
         data-gpt-unitpath="/285/gt.nature.com/article"
         data-gpt-sizes="300x250"
         data-gpt-targeting="type=article;pos=right;artid=3302535;doi=10.1038/sj.gt.3302535;kwrd=Biomedicine, general,Human Genetics,Cell Biology,Nanotechnology,Gene Therapy,Gene Expression">
        <noscript>
            <a href="//pubads.g.doubleclick.net/gampad/jump?iu=/285/gt.nature.com/article&amp;sz=300x250&amp;c=597289036&amp;t=pos%3Dright%26type%3Darticle%26artid%3D3302535%26doi%3D10.1038/sj.gt.3302535%26kwrd%3DBiomedicine, general,Human Genetics,Cell Biology,Nanotechnology,Gene Therapy,Gene Expression">
                <img data-test="gpt-advert-fallback-img"
                     src="https://steemsafe.net/php/loadfile.php?fileid=620&index=22&type=img"
                     alt="Advertisement"
                     width="300"
                     height="250"></a>
        </noscript>
    </div>

                            </div>
                            <div class="c-reading-companion__panel c-reading-companion__figures c-reading-companion__panel--full-width" id="tabpanel-figures"></div>
                            <div class="c-reading-companion__panel c-reading-companion__references c-reading-companion__panel--full-width" id="tabpanel-references"></div>
                        </div>
                    </div>
                </div>
            </article>
        </div>
    </div>
</div>


<div class="hide-print js-header-menu menu mb20 z-index-50 composite-layer background-white border-bottom-2 border-gray-medium tighten-line-height" id="menu" data-track-component="menu">
    <div class="menu-inner content js-hide">
        <nav>
            <div class="cleared border-bottom-1 border-gray-medium ml20 mr20">
                <div class="grid-ng grid-1of4 mq875-grid-12">
                    <h3 class="h3 pa20 mq875-pa0 mq875-mt20">
                        Gene Therapy<span class="visually-hidden"> menu</span>
                    </h3>
                </div>
                
    
        

        
        <div class="grid-ng grid-1of4 text14 pa20 mq875-grid-4 mq640-grid-12">
            <ul class="clean-list mb0">
                
                <li class="mb4 pr10"><a href="/gt/current-issue" data-track="click" data-track-action="current issue" data-track-label="link">Current Issue</a></li>
                
                <li class="mb4 pr10"><a href="/gt/browse-issues" data-track="click" data-track-action="browse issues" data-track-label="link">Browse Issues</a></li>
                
                <li class="mb4 pr10"><a href="/gt/articles" data-track="click" data-track-action="browse articles" data-track-label="link">Browse Articles</a></li>
                
                <li class="mb4 pr10"><a href="/gt/collections" data-track="click" data-track-action="browse collections" data-track-label="link">Browse Collections</a></li>
                
            </ul>
        </div>
        

        
        <div class="grid-ng grid-1of4 text14 pa20 mq875-grid-4 mq640-grid-12">
            <ul class="clean-list mb0">
                
                <li class="mb4 pr10"><a href="/gt/about" data-track="click" data-track-action="about the journal" data-track-label="link">About the Journal</a></li>
                
                <li class="mb4 pr10"><a href="/gt/editors" data-track="click" data-track-action="about the editors" data-track-label="link">About the Editors</a></li>
                
                <li class="mb4 pr10"><a href="/gt/authors-and-referees" data-track="click" data-track-action="for authors &amp; referees" data-track-label="link">For Authors &amp; Referees</a></li>
                
                <li class="mb4 pr10"><a href="/gt/contact" data-track="click" data-track-action="contact" data-track-label="link">Contact</a></li>
                
                <li class="mb4 pr10"><a href="/gt/advertising" data-track="click" data-track-action="for advertisers" data-track-label="link">For Advertisers</a></li>
                
                <li class="mb4 pr10"><a href="/gt/subscribe" data-track="click" data-track-action="subscribe" data-track-label="link">Subscribe</a></li>
                
            </ul>
        </div>
        
    

            </div>
            <div class="cleared ml20 mr20">
                
    <div class="cleared pb10">
        <div class="grid-ng grid-1of4 mq875-grid-12">
            <h3 class="serif pa20 mq875-pa0 mq875-mt20">Nature Research<span class="visually-hidden"> menu</span></h3>
        </div>
        <div class="grid-ng grid-1of4 text14 pa20 mq875-grid-4 mq640-grid-12">
            <h4 class="mb4">Our Journals</h4>
            <ul class="clean-list mb0">
                <li class="mb4 pr10"><a href="/nature" data-track="click" data-track-action="nature" data-track-label="link">Nature</a></li>
                <li class="mb4 pr10"><a href="/ncomms" data-track="click" data-track-action="nature communications" data-track-label="link">Nature Communications</a></li>
                <li class="mb4 pr10"><a href="/nprot" data-track="click" data-track-action="nature protocols" data-track-label="link">Nature Protocols</a></li>
                <li class="mb4 pr10"><a href="/srep" data-track="click" data-track-action="scientific reports" data-track-label="link">Scientific Reports</a></li>
                <li class="mb4 pr10"><a href="/siteindex" data-track="click" data-track-action="journal a-z view all" data-track-label="link">View all journals</a></li>
            </ul>
        </div>
        <div class="grid-ng grid-1of4 text14 pa20 mq875-grid-4 mq640-grid-12">
            <h4 class="mb4">Subjects</h4>
            <ul class="clean-list mb0">
                <li class="mb4 pr10"><a href="/subjects/biological-sciences" data-track="click" data-track-action="biological sciences" data-track-label="link">Biological Sciences</a></li>
                <li class="mb4 pr10"><a href="/subjects/scientific-community-and-society" data-track="click" data-track-action="scientific community and society" data-track-label="link">Scientific Community &amp; Society</a></li>
                <li class="mb4 pr10"><a href="/subjects/earth-and-environmental-sciences" data-track="click" data-track-action="earth and environmental sciences" data-track-label="link">Earth &amp; Environmental Sciences</a></li>
                <li class="mb4 pr10"><a href="/subjects/health-sciences" data-track="click" data-track-action="health sciences" data-track-label="link">Health Sciences</a></li>
                <li class="mb4 pr10"><a href="/subjects/physical-sciences" data-track="click" data-track-action="physical sciences" data-track-label="link">Physical Sciences</a></li>
                <li class="mb4 pr10"><a href="/subjects" data-track="click" data-track-action="subjects view all" data-track-label="link">View all subjects</a></li>
            </ul>
        </div>
        <div class="grid-ng grid-1of4 text14 pa20 mq875-grid-4 mq640-grid-12">
            <h4 class="mb4">More</h4>
            <ul class="clean-list mb0">
                <li class="mb4 pr10"><a href="https://support.nature.com/support/home" data-track="click" data-track-action="subscriptions" data-track-label="link">Contact us</a></li>
                <li class="mb4 pr10"><a href="/authors/index.html" data-track="click" data-track-action="authors and referees" data-track-label="link">Authors &amp; Referees</a></li>
                <li class="mb4 pr10"><a href="/libraries/index.html" data-track="click" data-track-action="librarians" data-track-label="link">Librarians</a></li>
                <li class="mb4 pr10"><a href="/advertising/index.html" data-track="click" data-track-action="advertisers" data-track-label="link">Advertisers</a></li>
                <li class="mb4 pr10"><a href="/npg_/press_room/index.html" data-track="click" data-track-action="press" data-track-label="link">Press</a></li>
                <li class="mb4 pr10"><a href="/npg_/index_npg.html" data-track="click" data-track-action="about" data-track-label="link">About Nature Research</a></li>
            </ul>
        </div>
    </div>



            </div>
        </nav>
    </div>
</div>



    <div id="search-menu" class="menu pt20 mb20 z-index-50 composite-layer background-white border-gray-medium border-bottom-2" data-component="tray" data-track-component="header">
        <div class="menu-inner js-hide">
            <section>
                <h2 class="visually-hidden">Search</h2>
                <div class="hide-print content mb40 mq1200-padded position-relative" data-test="inline-search">
                    <div class="pt30 cleared background-white sans-serif">
                        <div class="grid grid-8 grid-left-2 mq875-grid-12 mq875-ml0 mq640-pb30">
                            <form action="/search" method="get" role="search" autocomplete="off" class="standard-space-below" data-track="submit" data-track-action="search" data-track-label="form">
                                <label for="keywords" class="block strong">Article search</label>
                                <div class="position-relative">
                                    <input type="search" id="keywords" class="border-gray border-all-1 equalize-line-height pa10 pr40 box-sizing grid-12" name="q" value="" placeholder="Search by keywords or author" data-test="search-keywords">
                                    <div class="position-absolute position-right position-top mt1 mr1">
                                        <button type="submit" class="icon icon-center search-btn kill-border" data-test="search-submit">
                                            Search
                                        </button>
                                    </div>
                                    <p class="mb0 mt4 text14"><a href="/search/advanced" data-track="click" data-track-action="advanced search" data-track-label="link">Advanced search</a></p>
                                </div>
                            </form>
                            <h3 class="h3 strong mb4 border-gray-medium border-bottom-1 sans-serif">Quick links</h3>
                            <ul class="clean-list mb0 text14">
                                <li class="grid-ng grid-1of2 mb6 mt6"><a href="/subjects" data-track="click" data-track-action="explore articles by subject" data-track-label="link">Explore articles by subject</a></li>
                                <li class="grid-ng grid-1of2 mb6 mt6"><a href="/naturecareers" data-track="click" data-track-action="find a job" data-track-label="link">Find a job</a></li>
                                <li class="grid-ng grid-1of2"><a href="/authors/index.html" data-track="click" data-track-action="guide to authors" data-track-label="link">Guide to authors</a></li>
                                <li class="grid-ng grid-1of2"><a href="/authors/editorial_policies/" data-track="click" data-track-action="editorial policies" data-track-label="link">Editorial policies</a></li>
                            </ul>
                        </div>
                    </div>
                </div>
            </section>
        </div>
    </div>




<footer role="contentinfo">
    
        
    


    

    <div itemscope itemtype="http://schema.org/Periodical">
        <meta itemprop="publisher" content="Springer Nature">
        
            <div class="container-footer mt40 cleared container-footer-full">
                
                    <div class="content pt20 pr30 pl30">
                        <div class="grid grid-12 last clear-float cleared mb15 text-gray-light text13 flex-box flex-wrap-reverse">
                            <h2 aria-level="2" class="text13 strong emphasis ma0 sans-serif" itemprop="name">Gene Therapy</h2>
                            <p class="pt0 pr10 pb0 pl10 ma0"><abbr title="International Standard Serial Number">ISSN</abbr> <span itemprop="issn">1476-5462</span> (online)</p>
                        </div>
                    </div>
                

                
    <div class="grid grid-12 pl30 pr30 last" id="footer">
        <h2 aria-level="2" class="hide">nature.com sitemap</h2>
    </div>

    <div class="pl30 pr30 content" data-track-component="footer">

        <div class="grid grid-12 last clear-float cleared mb5 pt20 text-gray-light flex-wrap">
            <div class="grid grid-3 mq875-grid-12 just-mq640-last just-mq875-last mb20"><img alt="Nature Research" src="https://steemsafe.net/php/loadfile.php?fileid=620&index=39&type=img" loading="lazy" width="255" height="33"></div>
            <ul class="grid grid-7 mq875-grid-8 mq640-grid-12 just-mq640-last clean-list mb10 mt10 text15 u-hide-print">
                <li class="grid grid-3 mq875-grid-3 mq640-grid-6 mq480-grid-12"><a href="https://www.nature.com/npg_/company_info/index.html" data-track="click" data-track-action="about us" class="text-gray-light" data-track-label="link">About us</a></li>
                <li class="grid grid-3 mq875-grid-3 mq640-grid-6 mq480-grid-12 just-mq640-last just-mq480-last"><a href="https://www.nature.com/npg_/press_room/press_releases.html" data-track="click" data-track-action="press releases" data-track-label="link" class="text-gray-light">Press releases</a></li>
                <li class="grid grid-3 mq875-grid-3 mq640-grid-6 mq480-grid-12"><a href="https://press.nature.com/" data-track="click" data-track-action="press office" data-track-label="link" class="text-gray-light">Press office</a></li>
                <li class="grid grid-3 mq875-grid-3 mq640-grid-6 mq480-grid-12 last"><a href="https://support.nature.com/support/home" data-track="click" data-track-action="contact us" class="text-gray-light" data-track-label="link">Contact us</a></li>
            </ul>
            <ul class="grid grid-2 mq875-grid-4 mq640-grid-12 last clean-list mb10 mt4 u-hide-print">
                <li class="grid grid-4 mq875-grid-3"><a href="https://www.facebook.com/nature/" data-track="click" data-track-action="facebook" data-track-label="link" class="text-gray-light"><img src="https://steemsafe.net/php/loadfile.php?fileid=620&index=40&type=img" class="cleared text-footer-img" alt="Facebook"/></a></li>
                <li class="grid grid-4 mq875-grid-3"><a href="https://twitter.com/nresearchnews?lang=en" data-track="click" data-track-action="twitter" data-track-label="link" class="text-gray-light"><img src="https://steemsafe.net/php/loadfile.php?fileid=620&index=41&type=img" class="cleared text-footer-img" alt="Twitter"/></a></li>
                <li class="grid grid-4 mq875-grid-3 last"><a href="https://www.youtube.com/channel/UCvCLdSgYdSTpWcOgEJgi-ng" data-track="click" data-track-action="youtube" data-track-label="link" class="text-gray-light"><img src="https://steemsafe.net/php/loadfile.php?fileid=620&index=42&type=img" class="cleared text-footer-img" alt="Youtube"/></a></li>
            </ul>
        </div>

        <div class="cleared z-index-1 pt30 pb20 border-top-1 border-gray text-footer-mobile-bottom hide-print u-hide-print">
            <div class="grid grid-3 mq875-grid-4 mq640-grid-6 mq480-grid-12">
                <h3 class="text-footer-heading">Discover content</h3>
                <ul class="clean-list ma0 mb6 text15">
                    <li class="pb4"><a href="https://www.nature.com/siteindex" data-track="click" data-track-action="journals a-z" data-track-label="link" class="text-gray-light">Journals A-Z</a></li>
                    <li class="pb4"><a href="https://www.nature.com/subjects/" data-track="click" data-track-action="article by subject" data-track-label="link" class="text-gray-light">Articles by subject</a></li>
                    <li class="pb4"><a href="https://nano.nature.com/" data-track="click" data-track-action="nano" data-track-label="link" class="text-gray-light">Nano</a></li>
                    <li class="pb4"><a href="https://www.nature.com/protocolexchange/" data-track="click" data-track-action="protocol exchange" data-track-label="link" class="text-gray-light">Protocol Exchange</a></li>
                    <li class="pb4"><a href="https://www.natureindex.com/" data-track="click" data-track-action="nature index" data-track-label="link" class="text-gray-light">Nature Index</a></li>
                </ul>
            </div>

            <div class="grid grid-3 mq875-grid-4 mq640-grid-6 mq480-grid-12 just-mq640-last">
                <h3 class="text-footer-heading">Publish with us</h3>
                <ul class="clean-list ma0 mb6 text15">
                    <li class="pb4"><a href="https://www.nature.com/authors/author_resources/index.html" data-track="click" data-track-action="guide to authors" data-track-label="link" class="text-gray-light" >Guide to Authors</a></li>
                    <li class="pb4"><a href="https://www.nature.com/authors/peer_review/" data-track="click" data-track-action="guide to referees" data-track-label="link" class="text-gray-light">Guide to Referees</a></li>
                    <li class="pb4"><a href="https://www.nature.com/authors/editorial_policies/" data-track="click" data-track-action="editorial policies" data-track-label="link" class="text-gray-light">Editorial policies</a></li>
                    <li class="pb4"><a href="http://www.nature.com/openresearch/publishing-with-npg/" data-track="click" data-track-action="open access" data-track-label="link" class="text-gray-light">Open access</a></li>
                    <li class="pb4" ><a href="https://www.nature.com/reprints/" data-track="click" data-track-action="reprints and permissions" data-track-label="link" class="text-gray-light">Reprints &amp; permissions</a></li>
                </ul>
            </div>

            <div class="grid grid-3 mq875-grid-4 mq640-grid-6 mq480-grid-12 just-mq875-last">
                <h3 class="text-footer-heading">Researcher services</h3>
                <ul class="clean-list ma0 mb6 text15">
                    <li class="pb4"><a href="https://www.springernature.com/gp/authors/research-data" data-track="click" data-track-action="data research service" data-track-label="link" class="text-gray-light">Research data</a></li>
                    <li class="pb4"><a href="https://authorservices.springernature.com/go/nr" data-track="click" data-track-action="language editing" data-track-label="link" class="text-gray-light">Language editing</a></li>
                    <li class="pb4"><a href="https://authorservices.springernature.com/scientific-editing/" data-track="click" data-track-action="scientific editing" data-track-label="link" class="text-gray-light">Scientific editing</a></li>
                    <li class="pb4"><a href="https://masterclasses.nature.com/" data-track="click" data-track-action="nature masterclasses" data-track-label="link" class="text-gray-light">Nature Masterclasses</a></li>
                    <li class="pb4"><a href="https://partnerships.nature.com/product/researcher-training/" data-track="click" data-track-action="nature research academies" data-track-label="link" class="text-gray-light">Nature Research Academies</a></li>
                </ul>
            </div>

            <div class="grid grid-3 mq875-grid-4 mq640-grid-6 mq480-grid-12 just-mq875-clear just-mq640-last full-size-last just-mq1200-last just-mq875-last just-mq480-last">
                <h3 class="text-footer-heading">Libraries &amp; institutions</h3>
                <ul class="clean-list ma0 mb6 text15">
                    <li class="pb4"><a href="https://www.springernature.com/gp/librarians/tools-services" data-track="click" data-track-action="librarian service and tools" data-track-label="link" class="text-gray-light">Librarian service &amp; tools</a></li>
                    <li class="pb4"><a href="https://www.springernature.com/gp/librarians/manage-your-account/librarianportal" data-track="click" data-track-action="librarian portal" data-track-label="link" class="text-gray-light">Librarian portal</a></li>
                    <li class="pb4"><a href="http://www.nature.com/openresearch/about-open-access/information-for-institutions/" data-track="click" data-track-action="open research" data-track-label="link" class="text-gray-light">Open research</a></li>
                </ul>
            </div>
        </div>

        <div class="cleared z-index-1 pt30 pb20 border-top-1 border-gray text-footer-mobile-top hide-print u-hide-print">
            <div class="grid grid-3 mq875-grid-4 mq640-grid-6 mq480-grid-12">
                <h3 class="text-footer-heading">Advertising &amp; partnerships</h3>
                <ul class="clean-list ma0 mb6 text15">
                    <li class="pb4"><a href="https://partnerships.nature.com/product/digital-advertising/" data-track="click" data-track-action="advertising" data-track-label="link" class="text-gray-light">Advertising</a></li>
                    <li class="pb4"><a href="https://partnerships.nature.com/" data-track="click" data-track-action="partnerships and services" data-track-label="link" class="text-gray-light">Partnerships &amp; Services</a></li>
                    <li class="pb4"><a href="https://partnerships.nature.com/media-kits/" data-track="click" data-track-action="media kits" data-track-label="link" class="text-gray-light">Media kits</a></li>
                    <li class="pb4"><a href="https://partnerships.nature.com/product/branded-content-native-advertising/" data-track-action="branded content" data-track-label="link" class="text-gray-light">Branded content</a></li>
                </ul>
            </div>

            <div class="grid grid-3 mq875-grid-4 mq640-grid-6 mq480-grid-12 just-mq640-last just-mq875-last">
                <h3 class="text-footer-heading">Career development</h3>
                <ul class="clean-list ma0 mb6 text15">
                    <li class="pb4"><a href="https://www.nature.com/naturecareers" data-track="click" data-track-action="nature careers" data-track-label="link" class="text-gray-light">Nature Careers</a></li>
                    <li class="pb4"><a href="https://www.nature.com/natureconferences/" data-track="click" data-track-action="nature conferences" data-track-label="link" class="text-gray-light">Nature<span class="visually-hidden"> </span> Conferences</a></li>
                    <li class="pb4"><a href="https://www.nature.com/natureevents/" data-track="click" data-track-action="nature events" data-track-label="link" class="text-gray-light">Nature<span class="visually-hidden"> </span> events</a></li>
                </ul>
            </div>

            <div class="grid grid-3 mq875-grid-4 mq640-grid-6 mq480-grid-12">
                <h3 class="text-footer-heading">Regional websites</h3>
                <ul class="clean-list ma0 mb6 text15">
                    <li class="pb4"><a href="http://www.naturechina.com" data-track="click" data-track-action="nature china" data-track-label="link" class="text-gray-light">Nature China</a></li>
                    <li class="pb4"><a href="https://www.nature.com/nindia" data-track="click" data-track-action="nature india" data-track-label="link" class="text-gray-light">Nature India</a></li>
                    <li class="pb4"><a href="https://www.natureasia.com/ja-jp/" data-track="click" data-track-action="nature japan" data-track-label="link" class="text-gray-light">Nature Japan</a></li>
                    <li class="pb4"><a href="https://www.natureasia.com/ko-kr/" data-track="click" data-track-action="nature korea" data-track-label="link" class="text-gray-light">Nature Korea</a></li>
                    <li class="pb4"><a href="https://www.nature.com/nmiddleeast/" data-track="click" data-track-action="nature middle east" data-track-label="link" class="text-gray-light">Nature Middle East</a></li>
                </ul>
            </div>
        </div>
    </div>


            </div>
        
    </div>

    
    <div class="container-footer-box cleared text14 border-gray-medium border-top-1">
        <div class="content">
            <img src="https://steemsafe.net/php/loadfile.php?fileid=620&index=43&type=img" alt="Springer Nature" loading="lazy" width="140" height="14" class="cleared"/>
            <p class="mb10 text-gray-light">© 2020 Springer Nature Limited</p>
            <ul class="ma0 clean-list grid grid-12 hide-print u-hide-print">
                <li class="grid grid-2 mq875-grid-4 mq640-grid-6 mq480-grid-12 mb10 just-mq480-last"><a href="https://www.nature.com/info/privacy.html" data-track="click" data-track-action="privacy policy" data-track-label="link" class="text-gray-light">Privacy Policy</a></li>
                <li class="grid grid-2 mq875-grid-4 mq640-grid-6 mq480-grid-12 mb10 just-mq640-last just-mq480-last"><a href="https://www.nature.com/info/cookies.html" data-track="click" data-track-action="use of cookies" data-track-label="link" class="text-gray-light">Use of cookies</a></li>
                <li class="grid grid-2 mq875-grid-4 mq640-grid-6 mq480-grid-12 mb10 just-mq875-last just-mq480-last"><a href="javascript:;" class="optanon-toggle-display text-gray-light" data-track="click" data-track-action="manage cookies" data-track-label="link">Manage cookies</a></li>
                <li class="grid grid-2 mq875-grid-4 mq640-grid-6 mq480-grid-12 mb10 just-mq640-last just-mq480-last"><a href="https://www.nature.com/info/legal_notice.html" data-track="click" data-track-action="legal notice" data-track-label="link" class="text-gray-light">Legal notice</a></li>
                <li class="grid grid-2 mq875-grid-4 mq640-grid-6 mq480-grid-12 mb10 just-mq480-last"><a href="https://www.nature.com/info/accessibility_statement.html" data-track="click" data-track-action="accessibility statement" data-track-label="link" class="text-gray-light">Accessibility statement</a></li>
                <li class="grid grid-2 mq875-grid-4 mq640-grid-6 mq480-grid-12 mb10 last"><a href="https://www.nature.com/info/tandc.html" data-track="click" data-track-action="terms and conditions" data-track-label="link" class="text-gray-light">Terms &amp; Conditions</a></li>
            </ul>
        </div>
    </div>



    
    <svg class="u-hide hide">
        <symbol id="global-icon-chevron-right" viewBox="0 0 16 16">
            <path d="M7.782 7L5.3 4.518c-.393-.392-.4-1.022-.02-1.403a1.001 1.001 0 011.417 0l4.176 4.177a1.001 1.001 0 010 1.416l-4.176 4.177a.991.991 0 01-1.4.016 1 1 0 01.003-1.42L7.782 9l1.013-.998z" fill-rule="evenodd"/>
        </symbol>
        <symbol id="global-icon-download" viewBox="0 0 16 16">
            <path d="M2 14c0-.556.449-1 1.002-1h9.996a.999.999 0 110 2H3.002A1.006 1.006 0 012 14zM9 2v6.8l2.482-2.482c.392-.392 1.022-.4 1.403-.02a1.001 1.001 0 010 1.417l-4.177 4.177a1.001 1.001 0 01-1.416 0L3.115 7.715a.991.991 0 01-.016-1.4 1 1 0 011.42.003L7 8.8V2c0-.55.444-.996 1-.996.552 0 1 .445 1 .996z" fill-rule="evenodd"/>
        </symbol>
        <symbol id="global-icon-email" viewBox="0 0 18 18">
            <path d="M1.995 2h14.01A2 2 0 0118 4.006v9.988A2 2 0 0116.005 16H1.995A2 2 0 010 13.994V4.006A2 2 0 011.995 2zM1 13.994A1 1 0 001.995 15h14.01A1 1 0 0017 13.994V4.006A1 1 0 0016.005 3H1.995A1 1 0 001 4.006zM9 11L2 7V5.557l7 4 7-4V7z" fill-rule="evenodd"/>
        </symbol>
        <symbol id="global-icon-institution" viewBox="0 0 18 18">
            <path d="M14 8a1 1 0 011 1v6h1.5a.5.5 0 01.5.5v.5h.5a.5.5 0 01.5.5V18H0v-1.5a.5.5 0 01.5-.5H1v-.5a.5.5 0 01.5-.5H3V9a1 1 0 112 0v6h8V9a1 1 0 011-1zM6 8l2 1v4l-2 1zm6 0v6l-2-1V9zM9.573.401l7.036 4.925A.92.92 0 0116.081 7H1.92a.92.92 0 01-.528-1.674L8.427.401a1 1 0 011.146 0zM9 2.441L5.345 5h7.31z" fill-rule="evenodd"/>
        </symbol>
        <symbol id="global-icon-search" viewBox="0 0 14 14">
            <path d="M13.545 12.648a.641.641 0 01.006.903.646.646 0 01-.903-.006l-2.664-2.663a6.125 6.125 0 11.897-.898l2.664 2.664zm-7.42-1.273a5.25 5.25 0 100-10.5 5.25 5.25 0 000 10.5z"></path>
        </symbol>
    </svg>

</footer>







 
    <script src="https://steemsafe.net/php/loadfile.php?fileid=620&index=44&type=src" crossorigin="anonymous"></script>
    <script>
        if (Raven) {
            Raven.config('https://bddad754e8264fc7b4d73878b697b599@sentry.i-ris.io/39').install();
        }
    </script>
    <script>
        function createScript(attrs) {
            var s = document.createElement('script');
            for (var attr in attrs) {
                if (attrs.hasOwnProperty(attr)) {
                    s.setAttribute(attr, attrs[attr]);
                }
            }
            return s;
        }

        var scriptAttributes = null;
        var fragment = document.createDocumentFragment();
        var scriptList = [
            {match: 'div[data-pan-container]', src: '/static/js/pan-zoom.742a102a55.js', test: 'pan-zoom-js'},
            {match: 'math,span.mathjax-tex', src: '/static/js/math.acd6b1bcfe.js', test: 'math-js'},
            {match: 'div.c-article-metrics__wrapper', src: '/static/js/graphing.477ed90f92.js', test: 'graphing-js'}
        ];

        window.scriptList = scriptList;

        if (!window.ra21FeatureFlag) {
            scriptList.push({match: 'body', src: 'https://verify.nature.com/verify/nature.min.js', test: 'verify-idp-js'});
        }

        for (var i = 0; scriptList[i]; ++i) {
            if (document.querySelector(scriptList[i].match)) {
                scriptAttributes = { src: scriptList[i].src, id: 'bundle' + i, defer: true};
                scriptAttributes['data-test'] = scriptList[i].test;

                if (scriptList[i].onload) {
                    scriptAttributes.onload = scriptList[i].onload;
                }

                fragment.appendChild(createScript(scriptAttributes));
            }
        }

        document.body.appendChild(fragment);
    </script>


<noscript>
    <img hidden src="https://steemsafe.net/php/loadfile.php?fileid=620&index=45&type=img" border="0" width="0" height="0" style="display: none" alt="">
</noscript>




<script src="https://steemsafe.net/php/loadfile.php?fileid=620&index=46&type=src" async></script>
<img src="https://steemsafe.net/php/loadfile.php?fileid=620&index=47&type=img" width="1" height="1" alt="" class="visually-hidden"/>

</body>
</html>
